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Abstract 
Paltamaa J. Assessment of physical functioning in ambulatory persons with 
multiple sclerosis. Aspects of reliability, responsiveness, and clinical useful-
ness in the ICF framework. Helsinki: The Social Insurance Institution, Finland, 
Studies in social security and health 93, 2008. 201 pp. ISBN 978-951-669-764-5 
(print), ISBN 978-951-669-765-2 (pdf).
The main aim of this thesis was to examine the psychometric 
properties of existing physical functioning measures and to 
assess the clinical usefulness of the measures in ambulatory 
persons with MS (PwMS). The International Classification 
of Functioning, Disability and Health (ICF) was used as a 
framework for the study. Participants were obtained from a 
population-based cohort of PwMS (n = 277) living in Central 
Finland in 2000. High proportion of the 240 PwMS who 
answered the questionnaire reported a fairly good level of 
physical functioning. The high reliability scores found showed 
that the selected clinical measures of physical functioning could 
be used with confidence in ambulatory PwMS. These measures 
along with self-reported performance in self-care, mobility, and 
domestic life were used in a 2-year prospective longitudinal 
study (n = 120). The predictors of self-reported performance 
were identified using multinomial logistic regression. The results 
revealed the value of the clinical outcome measures in detecting 
minor decrements in functioning that precede and often predict 
the onset of detectable dependence in performance. In particular, 
the clinical measures in the ICF activities component predicted 
poor performance. During the 2-year follow-up, 51% of PwMS 
reported deterioration compared to the 26% rated as deteriorated 
by the clinician. Clinically meaningful change was described 
using multiple anchor- and distribution-based estimates. The 
thesis provides recommendations for reliable, responsive 
and clinically useful physical functioning measures suitable 
for assessing ambulatory PwMS. Assessment for reducing or 
postponing functional limitations needs to be extended to those 
who are independent but perceive difficulties in performance. 
By using responsive measures it is possible to identify early 
decline and plan interventions to maintain functioning. The 
ICF was found to be helpful in supplementing the information 
provided by the measures and in describing the physical 
functioning of ambulatory PwMS.
Keywords: multiple sclerosis, physiotherapy, ICF, physical 
functioning, outcome measures, reliability, responsiveness 
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Tiivistelmä
Paltamaa J. Fyysisen toimintakyvyn arviointi kävelevillä MS-tautia  
sairastavilla henkilöillä. Mittareiden reliabiliteetti, muutosherkkyys ja 
kliininen käyttökelpoisuus ICF-viitekehyksessä. Helsinki: �ela, Sosiaali- �a    
terveysturvan tutkimuksia 93, 2008. 201 s. ISBN 978-951-669-764-5 (nid.),   
ISBN 978-951-669-765-2 (pdf). 
Tutkimuksessa selvitetään käytössä olevien fyysistä toiminta-
kykyä arvioivien mittareiden psykometrisia ominaisuuksia ja 
kliinistä käyttökelpoisuutta kävelevillä MS-tautia sairastavilla 
henkilöillä ICF-luokituksen viitekehyksessä. Tämän väestö-
tutkimuksen perusjoukko oli Keski-Suomen alueella vuonna 
2000 asuneet MS-tautia sairastavat (n = 277). Heistä kyselyyn 
vastasi 240 henkilöä, joista suuri osa koki toimintakykynsä varsin 
hyväksi. Reliabiliteettitutkimus osoitti, että valittuja fyysistä 
toimintakykyä arvioivia kliinisiä mittareita voidaan luotettavasti 
käyttää kävelevillä MS-tautia sairastavilla. Näitä mittareita käy-
tettiin kahden vuoden seurantatutkimuksessa (n = 120) yhdessä 
kyselyn kanssa, jossa tutkittava arvioi omaa suoritustasoaan 
itsestä huolehtimisessa, liikkumisessa ja kotielämässä. Koettua 
suoristustasoa ennustavia tekijöitä selvitettiin multinomiaalisen 
regressionanalyysin avulla. Kliinisillä mittareilla voitiin havaita 
vähäisiä muutoksia, jotka usein edeltävät ja ennustavat rajoituk-
sia koetussa suoritustasossa. Erityisesti ICF-luokituksen suorituk-
set-osa-alueen mittarit ennustivat huonoa suoritustasoa. Kahden 
vuoden seurannassa 51 prosenttia MS-tautia sairastavista koki 
terveydentilansa huonontuneen verrattuna niihin 26 prosent-
tiin, joiden sairauden vaikeusaste heikkeni neurologin tekemän 
arvioinnin mukaan. Kliinisesti merkitsevää muutosta kuvattiin 
useilla sekä ulkoisia kriteereitä käyttävillä että jakaumaperustei-
silla menetelmillä. Tämä väitöskirjatutkimus esittää suositukset 
reliaabeleista, muutosherkistä ja kliinisesti käyttökelpoisista mit-
tareista fyysisen toimintakyvyn arviointiin kävelevillä MS-tautia 
sairastavilla. Arviointi toiminnallisten rajoitusten vähentämiseksi 
tai lykkäämiseksi tulee ulottua myös heihin, jotka ovat itsenäisiä 
mutta kokevat vaikeuksia suoriutumisessa. Herkkiä mittareita 
käyttämällä on mahdollista tunnistaa fyysisen toimintakyvyn 
heikentyminen jo varhaisvaiheessa ja suunnitella kuntoutusta 
toimintakyvyn ylläpitämiseksi. ICF-luokitus todettiin hyödyl-
liseksi täydentämään mittareiden antamaa tietoa ja kuvaamaan 
kävelevien MS-tautia sairastavien fyysistä toimintakykyä. 
Avainsanat: MS-tauti, fysioterapia, ICF, fyysinen toimintakyky, 
mittarit, reliabiliteetti, herkkyys 
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Sammandrag
Paltamaa J. Bedömning av fysisk funktionsförmåga hos MS-sjuka personer 
med gångförmåga. Aspekter på reliabilitet, sensitivitet och klinisk användbar-
het inom referensramen för ICF-klassifikation. Helsin�fors: FP�, Social try��het    
och hälsa: Undersöknin�ar 93, 2008. 201 s. ISBN 978-951-669-764-5 (inh.),  
ISBN 978-951-669-765-2 (pdf). 
Huvudsyftet med denna avhandling var att studera psyko-
metriska egenskaper hos existerande mätare som bedömer fysisk 
funktionsförmåga och att utvärdera dessas kliniska användbar-
het vid undersökning av MS-sjuka personer med gångförmåga. 
Den internationella ICF-klassifikationen utgjorde referensram för 
undersökningen. Deltagarna valdes ut från en befolkningsbase-
rad kohort av personer med MS som bodde i Mellersta Finland 
år 2000 (n = 277). En övervägande majoritet av dessa 240 som 
svarade på förfrågan meddelade att deras fysiska funktionsnivå 
var relativt god. De höga reliabilitetsvärdena visade att de valda 
kliniska mätarna för fysisk funktionsförmåga var tillförlitliga för 
att kunna användas på MS-sjuka personer med gångförmåga. 
Dessa mätare tillsammans med ett frågeformulär om prestation 
i personlig vård, förflyttning och hemliv användes i en tvåårig 
longitudinell prospektiv studie (n = 120). Prediktorerna för själv-
rapporterade prestationer fastställdes med multinomial logistisk 
regression. Resultaten avslöjade betydelsen av mätskalorna för 
identifieringen av små funktionsnedsättningar som framträder, 
och kunde förutspå ett märkbart beroende vid prestation. Speciellt 
kliniska mätare inom ICFs aktivitetskomponent förutspår dålig 
prestation. Under den tvååriga uppföljningsperioden rapportera-
de 51 % av de MS-sjuka personerna nedsättningar, medan neuro-
logen klassificerade andelen nedsättningar till 26 %. En kliniskt 
betydelsefull förändring åskådliggjordes genom användning av 
multipla metoder. Avhandlingen ger rekommendationer om till-
förlitliga, sensitiva och kliniskt användbara mätare för mätning 
av fysisk funktionsförmåga hos MS-sjuka personer med gång-
förmåga. För att minska eller uppskjuta funktionsbegränsningar 
bör bedömningen omfatta även självständiga personer som 
uppvisar prestationssvårigheter. När sensitiva mätare används 
kan begynnande nedgång upptäckas och interventioner planeras 
för att bibehålla funktionsförmågan. ICF visade sig vara nyttig 
som komplement till den information som mätarna gav och vid 
beskrivning av fysisk funktionsförmåga hos MS-sjuka personer.
Nyckelord: multipel skleros, fysioterapi, ICF, fysiskt funktions-
tillstånd, mätare, reliabilitet, sensitivitet
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1 INTRODUCTION
Multiple sclerosis (MS) is an inflammatory autoimmune disorder of the central nervous 
system and, with a lifetime risk of one in 400, potentially the most common cause of 
neurological disability in young adults. Although MS has little effect on longevity, it 
has a major impact on physical function, employment and quality of life (Hobart et 
al. 2004b). It is a complex disorder with diverse effects, an unpredictable course, and 
variable manifestations that pose unique problems to persons with MS (PwMS) and 
to their families (Hobart et al. 2004b).
For most symptoms, lifestyle changes and rehabilitative interventions are first-line 
treatments (Noseworthy et al. 2000; Schapiro 2002; Goldman et al. 2006). Many 
symptoms are best treated by a multidisciplinary approach that involves specialists 
in rehabilitation (Noseworthy et al. 2000). Drug therapy for MS includes treatment of 
acute relapses with corticosteroids, the use of disease-modifying agents that alter the 
natural history of relapsing-remitting multiple sclerosis, and symptom management 
(Noseworthy et al. 2000; Fox et al. 2006). 
It is important to demonstrate the effectiveness of rehabilitation and drug treatment 
through the appropriate use of scientifically sound outcome measures (Thompson 
1998). An outcome measure should be reliable, valid, and responsive to the clinical 
change that occurs over time (Finch et al. 2002) as well as have clinical familiarity 
and client acceptability (Kay et al. 2001). 
A range of constructs should be measured since MS symptoms vary greatly (Thomp-
son 1998) and the interactions between different domains of health, either in terms 
of the pattern or timing of the outcomes expected, remain unclear (Freeman 1999). 
It is highly unlikely that one measurement tool will be sufficient to cover the number 
of items necessary to reflect the full range of ability levels (Thompson 1998; Schwid 
et al. 2002; Haley et al. 2004a).
While there appears to be increasing agreement on what areas it is important to 
measure, a consensus on the measures that should be used has not been achieved 
(Freeman 1999). A recent survey of outcome measures commonly used in Europe 
to assess PwMS found over 100, although the majority of these measures were only 
used in a small number of centres (Haigh et al. 2001). An overview of the evidence on 
rehabilitation by the Consensus Reference Group of the National Institute for Clinical 
Excellence (NICE) found that over 60 different measures had been used in research 
and that, apart from the Expanded Disability Status Score (EDSS), few had been used 
on more than 10 occasions (National Collaborating Centre for Chronic Conditions 
2004). They concluded that the utility of different measures in different situations has 
been little researched and that only relatively few measures have any evaluative data 
at all been published. 
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The challenge faced by assessment is to identify an optimal set of functional items that 
is relevant for PwMS across different settings yet also feasible in the current health 
care environment. It is important to identify early decline in physical functioning in 
PwMS. To be able to choose the appropriate outcome measure for this purpose, it is 
essential to understand the properties of different measures. 
The present study focuses on describing the reliability, responsiveness, and clinical 
usefulness of a set of physical functioning outcome measures across ambulatory PwMS 
in community settings. The World Health Organization’s International Classification 
of Functioning, Disability and Health (ICF) was used as a framework to ensure that 
the most relevant aspects of physical functioning are represented. An attempt is also 
made to describe the level of functioning in a population based survey of PwMS. 
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2 REVIEW OF THE LITERATURE
2.1 Concepts
The definitions and explanations are presented in Appendix 1. They are taken prima-
rily from official publications or scientific papers. Other explanations are proposed in 
cases where no published definitions have been found.
2.2 Multiple sclerosis (MS)
2.2.1 Epidemiology
Multiple sclerosis (MS) is a common chronic disorder of the central nervous system 
(Hafler 2004). On the basis of epidemiological studies various environmental factors 
have been hypothesized to interact with genetically susceptible individuals; however, 
the cause of MS and the sequence of events that initiates the disease remains largely 
unknown (Noseworthy et al. 2000; Wingerchuk and Weinshenker 2000). MS oc-
curs worldwide, although incidence and prevalence rates vary significantly among 
geographical areas (Pugliatti et al. 2006). The total mean incidence rate in Europe is 
estimated to be four cases per 100,000 / year (Pugliatti et al. 2006). The prevalence 
is particularly high (rates of 30 or more per 100,000 population) in northern Europe 
from Iceland to Russia, Canada and the northern United States, and New Zealand 
(Kurtzke 2005). 
Finland is one of the high-risk regions of MS (Kurtzke 2005). In the 1990s MS was 
diagnosed in 5 to 12 people per 100,000 of the Finnish population annually and the 
prevalence (frequency in the population) varied between 100 and 220 cases per 100,000 
(only definite cases according to the Poser criteria were considered) (Sumelahti et al. 
2001). In Finland, epidemiological studies since 1964 have shown regional variation 
in MS prevalence, with high-risk regions located in the western, medium risk regions 
between the western and eastern districts, and a low-risk region in the eastern part of 
the country (Rinne et al. 1966; Wikström and Palo 1975; Kinnunen et al. 1983; Kin-
nunen 1984; Sumelahti et al. 2001). In central Finland in 2000, the prevalence was 
105 per 100,000 and incidence 9.2 per 100,000 (Sarasoja et al. 2004). MS is over two-
fold more frequent among women than men. In Uusimaa the ratio of women to men 
with MS was 2.3 : 1 (Sumelahti et al. 2001) and in Central Finland 2.5 : 1 (Sarasoja et 
al. 2004). In Finland the first symptoms generally appear at age 20–30 years (Hafler 
2004), peaking at age 40–49 years (Sumelahti et al. 2000; Sarasoja et al. 2004).
The total number of persons with MS (PwMS) in Finland in 2000 was approximately 
6,000 of whom 2,919 were on a disability pension (1.1% of all pensions), 2,062 received 
a disease care allowance, 1,769 used the rehabilitation services provided by the Social 
Insurance Institution and 3,006 received special refunds for medical costs (Social 
Insurance Institution 2000).
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2.2.2 Clinical characteristics and diagnosis of MS
The symptoms and signs of MS depend on the location of the lesion in the central 
nervous system (Compston and Coles 2002). MS inflammation can occur anywhere 
in the brain, spinal cord, or optic nerve, and the resulting symptoms can involve a 
single neurologic function or a combination of these (Fox et al. 2006). The symptoms 
merely reflect the functional anatomy of impaired salutatory conduction at affected 
sites, although most inflammatory foci do not cause symptoms (Compston and Coles 
2002). The patterns of demyelinisation are heterogeneous among PwMS and may in-
volve various pathogenic mechanisms (Noseworthy et al. 2000). Early symptoms of 
MS are widely believed to result from axonal demyelination, which leads to the slowing 
or blockade of conduction (Noseworthy et al. 2000). There is growing evidence that, 
although myelin is the primary target of the disease, axonal damage occurs early and 
increases over time (Wingerchuk and Weinshenker 2000).
The most common symptoms of MS onset are visual abnormalities (49%), motor 
symptoms involving weakness and spasticity (43%), and sensory symptoms (41%) 
(Poser et al. 1979). Coordination abnormalities, and bladder and bowel dysfunction 
are uncommon as symptoms of MS onset but occur in more than 50% of PwMS 
during the course of their disease (Poser et al. 1979). Cognitive impairment occurs 
in approximately 50% of PwMS, sometimes early in the disease course (Amato et al. 
2001). The prevalence of depression in PwMS has been estimated to be 27% to 50%, 
and thus higher than in the most other chronic neurologic diseases, supporting the 
idea that an organic mechanism contributes to depression in MS (Goldman et al. 
2006). Between 60% and 90% of PwMS report fatigue (Goldman et al. 2006). The 
many symptoms associated with MS cause functional impairment (e.g. gait and bal-
ance disorders) later in the course of the disease (Compston and Coles 2002). Many 
symptoms of MS can be both primary and secondary in nature (Schapiro 2002). For 
example, although fatigue appears to be a product of demyelination, it can also be a 
secondary symptom related to the adverse effects of drug therapy, deconditioning, 
and psychological aspects of the disease (Schapiro 2002).
A diagnosis of MS should be made clinically by a physician with specialist neurological 
experience on the basis of evidence of central nervous lesions scattered in space and 
time, and primarily on the basis of the history and examination (National Collaborat-
ing Centre for Chronic Conditions 2003). The diagnostic criteria for MS were updated 
in 2001 (McDonald et al. 2001) and now include magnetic resonance imaging (MRI) of 
the brain and spine and other paraclinical testing to fulfil the “dissemination in time 
and space” criteria for definite MS. A patient presenting with the appropriate clinical 
symptoms and whose evaluation meet some but not all of the necessary criteria, is 
considered to have possible MS (McDonald et al. 2001). The previous diagnostic cri-
teria for MS by Poser (Poser et al. 1983) have been widely applied in clinical practice 
and used for inclusion criteria in various studies. The diagnostic criteria include both 
clinical presentation and paraclinical examinations including abnormalities typical 
for MS found in the cerebrospinal fluid and studies of evoked potential (Poser et al. 
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1983). The criteria by Poser include clinically definite MS, laboratory supported definite 
MS, probable MS (either clinically or laboratory supported), and possible MS.
2.2.3 Clinical course
MS clinically presents with signs of multiple neurological dysfunctions followed by 
recovery or by increasing disability because of irreversible functional disability over 
time (Fox et al. 2006). At onset, MS can be clinically categorized as either relapsing-
remitting MS (RRMS, observed in 85–90% of patients) or primary progressive MS 
(PPMS). Relapses typically present subacutely, with symptoms developing over hours 
to several days, persisting for several days or weeks, and then gradually dissipating. 
Such relapses are likely caused by the traffic of activated, myelin-reactive T cells into 
the central nervous system, causing acute inflammation with associated oedema. With 
time, the extent of recovery from relapses is often reduced, and baseline neurological 
disability accrues. Ultimately, approximately 40% of relapsing-remitting individuals 
stop having relapses and develop what may be a progressive neurodegenerative sec-
ondary disorder related to chronic inflammation of the central nervous system and 
known as secondary progressive MS (SPMS). PPMS is characterized by the absence of 
acute relapses, showing instead a gradual clinical decline from disease onset. (Hafler 
2004)
This classification of RRMS, SPMS and PPMS is useful for prognosis, because major 
permanent impairment and disability occur in the progressive types or phases of the 
disease in most people, rather than as sequelae of relapses (Wingerchuk and Weinsh-
enker 2000). The prognosis for disability and mortality is clearly worse in the PPMS 
group than for those with RRMS and SPMS (Ebers 2001; Myhr et al. 2001; Compston 
and Coles 2002; de Groot et al. 2005). The median time from MS onset until conver-
sion to SPMS is approximately 10 years (Weinshenker et al. 1989). The median time 
from SPMS onset until a cane is required is about 5 years, and until a wheelchair is 
required constantly about 24 years (Weinshenker et al. 1989). Therefore, many PwMS 
are able to walk, albeit with some type of assistance, for more than 20 years after the 
progressive phase begins (Wingerchuk and Weinshenker 2000). 
Although the clinical course is highly variable, most patients eventually develop severe 
neurological disability (Wingerchuk and Weinshenker 2000). There is evidence that 
motor function (i.e., gait and balance) may begin to deteriorate in the early stages of 
the disease, even when the neurological signs are mild (Martin et al. 2006). PwMS 
have been found to experience limitations in daily functioning after three years from 
diagnosis, although neurological deficits were relatively minor and mental health were 
relatively unaffected (de Groot et al. 2005). In about one quarter of PwMS, MS never 
affects activities of daily living; conversely, up to 15% become severely disabled within 
a short time (Compston and Coles 2002). Approximately 10–20% of all PwMS has 
the mildest form of MS, known as benign MS (Ramsaransing and De Keyser 2006), 
which describes PwMS who maintain normal or only mildly impaired neurologic 
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function despite living with MS for many years or even decades (Wingerchuk and 
Weinshenker 2000). 
Drug therapy for MS can be viewed considered as three parallel pathways: treatment of 
acute relapses with corticosteroids, symptom management to alleviate e.g., spasticity, 
bladder symptoms, pain and fatigue, and the use of new disease-modifying agents that 
alter the natural history of RRMS (Noseworthy et al. 2000; Fox et al. 2006). The effects 
on prognosis of the newer treatment regiments are not as yet clear (Hafler 2004).
2.3 Perspectives of physical functioning
2.3.1 The disease-centred approach to disability 
Within physiotherapy, the disablement model has proven useful as a language to 
delineate the consequences of disease and injury (Jette 1994). A number of models 
exist that provide a conceptualization of health and disability. The terminology used 
in the field of disablement led to confusion and controversy across and within disci-
plines. In the earlier, Nagi (1965) and ICIDH (WHO 1980) disablement schemes, the 
central goals were to delineate the major pathways from disease or active pathology to 
various types of functional consequences. In both of these models functioning is seen 
as a continuum ranging from minimal, tissue or organ-level deviations from normal 
bodily functioning [referred as pathology (Nagi 1965) or disease (WHO 1980)] to 
major functional limitations, where the individual’s overall ability to perform various 
activities is limited, and ultimately to what has been referred to as disability (Nagi 1965) 
or handicap (WHO 1980). Apart from the previous models, the disablement model 
described by Verbrugge and Jette (Verbrugge and Jette 1994) emphasized the contribu-
tion of risk factors and extra- and intra-individual factors to the main pathway.
2.3.2 The biopsychosocial approach: the International Classification of Functioning,  
Disability and Health (ICF)
In 2000, the World Health Organization (WHO) introduced the International Classifi-
cation of Functioning, Disability and Health (ICF) (WHO 2001), which provides a stand-
ard language for the description of health-related functioning and the consequences of 
health conditions. Changes in health and functioning can take place at any time of life 
because of disease, disorder or injury, and take place inevitably as we get older. 
The ICF incorporates the biopsychosocial model, a synthesis of the existing medical 
and social approaches. It has moved away from being “consequences of disease” to 
“components of health”. The ICF has preserved the basic structure of three levels of 
functioning. Functioning is now an umbrella term for positive aspects of the interac-
tion between an individual (with a health condition) and that individual’s contextual 
factors. Disability is the negative umbrella term, and no longer the term for one of the 
three levels of the disease-centred disability models. (WHO 2001)
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The ICF has two parts, Functioning and Disability and Contextual Factors, each with 
two components. Each component consists of various domains and, within each 
domain, categories, which are the units of classification (Figure 1). The definitions of 
the terms used by the ICF are presented in Appendix 1.
ICF
Part 1: Functioning and disability Part 2: Contextual factors
Body functions and structures Activities and participation Environmental factors Personal factors
Change in body
 function
Change in body 
structure
Capacity Performance Facilitator/barrier
Item levels
– 1st
– 2nd
– 3rd & 4rd
Item levels
– 1st
– 2nd
– 3rd & 4rd
Item levels
– 1st
– 2nd
– 3rd & 4rd
Item levels
– 1st
– 2nd
– 3rd & 4rd
Item levels
– 1st
– 2nd
– 3rd & 4rd
Classification
Parts
Components
Constructs/qualifiers
Domains and categories
at different levels
Figure 1. Structure of the ICF (WHO 2001). Reprinted with the permission of the World Health Organization (WHO).
The interactions in the ICF are bidirectional, and an individual’s functioning in a 
specific domain is an interaction or complex relationship between the health condition 
and contextual factors (i.e. environmental and personal factors) (WHO 2001). There 
is a dynamic interaction among these entities: interventions in one entity have the 
potential to modify one or more of the other entities. These interactions are specific 
and not always in a predictable one-to-one relationship. It is important, however, to 
collect data on these constructs independently and thereafter explore associations 
and causal links between them. If the full health experience is to be described, all the 
components are useful. While assessment of functional status made by health-care 
professionals is important, it only provides part of the picture. On the practical level, 
the ICF as a biopsychosocial model takes to view that understanding the person’s 
subjective experience is essential for accurate diagnosis, health outcomes, and ap-
propriate care. 
2.3.3 Activities of daily living 
For several decades disability measures used in rehabilitation research have been 
organized along the single construct of activities of daily living (ADLs), with a dis-
tinction between the categories of personal (P-ADL) and instrumental (I-ADL) ADLs 
(Lawton and Brody 1969; Leveille et al. 2004). The ICF has specified several domains 
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in the component of activities and participation in order to define the domain of daily 
activities (Coster et al. 2004). Items representing all of these domains have appeared 
in one or more of the existing measures of P-ADL and I-ADL (Coster et al. 2004). 
However, it might not be possible to describe by a single ICF category (Haglund and 
Henriksson 2003). Thus, classification of activity items as P-ADL or I-ADL or as be-
longing in a particular subdomain has not been based on a clear priori conceptual 
model (Coster et al. 2004).
The main rationale underlying the various categorizations has been to put together 
activities (items) that have the same general functional goal (WHO 2001) and reflect 
a single functional continuum. The relevant underlying continua may not reflect a 
distinction whether an activity is personal or instrumental but rather the key abilities 
that support the performance or the activity (Coster et al. 2004). 
2.4 Outcome measurements
2.4.1 Choosing an outcome measure
The use of outcome measures is recognized as a core standard of physiotherapy 
practice by the European region of the World Confederation for Physical Therapy 
(World Congress of Physical Therapy (WCPT) 2002). An outcome measure should be 
standardized, with explicit instructions for administration and scoring (Rudick et al. 
1996; Finch et al. 2002). A wide selection of standardized measures have been published 
(Finch et al. 2002; Wade 2003). The following questions, according to Hammond 
and Kendall (Kendall 1997; Hammond 2000), should be considered when a choice of 
method is done: (a) Why do you want to measure?; (b) What do you want to record?; 
(c) Who is the information for?; (d) How will you measure it accurately? 
As part of evidence-based practice and clinical decision making processes, physi-
otherapists are required to assess the effectiveness of their interventions, and the 
use of appropriate and high quality outcome measures aids this process (Finch et al. 
2002; Horner and Larmer 2006). Other reasons for using outcome measures include 
definition of the characteristics of individuals (discrimination) and predicting the 
prognosis (Guyatt et al. 1992; Freeman 1999; Finch et al. 2002).
Choosing what to measure depends on the rehabilitation goals (Kendall 1997). In reha-
bilitation, many interventions are often given over time with the result that the relevant 
outcome is not always obvious (Finch et al. 2002; Wade 2003). It is not uncommon 
to expect several effects, each of which may need a measure (Wade 2003). Tradition-
ally, physiotherapists have focused on the measurement of impairments such as pain, 
range of motion and muscle strength, but have not utilized standardized measures 
of activities and participation (Vanderkooy et al. 1999; Haigh et al. 2001; Kay et al. 
2001). It is difficult for one measure to cover the number of items necessary to reflect 
the full range of ability levels (Haley et al. 2004a). Although all the ICF components 
should be measured to fully assess the effect of physiotherapy, it has been suggested 
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that the measure should have items measuring a single outcome (i.e. body functions 
or activities and participation) as there is more chance of detecting a true treatment 
effect rather than a masking effect, which could occur if a measure contain items 
that assess more than one construct (Wade 2003). Primary outcome measures in re-
habilitation research will be at the level of activities, but impairment-based measures 
are useful both to measure prognosis (case mix) and to track the (process) effects of 
interventions (Wade 2003). 
The key outcomes that are important to individuals, treatment providers, employers, 
and financier should be clearly identified (Kendall 1997). In selecting outcome meas-
ures, physiotherapists must decide whether to assess physical functioning by means 
of a self-report measure (i.e., the individual is reporting his or her perception of abil-
ity to complete a task) and/or clinical outcome measure (i.e., the person’s ability to 
complete a task is examined by observing his or her performance), as well as disease 
specific and/or generic measures (Kay et al. 2001; Brach et al. 2002). Disease-specific 
measures focus on the specific complaints that are attributable to a condition and ge-
neric measures are intended to be broadly applicable across different types of disease 
and different populations (Fitzpatrick et al. 1998; Hammond 2000). 
An informed decision is reliant on knowledge of the psychometric (reliability, validity, 
and responsiveness) properties of available measures (Freeman 1999; Finch et al. 2002). 
In addition, it is important to judge the feasibility and overall clinical usefulness of 
an outcome measure (Auger et al. 2006). They address the practical aspects of using 
an outcome measure such as time to administer, user friendliness, appropriateness to 
the target population, and burden of patient when an outcome measure is appraised 
in a specific clinical context, for a specific purpose (Thompson 1998; Freeman 1999; 
Hammond 2000; Finch et al. 2002; Auger et al. 2006). 
2.4.2 Psychometric properties of outcome measures
Psychometric theory is concerned with the science of assessing the characteristics 
of outcome measures such as reliability (the instrument is free from random error), 
validity (the instrument measures what it purports or is intended to measure) and 
responsiveness (the instrument is capable of measuring clinically significant change) 
(Fitzpatrick et al. 1998). Discriminative outcome measures, i.e. measures designed to 
measure cross-sectional differences between people, are required to be both repro-
ducible and valid. For evaluative outcome measures, i.e. those designed to measure 
longitudinal differences within people over time, an additional property, responsive-
ness, is required. (Guyatt et al. 1992.) 
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Reliability
The principal definition of reliability is the degree to which a measure is free from 
random error (Fitzpatrick et al. 1998; Lohr 2002), which can be defined as chance 
unexplained fluctuations in the data (Nunnally and Berstein 1994). The reliability of 
a particular measure is not a fixed property (Streiner and Norman 1996; Bruton et 
al. 2000), but must be identified for a specific population (Horner and Larmer 2006). 
Classical approaches to examining reliability include internal consistency and repro-
ducibility, or the stability of a measure (Lohr 2002). 
The reproducibility of the scores when a scale is applied by the same rater (intra-rater), 
by different raters (inter-rater), or by the same patient at different times (test-retest) 
(Streiner and Norman 1996) is a very important property of any outcome measure 
because it is essential to establish that any changes observed in a trial are due to the 
intervention and not to problems in the measure itself (Bruton et al. 2000). As the 
random error of an outcome measure increases, the size of the sample required to 
obtain a precise estimate of the effects in a trial will also increase (Streiner and Nor-
man 1996; Bruton et al. 2000). 
In addition, two types of reliability have been identified: relative and absolute. Meth-
ods based on correlation coefficients and regression analyses provide an indication of 
relative reliability (Atkinson and Nevill 1998; Bruton et al. 2000). Relative reliability 
is the degree to which individuals maintain their position in a sample over repeated 
measurements (Bruton et al. 2000). It is recommended to examine relative reliability 
by means of an intraclass correlation coefficient (ICC) (Lohr 2002), which reflects both 
degree of consistency and agreement among ratings for quantitative, continuous data 
(Bruton et al. 2000). The Kappa statistic for determining agreement between ratings of 
categorical data can also be used to represent relative reliability (VanSwearingen and 
Brach 2001). Absolute reliability is the degree to which repeated measurements vary 
for patients, i.e., the less they vary, the higher the reliability (Bruton et al. 2000). This 
type of reliability is expressed either in the actual units used in the measurement, or 
as a proportion of the measured values. Methods used to describe absolute reliability 
include the standard error of measurements (SEM), coefficient of variation (CV), and 
limits of agreement (Atkinson and Nevill 1998; Bruton et al. 2000). 
Validity
The validity of a measure is defined as the extent to which a measure assesses what it 
was intended to do (Finch et al. 2002; Lohr 2002). Validity should be considered as 
a measure validated for use in relation to a specific purpose or a set of purposes, i.e. 
as a relation between the concept to be measured and the scale used to assess that 
concept (Fitzpatrick et al. 1998). 
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Validity has historically been divided into three basic types: content validity, criterion 
validity, and construct validity (Streiner and Norman 1996). Content validity can be 
defined as evidence that the domain of a measure is appropriate relative to its intended 
use (Lohr 2002), i.e. how well a measurement battery covers the important parts of 
health components to be measured (Fitzpatrick et al. 1998). Face validity, as part of 
it, refers to whether a measure seems appropriate for the intended purpose (Hays et 
al. 1993a), i.e. measures are judged at the outset for their relevance (Williams and 
Naylor 1992). Criterion validity expresses the extent to which a measure provides 
results consistent with a gold standard (criterion) measure obtained at a similar point 
in time (concurrent validity) or at a later time (predictive validity). Construct validity 
establish the validity of a measure when no criterion or universe of content is accepted 
as entirely adequate to define the attribute being measured. (Streiner and Norman 
1996; Lohr 2002.) Content validity usually relies on expert judgments, whereas the 
criterion and construct validity can be estimated statistically by demonstrating a 
high correlation between the scale used and a gold standard (criterion validity) or by 
examining the degree of association between a scale and other widely used measures 
(construct validity) (Horner and Larmer 2006). 
Responsiveness
Responsiveness has been defined as the ability of a measure to detect true change in 
a patient’s status over time (Finch et al. 2002; Lohr 2002). The terminology applied in 
the literature on the ability to detect change is confusing, as the term responsiveness is 
often used interchangeably with sensitivity to change, and no agreement exists on the 
preferred statistical measure (Finch et al. 2002; Horner and Larmer 2006). An outcome 
measure may detect statistically significant change (i.e., be sensitive), but the patient 
or the health profession may not consider that change to be meaningful or important 
(i.e., interpretation of the change) (Lohr 2002; Horner and Larmer 2006). 
The main criteria for responsiveness are: (1) evidence of changes in the scores of a 
measure; (2) longitudinal data comparing a group that is expected to change with a 
group that is expected to remain stable; and (3) population(s) on which responsiveness 
has been tested, including the time intervals between the assessments, interventions 
or measures involved in evaluating change, and populations assumed to be stable 
(Lohr 2002). 
An integrated system for defining clinically meaningful change that combines anchor-
based and distribution-based methods has been recommended (Crosby et al. 2003; 
Haley and Fragala-Pinkham 2006). Anchor-based methods focus on the correspond-
ence between change in the outcome measure of interest and change in an external 
criterion (Haley and Fragala-Pinkham 2006). Longitudinal anchor-based methods are 
preferable to cross-sectional methods, as the former are more directly linked to change 
(Crosby et al. 2003). In considering these longitudinal methods, patients self-ratings 
are especially well suited to assessing perception of change from the individual’s per-
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spective and clinicians’ global ratings are the most suitable methods of determining 
meaningful change from the clinician’s perspective (Crosby et al. 2003; Haley and 
Fragala-Pinkham 2006). Distribution-based methods include those based on statisti-
cal significance, sample variability, and measurement precision (Crosby et al. 2003). 
They require statistics which translate before-and after changes into a standard unit of 
measurement; essentially, they involve dividing the change score by another variance 
denominator (Lohr 2002; Crosby et al. 2003; Haley and Fragala-Pinkham 2006).
2.5 Outcome measures in persons with MS (PwMS)
2.5.1 Measures related to disease severity
Over the past two decades, outcome measurement of disease severity and MS disability 
in natural history studies and randomized controlled trials (RCTs) has relied heavily 
on the Expanded Disability Status Scale (EDSS) (Thompson and Hobart 1998; Hobart 
2003). The EDSS (Kurtzke 1983) is a familiar measure, usually performed by a neurolo-
gist. It is relatively easy to use, but it has several drawbacks, such as it mixes the measure-
ment of different domains, generates ordinal rather than interval measures, and has 
limited psychometric properties (Sharrack et al. 1999; Hobart et al. 2000; Wingerchuk 
and Weinshenker 2000; Hobart 2003). The inter- and intra-observer reliability of the 
EDSS are modest (Hobart et al. 2000; Wingerchuk and Weinshenker 2000), especially 
in the lower echelons of the scale where a more subjective interpretation of symptoms 
and signs is required (Wingerchuk and Weinshenker 2000). The predictive validity 
of short-term changes in the EDSS for long-term, clinically important outcomes has 
not been evaluated adequately (Wingerchuk and Weinshenker 2000).
Criticisms of the EDSS have resulted in research directed towards the development of 
new measures, such as the Multiple Sclerosis Functional Composite (MSFC) (Cutter 
et al. 1999; Fischer et al. 1999), which is composed of measures of ambulation (timed 
25-feet walk), arm and hand function (Nine-Hole Peg test), and cognition (Paced Au-
ditory Serial Addition Task). The results obtained from the three individual measures 
are combined into a single composite score. Studies have found that the MSFC has 
greater reliability, sensitivity, and statistical validity than the traditional EDSS (Cohen 
et al. 2000; Kalkers et al. 2000), and it has been found to be better than the EDSS for 
detecting differences between groups of PwMS (Hobart et al. 2004a). 
Other alternative rating scales have been developed, some based solely on a neurologic 
examination (e.g., Scripps Neurologic Rating Scale), and others combining neurologic 
examination findings with simple quantitative measures of functioning (e.g., MS 
Impairment Scale) (Thompson and Hobart 1998). However, these less well-known 
scales have several features common with the EDSS, and consequently have similar 
psychometric limitations (Fischer et al. 1999). In addition, clinical measures of dis-
ease activity, such as relapse rate, and MRI have been used (Hobart et al. 2004b), but 
they only address the pathological basis of the disease (Hobart et al. 2004b). Also, the 
relationship between these measures and long-term clinical outcomes has not been 
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firmly established (Fischer et al. 1999), and they are inappropriate for a purpose of 
rehabilitation (Thompson 2000).
2.5.2 Physical functioning measures
Measurement plays an important part in rehabilitation because inferences are based on 
it (Hobart 2003). For example, in clinical trials different variables are measured, statisti-
cal tests are performed on the results generated by outcome measures, and conclusions 
are drawn. These conclusions influence PwMS care, prescribing, policymaking, and 
the use of public funds. Thus, the validity of inferences drawn from clinical trials is 
directly dependent on the quality of the outcome measures used (Hobart 2003). 
The evidence base specifically concerning physiotherapy for PwMS is relatively 
limited (National Collaborating Centre for Chronic Conditions 2004). The intensity 
and frequency of physiotherapy, as well as realistic treatment goals, i.e. goals which 
match the specific needs of individual PwMS, should be based on comprehensive 
and accurate assessment at regular intervals, and be evaluated through appropriate 
clinical outcome measures (LaBan et al. 1998; Thompson 2000; Schapiro 2002; Kes-
selring and Beer 2005). The majority of the MS studies which have been carried out 
have utilized measures which are inadequate (Thompson and Hobart 1998; Freeman 
1999; Thompson 2000). 
Several measures have been used in the field of rehabilitation in the assessment of the 
physical functioning of PwMS (Haigh et al. 2001; National Collaborating Centre for 
Chronic Conditions 2004). In a recent survey in European rehabilitation units (Haigh 
et al. 2001), over 100 measures were found to be used to assess PwMS, although the 
Kurtzke Incapacity Status Scale, Berg Balance Scale and Rivermead Mobility Index 
were the only measures that were used in more than five centres. However, no Finn-
ish rehabilitation units participated in this survey. A review of the measures used in 
rehabilitation research in PwMS by the Consensus Reference Group of the National 
Institute for Clinical Excellence (NICE) showed that over 60 different measures have 
been used and apart from the EDSS, few have been used on more than 10 occasions 
(National Collaborating Centre for Chronic Conditions 2004). The most widely used 
outcome measures in MS rehabilitation RCTs and controlled trials were the EDSS (84 
studies), non-specified ADL measures (13 studies), the Hauser Ambulation Index (13 
studies), the Ashworth scale (13 studies), the Medical Outcomes Study 36-Item Short 
Form Health Survey (12 studies), the Fatigue Severity Scale (11 studies) and the Beck 
Depression Inventory (10 studies). The NICE group concluded that very little research 
has been attempted on the utility of different measures in different situations and that 
no consensus exists as to which measures are the most suitable. Thus, they did not 
recommend specific measures or assessments. Instead, they suggested that future re-
search programmes should be set up to investigate simple measures for routine use. 
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Systematic review of the outcome measures
To provide a comprehensive overview of the outcome measures used in randomized 
clinical trials (RCT) of physiotherapy-related interventions for PwMS, a systematic 
search of the literature was conducted in the following computerized databases: 
MEDLINE (1966 through January 2007), CINAHL (1982 through March 2007), and 
EMBASE (1974 through February 2007). Search strategies were developed for each 
database separately. The main keywords were “Multiple Sclerosis”, “MS” and “De-
myelinating Autoimmune Diseases, Central Nervous System”. Several keywords and 
MeSH relevant to the research question were used to identify physiotherapy-related 
interventions. Two independent and blinded researchers read and selected papers.
Papers were selected for this review if (a) the study population included PwMS, regard-
less of clinical course and level of disability, (b) the effectiveness of physiotherapy was 
addressed using a RCT, and (c) the study consisted of physiotherapy interventions for 
cardiovascular fitness, strength and mobility (i.e., balance and gait). Thus, studies on 
counselling, electrical stimulation for pain, therapy for bladder dysfunction, or envi-
ronmental factors (e.g. orthosis) were excluded as were multidisciplinary rehabilitation 
studies and studies with quality of life as the primary outcome. The methodological 
quality and levels of evidence of the selected studies were not assessed. 
The search identified 49 published RCT studies, of which 17 fulfilled the inclusion 
criteria. The selected papers are presented in Appendix 2. The content of the outcome 
measures included in the studies was classified according to the ICF and those dealing 
with neuromusculosceletal and movement-related functions (b710–b799) and mobility 
(d410–d499) were included in the further analysis. 
The purpose of this systematic review was to identify the outcome measures used in 
physiotherapy RCTs and to explore whether the psychometric properties were de-
scribed or defined in the original paper (Appendix 2). The outcomes measures used in 
these RCTs were identified, classified and linked to the different domains of the ICF. 
To evaluate whether the measures are standardized outcome measures for PwMS, each 
outcome measure was assessed for the thoroughness with which its reproducibility 
has been reported in the literature concerning PwMS (Tables 1 and 2). 
This review showed, similarly to that by Hobart (Hobart 2003) and the NICE group 
(National Collaborating Centre for Chronic Conditions 2004), that surprisingly few 
studies had taken the next step to determine the implications for clinical trails of their 
choice of outcome measure. Only few measures have any evaluative data at all on their 
psychometric properties published in the PwMS studies. In addition to the studies 
mentioned in Tables 1 and 2, there were several studies in which the results were not 
separated adequately to report the psychometric properties for PwMS; as measures as 
the timed 10-m walk, 2-min walk, and Rivermead Mobility Index (Rossier and Wade 
2001), the Box and Block Test (Platz et al. 2005), and the Modified Ashworth Scale 
(Bohannon and Smith 1987). 
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This review has some limitations: only RCTs were considered in this review, the as-
sumption being that in well-designed trials careful attention would be paid to the 
selection of outcome measures. There are, however, a number of large follow-up and 
cohort studies which also report outcomes from physiotherapy, and the inclusion of 
these studies might have highlighted additional outcome domains and measures.
In sum, the reliability of the physical functioning measures included in this review 
has not previously been fully investigated in the case of PwMS. Thus, there were rather 
few standardized measures for assessing PwMS. This dearth of published data raises 
questions about the use of the existing measures for monitoring responses to physio-
therapy interventions, despite the widespread use of some of them for these purposes. 
Only two out of these 32 measures were self-report measures. Contrary to previous 
findings (Vanderkooy et al. 1999; Haigh et al. 2001; Kay et al. 2001), the focus of the 
outcome measures was on activities (24 measures), not body functions (8 measures). 
The measures were located in three domains of the ICF activities component and five 
domains in the ICF body functions component.
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3 AIMS OF THIS STUDY
General aims of this study were to evaluate the level of physical functioning in PwMS, 
and to investigate the psychometric properties and clinical usefulness of physical 
functioning measures in the ICF framework for use in ambulatory PwMS. The specific 
aims of the study were (Roman numerals refer to original publications):
1. to describe the impact of MS on PwMS performance in physical function-
ing, particularly in the domains of self-care, mobility and domestic life in a 
population-based survey in Central Finland (I) 
2. to assess the reproducibility of selected physical functioning measures in 
ambulatory PwMS in terms of (a) test-retest reliability and (b) inter-rater reli-
ability (II); and to assess the feasibility of the physical functioning measures 
during the test-retest study
3. to identify the most important predictors of performance in self-care, mobil-
ity, and domestic life in ambulatory PwMS by studying the cross-sectional 
associations of physical functioning measures with self-rated performance 
(III)
4. to provide estimates of responsiveness for physical functioning measures dur-
ing a 2-year prospective longitudinal study (IV) by (a) providing evidence on 
changes in the scores of the physical functioning measures, and (b) examining 
clinically significant deterioration in the physical functioning measures in re-
lation both to PwMS’ perceived change in health and to a clinician’s rating.
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4 MATERIAL AND METHODS
4.1 Subjects and study design
A population-based sample of 240 PwMS participated in the physical functioning 
survey (I) and of these, a cohort of 120 ambulatory PwMS participated in the 2-year 
prospective longitudinal study to conduct a psychometric evaluation of the selected 
physical functioning measures (III–IV). In addition, a sample of 19 PwMS and 9 
PwMS participated in the test-retest reliability and inter-rater reliability studies (II), 
respectively. The study design was approved by the Ethics Committee of the Central 
Finland Health Care District. The WHO’s International Classification of Function-
ing, Disability, and Health (ICF) formed the framework for the selection of all the 
measures and data used in the present thesis.
4.1.1 Reliability studies of selected outcome measures (II)
The repeated-measures design was used to examine the test-retest and inter-rater 
reliability of the selected physical functioning measures (II) and to evaluate the fea-
sibility of those. 
The participants were recruited from the Department of Neurology at the hospital of 
Central Finland. To be included, PwMS had to have clinically definite MS according 
to Poser’s criteria (Poser et al. 1983), be able to walk at least 20 metres with or without 
a walking aid according to the EDSS (score ≤ 6.5), be in a stable clinical state, have 
visited a physician within three months of inclusion, and be living within 60 kilometres 
from Jyväskylä. A sample of 20 PwMS (the first enrolled) was invited to participate 
in the test-retest reliability study. One dropped out after the first assessment session 
for work-related reason, and thus 19 PwMS participated in the test-retest reliability 
study. In the inter-rater reliability study the first nine PwMS enrolled after a visit to a 
physician were recruited. The demographic and MS-related characteristics of PwMS 
are presented in Table 3. All the participants gave their written informed consent to 
participate in the study.
For the test-retest reliability study, each PwMS participated in three assessment ses-
sions in a hospital department of physical medicine and rehabilitation at one-week 
intervals. Each PwMS was examined at the same time of day and on the same day of 
the week by the same physiotherapist. The measures were administered in the same 
order each time and a detailed protocol that included precise, standardized instruc-
tions was used. Rest breaks were given, as needed, both within and between measures. 
The safety and feasibility of this set of outcome measures were examined during the 
test-retest reliability study. After the test-retest reliability study, the measures were 
re-evaluated and minor modifications made to the instructions and to the measures 
used, as described later in the methods section. 
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Table 3. Demographic and MS-related characteristics of PwMS in reliability studies (II). Reproduced with the kind 
permission of John Wiley and Sons Limited.
Test-retest reliability
(n = 19)
Inter-rater reliability
(n = 9)
Women      n (%)
Men           n (%)
9 (47.4%)
10 (52.6%)
6 (66.7%)
3 (33.3%)
��e (years) # 2.7 ± 9.2 (24–58) 48.9 ± 8.8 (34–58)
Clinical course of MS
Relapsin� remittin�         n (%)
Secondary pro�ressive   n (%)
Primary pro�ressive        n (%)
14 (73.7%)
2 (10.5%)
3 (15.8 %)
5 (55.6%)
2 (22.2%)
2 (22.2%)
Disease duration since dia�nosis (years) # 5.8 ± 5.7 (1–19) 9.3 ± 8.3 (1–24)
EDSS score
0.0–1.5          n (%)
2.0–3.5          n (%)
4.0–6.5          n (%)
4 (21.1%)
11 (57.8%)
4 (21.1%)
2 (22.2%)
3 (33.3%)
4 (44.5%)
Users of walkin� aid     n (%) 5 (26.3%) 4 (44.5%)
#  Mean ± SD (ran�e).
MS = multiple sclerosis, SD = standard deviation, EDSS = Expanded Disability Status Scale.
The procedure was the same for the inter-rater reliability study except that each 
PwMS was examined in two sessions by two physiotherapists (one session to each). 
Both examiners were fully qualified physiotherapists, but one (JP) had much greater 
experience of clinical neurological assessment than the other examiner. The order of 
measuring by the two examiners was reversed for half of the participants to control 
for order effects, such as familiarity with the examiner or with the procedure. 
4.1.2 Population-based survey of physical functioning in PwMS (I)
The participants for this study were obtained through an epidemiological survey in the 
Central Finland Health Care District carried out in the year 2000 (Sarasoja et al. 2004). 
At that time there were 30 local municipalities with several subregional units in the 
Central Finland health care district, which covered the whole area of Central Finland 
region. The geographical location of the region under study is shown in Figure 2.
The potential participants were collected from the Hospital Discharge Registry, and 
included all 277 PwMS living in the Central Finland region (population 263,886) in the 
year 2000 who had a definite diagnosis of MS according to a Poser’s criteria (Poser et 
al. 1983).The prevalence rate was 105/100,000 (Sarasoja et al. 2004). In this population-
based cohort 73 PwMS were resident in Jyväskylä, fewer than ten PwMS came from 
23 of the 30 municipalities while only one small local municipality had no PwMS.
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Figure 2. Geographical location of the Central Finland region with its subregional units specified.
Eleven of the prevalent cases were excluded from this study on ethical grounds: 
six because the PwMS seemed unaware of the MS diagnosis, and five who had not 
contacted the Central Hospital of Jyväskylä. Finally, 266 PwMS were eligible for this 
survey (Figure 3). Data were collected by a postal questionnaire, which was returned 
by pre-paid mail. If no correspondence was received within 2 weeks, a second ques-
tionnaire was sent. The respondents were instructed to answer the questionnaire by 
themselves, or if needed, to get help filling it in. They were also instructed to call the 
researcher if they had any queries. Of them, 240 persons returned the questionnaire, 
giving a response rate of 90%. Answers were obtained from every municipality with 
MS and in 16 out of 30 municipalities the response rate was 100%. The characteristics 
of the prevalent cases and participants of this survey are presented in Table 4. 
4.1.3 Prospective 2-year longitudinal study of physical functioning in a cohort of ambula-
tory PwMS (III–IV)
The single-group design method was used in this study. The potential participants 
for this study were PwMS from the previous population-based survey of physical 
functioning (I) whose diagnosis of MS has been confirmed prior to 1st August 2000 
by a neurologist (n = 199). To be eligible for participation in the present study, PwMS 
had to be able to move independently, walk at least 20 m with bilateral assistance 
(EDSS ≤ 6.5) and have no major additional diseases (e.g., a major musculoskeletal 
disorder) that would affect their ability to perform the tests. Overall 143 PwMS met 
these criteria, 46 were ineligible due to the walking criteria and 10 had a major ad-
ditional disease. 
A plain language statement inviting participation and outlining the aims and test 
requirements of the study was mailed to all the 143 PwMS who fulfilled the inclusion 
criteria. Those who were willing to participate returned a form to the hospital in a 
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pre-paid envelope. On this form they gave their contact information and the best 
days and times to contact them. A total of 120 PwMS volunteered to participate in 
the study (Figure 3). All the participants gave their written informed consent before 
entering the study. 
A 2-year follow-up study was conducted in order to identify which of the physical 
functioning factors in the ICF activities and body functions components predict self-
reported performance in mobility, self-care and domestic life in ambulatory PwMS, and 
to provide estimates of responsiveness for a variety of physical functioning measures 
in ambulatory PwMS. Each participant attended three assessment sessions over the 
period September 2000 to December 2002. Measurement sessions were separated by 
nearly one year in order to minimize the effect of season on functioning. At time of 
each measurement, the participants had to be stable in their MS, with no ongoing 
relapse. All the measures were conducted in the department of physical medicine 
and rehabilitation at the hospital of Central Finland by two physiotherapists. Each 
session included self-report questionnaires and clinical measures of physical func-
tioning. The examiners used a detailed protocol that included precise, standardized 
instructions. The measures were administered in the same order during each testing 
session, as in the inter-rater reliability study (II). Rest breaks were given, as needed, 
both within and between measures. The same experienced neurologist obtained all 
of the participants’ EDSS scores every year prior to or within three days following the 
physical functioning test session. 
The cross-sectional data of 120 PwMS at the baseline were used in study III. Eleven 
participants were subsequently lost to follow-up (one died, and 10 dropped out because 
of some obstacle to continuing their participation). In all, 109 PwMS (91%) completed 
the 2-year follow-up study (IV).
The characteristics of the 120 PwMS at baseline (III) are presented in Table 4. Ap-
proximately half of the participants (n = 62) had had MS symptoms for over 10 years. 
Disease severity, as assessed with the EDSS, varied from a score of 0 to 6.5 (median = 
2.0). Overall, 40 participants had no disability (EDSS score 0–1.5), 47 had mild dis-
ability (EDSS score 2.0–3.5), and 33 had moderate disability (EDSS score 4.0–6.5). 
Twenty-seven PwMS reported permanent use of a walking aid outdoors. Self-reported 
time from previous relapse was over 1 month in all cases and in most cases over 6 
months (79%). Sixty-two PwMS did not use any medication for MS, while 20 used 
symptomatic medication, e.g. for spasticity, bladder symptoms, pain and fatigue, and 
38 received disease-modifying therapies either alone (n = 29) or with symptomatic 
medication (n = 9). Of the PwMS, 52 were retired, 55 were working full- or part-time 
(including students), and the rest of 13 were either unemployed or otherwise not 
working. Forty PwMS reported having an additional disease. 
37Assessment of physical functioning in ambulatory persons with multiple sclerosis
Excluded: EDSS ≥ 7 (n = 46)
Excluded: another disease (n = 10)
Refused to participate (n = 23)
Excluded for ethical reasons (n = 11)
PwMS in the Central Finland health care district 2000
Population of MS subjects (n = 277)
Prevalence rate 105/100,000
Postal questionnaire sent (n = 266)
Non-respondents
(n = 26)
Prospective study of physical functioning
in a cohort of ambulatory PwMS
(III n = 120, IV n = 109)
MS diagnosis confirmed
prior to 1st Aug 2000 (n = 199)
Population-based survey (I)
(n= 240)
Test-retest reliability (n = 19)
and inter-rater (n = 9) reliability
studies (II)
Figure 3. Flow chart of participant recruitment. Reproduced with the kind permission of the American Physical 
Therapy Association.
Table 4. Overview of the characteristics of the PwMS in study groups I, III and IV.
Prevalence cases of 
definite MS in 2000
(Saraso�a et al. 2004)
PwMS in the  
questionnaire study 
(I)
Ambulatory PwMS a) 
included in the physical 
functioning study 
(III, IV)
No of PwMS 277 240 120
Women   n (%)
Men         n (%)
198 (71.5%)
  79 (28.5%)
179 (74.6%)
  61 (25.4%)
  90 (75.0%)
  30 (25.0%)
��e (years) # 48.2 ± 12.3 (18–78) 48.2 ± 11.9 (20–76) 45.0 ± 10.8 (20–71)
Clinical course of MS 
Primary remittin� b)
Primary pro�ressive
Unknown
225 (81.2%)
  51 (18.4%)
    1 (0.4%)
196 (81.7%)
  43 (17.9%)
    1 (0.4%)
106 (88.3%)
   13 (10.9%)
     1 (0.8%)
Years since onset c) #  15.9 ± 10.7 (0–56) 15.8 ± 10.7 (0–56) 12.3 ± 8.8 (1–39)
Years since dia�nosis # 10.5 ± 9.0 (0–42) 10.4 ± 8.7 (0–42) 7.1 ± 6.2 (0–26)
# Mean ± SD (ran�e).
a) �mbulatory PwMS; Expanded Disability Status Scale (EDSS) ≤ 6.5.
b) Primary remittin�, includin� relapsin�-remittin� MS (RRMS), and secondary-pro�ressive MS (SPMS).
c) Date of onset defined as the time of the first appearance of neurolo�ical si�ns and symptoms attributable to the disease.
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4.2 Methods
4.2.1 Population-based survey (I)
Data were collected by a postal questionnaire and from medical records. The question-
naire contained closed and open-ended questions on sociodemographic characteristics, 
and on the body functions, activities and participation component of the ICF.
The sociodemographic characteristics taken into account were sex, age, type of hous-
ing (own apartment or health centre ward), level of education (secondary education 
with practical courses, vocational education or university education), medication (no 
medication, disease-modifying therapies or symptom-specific therapies), presence 
of additional diseases, outpatient physiotherapy, and the use of walking aids (cane, 
crutch, walker) or wheelchair. 
The medical records of the PwMS were reviewed by a neurologist to obtain clinical 
characteristics: date of symptoms onset, year of diagnosis of MS and clinical course of 
the disease (Sarasoja et al. 2004). The date of onset, i.e., the time of the first appearance 
of neurological signs and symptoms attributable to the disease, was used to define 
disease duration, which was later classified into five groups (0–4.9 years, 5.0–9.9 years, 
10.0–14.9 years, 15.0–19.9 years, and ≥ 20.0 years). The clinical course of the disease 
was defined as primary remitting (RRMS or SPMS) or primary progressive (PPMS).
Symptoms of MS. The PwMS were asked to report three major symptoms which had 
an impact on their daily life. The question was open-ended and the answers were 
classified into 1) no symptoms or signs of MS and 2) at least one symptom having an 
impact on daily life. 
Walking and moving around (a450–469) were examined with two questionnaires. 
First, a 5-point rating scale modified from the questionnaire by Goodin (Goodin 1998) 
was used to assess mobility level, i.e., the PwMS ability to walk or move around in his 
or her current environment, with a walking aid if needed. The mobility level scale was 
as follows: 1) no to moderate MS symptoms and able to walk without any problem; 2) 
some difficulties in walking but able to walk unaided up to 500 meters; 3) requires an 
aid (e.g. cane, crutch, walker) to walk about 100 meters; 4) uses a wheelchair regularly; 
and 5) confined to bed most of the time. Secondly, walking capacity without assist-
ance was assessed using the Walking Impairment Questionnaire (WIQ), which was 
originally designed to measure community-walking ability in patients with peripheral 
arterial disease (Regensteiner et al. 1990). Only the WIQ distance score was used in 
this survey. The scores (No, Some, Much, Did not do) and the questions on distances 
in feet were translated into Finnish and given in metric units. Eight different distances 
ranging from walking indoors around the home (5 m) to walking several blocks 
(1000 m) were used. The PwMS was asked to report the degree of difficulty of walking 
each distance without a walking aid during the previous two months, selecting from 
one of four response categories ranging from 0 (not able to walk) to 3 (no difficulty at 
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all). The responses were transformed to obtain percentage scores from 0 (no walking 
ability at all) to 100 (no walking difficulties over the different distances). 
Self-care (a510–a599), domestic life (household tasks p630–p649, acquisition of 
goods and services p620; and taking care of plants, indoors and outdoors p6505), 
and vigorous activities (sports p9201). Perceived difficulties in self-care (e.g. eating, 
dressing or bathing) were examined with one question and in domestic life with 
three questions (e.g. household tasks, doing errands and gardening) drawn from the 
Functional Status Questionnaire (FSQ) (Jette et al. 1986), which reflects former P-ADL 
and I-ADL, respectively. Participation in vigorous activities was examined with one 
question from the FSQ. The PwMS graded their perceived difficulties during the pre-
vious two months on a 5-point rating scale: “usually did with no difficulty”, “usually 
did with some difficulty”, “usually did with much difficulty (i.e. required some aid 
or assistance)”, “usually did not do because of MS”, and “usually did not do for other 
reasons”. The calculation of the FSQ score, which ranged between 0 (fully dependent) 
and 100 (fully independent), was transformed according to published algorithms (Jette 
et al. 1986). Perceived difficulties in domestic life were subsequently divided into two 
classes: 1) no restriction in participation (FSQ in domestic life between 66 and 100) 
and 2) restriction in participation (FSQ in domestic life between 0–65). 
Remunerative employment (p850). Employment status was assessed as either en-
gaged in working life (full- or part-time employment, unemployed, student, house-
wife/husband, on sick leave) or as retired (full- or part-time disability pension or old 
age pension). 
4.2.2 Outcome measures in the physical functioning studies (II, III, IV)
The selection of the outcomes and measures was based on the recommendations made 
by an international consensus meeting held in 1997 by the American National Multiple 
Sclerosis Society (Rudick et al. 1997). They recommended that MS clinical outcome 
measures should: (a) be multidimensional in order to reflect the principal ways in 
which MS may affect an individual; (b) have high reliability; (c) should be sensitive 
to changes in disease progression; (d) provide interval data rather than categorical 
or ordinal data; and (e) focus on neurologic impairment and disability rather than 
handicap or quality of life. 
 
In this study the selection of physical functioning measures was based on the following 
procedure. First, the relevant ICF domains for ambulatory PwMS were identified. Sec-
ond, of the available measures, the most appropriate existing generic or disease-specific 
measure for each domain was selected on the basis of a good level of appropriateness, 
standardization and reliability, as found in previous studies. For selection purposes, 
studies on MS or other related disorders, or on adult health populations were taken. 
Third, if possible, the measures needed to be quantitative as there is a lack of sensi-
tive and specific operational definitions of grades, such as mild, moderate and severe. 
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Another criterion was that the measures could be used in almost any clinical setting 
with minimal to moderate equipment, cost or special requirements.
In the present study (II–IV), performance (i.e., what individuals do in their current 
environment) in the activities and participation component was assessed by self-re-
portedscores in self-care, mobility and domestic life. Capacity, indicating the highest 
probable level of physical functioning that a subject may attain in a given activity 
domain at a given moment, and body functions were assessed by quantitative clinical 
outcome measures. The constructs of these measures were linked to the ICF, and the 
physical functioning variables used in this study were drawn from the ICF activities 
and body functions categories (9 and 14 variables, respectively). Figure 4 provides a 
description of the ICF framework adopted in the study.
Performance in the self-care, mobility, and domestic life domains in the activities and participation 
component
The Functional Status Questionnaire (FSQ). Performance regarding self-care 
(d510–d560), mobility (d450–d475) and domestic life (d610-d640) were assessed by 
self-reported scores from the FSQ (Jette et al. 1986) (III, IV). The aim of the FSQ is 
to describe what persons do in their current environment, i.e., describe restrictions 
in their performance. Only FSQ items that assess aspects of physical function were 
included. They were found to cover several activity and participation domains, thus 
making it difficult to distinguish between activities and participation. The ICF manual 
offer four alternative options for structuring the relationship between activities and 
participation (WHO 2001). For the purposes of the present study it was decided to 
link the FSQ items for both activities and participation, thus allowing total overlap 
of the domains (option 4). 
A Finnish language version of the FSQ was constructed in several steps. First, the origi-
nal physical function items were updated to correspond to the most recent evidence. 
Second, a researcher translated the FSQ items into Finnish. Third, the selected items 
were reclassified to enable each item to be linked to the ICF activities and participation 
component. This was done independently by the researcher and other professional 
familiar with the ICF. A reconciled form was developed and a native English speaker 
who was fluent in Finnish then translated it back into English. This was compared 
to the English FSQ items by the researcher. The result was a four-item scale for self-
care (washing d510; toileting d530; dressing d540; and eating d550), a five-item scale 
for mobility (walking inside d4600; climbing stairs d4551; walking ½ km distances 
d4500; driving a car d475; and using public transportation d470) and a five-item scale 
for domestic life (preparing meals d630; washing clothes d6400; cleaning the house 
d640; acquisition of goods and services d620; and taking care of plants, indoors and 
outdoors d6505). 
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Self-reported difficulty performing the self-care, mobility, and domestic life items dur-
ing the past month was scored on the FSQ as follows: “usually did with no difficulty”, 
“usually did with some difficulty”, “usually did with much difficulty (i.e. required 
some aid or assistance)”, “usually did not do because of MS”, and “usually did not 
do for other reasons”. The calculation of each FSQ score was transformed according 
to published algorithms (Jette et al. 1986). The FSQ score ranges between 0 and 100, 
with 0 representing fully dependent and 100 fully independent performances. The 
reliability of the original FSQ scales has been found to be high across a wide range 
of settings and patient populations (Jette et al. 1986; Murphy et al. 1998; Cleary and 
Jette 2000). 
Clinical measures of the activities (capacity)
The domains measured were fine hand use (a440), changing and maintaining body posi-
tions (a410–a429) and walking (a450) (see Figure 4), using following six measures:
The Box and Block Test (BBT), a measure of unilateral gross manual dexterity, was 
administered using the procedure standardized by Mathiowetz et al. (1985b). This test 
consists of moving, one by one, as many blocks as possible from one compartment of 
a box to another of equal size, within 60 seconds. The score was the number of blocks 
moved using the dominant (II–IV) and the non-dominant hand (II) in 1 minute. Inter- 
rater reliability has been reported for healthy adults (Mathiowetz et al. 1985b), and 
test-retest reliability for healthy adults (Mathiowetz et al. 1985b), for elderly persons 
with upper limb impairment (Desrosiers et al. 1994), and for persons with neurologic 
disabilities (Carey et al. 2002; Platz et al. 2005; Svensson and Hager-Ross 2006).
The Berg Balance Scale (BBS) is a 14-item measure for individuals with some degree 
of balance impairment (Berg et al. 1989). Each item is scored on a 5-point scale, from 0 
(cannot perform) to 4 (normal performance). Tandem standing and single-leg standing 
were noted as the 2 most difficult items, but the original instructions do not define 
the leg that the participant used (Berg et al. 1989). This might be a cause of variability, 
especially in a disease like MS. Thus, as exceptions to the standard instructions, the 
tandem stance and one leg stance were performed on both legs. The poorest score was 
taken for the analyses on the grounds that in daily activities it is not possible to rely 
only on the better leg (II–IV). The total score ranged from 0–56. Inter-rater reliability 
and test-retest reliability have been reported for older adults and for clients with stroke 
(Berg et al. 1992 and 1995). 
The Kela Coordination Test, a measure developed by Social Insurance Institution 
of Finland (Kela) (Vaara 2003) consists of two parts: walking forward and backward 
on a narrow plank (width 9 cm and height 4 cm) and performing a series of steps 
on a track. The time (in seconds) taken to complete the task was measured, and the 
number of possible errors (stepping off the plank or outside the marks) were counted 
(II–IV). It is designed to assess body use and body movements, especially co-ordination 
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and dynamic balance, in people with no evident balance problems. The reliability of 
time and error counting has been assessed in a group of middle-aged healthy adults 
(Vaara 2003). 
Postural stability by the force platform. The tests were performed on a Good Balance 
force platform [Metitur Ltd, Jyväskylä, Finland] (Era et al. 1996 and 2006). PwMS 
stand feet 20 cm apart with eyes open and with eyes closed (II–IV). Two additional 
stance conditions (feet together with eyes open and with eyes closed) were used in the 
inter-rater reliability study (II). Voluntary arm movement was suppressed by having 
the PwMS standing with their hands on their hips. Sway during a 30-second period 
was recorded and the median velocity (velocity moment; mm2/s) was analyzed as the 
outcome. Test-retest reliability has been reported for healthy adults (Hoffman 1998; 
Mustalampi et al. 2003) and for patients after ACL reconstruction (Mustalampi et al. 
2003).
10-meter walk test (10MWT) speed. Time needed to walk a distance of 10 meters 
was measured by photocells [Newtest, Oulu, Finland] at normal gait speed (“own 
speed”) and maximum gait speed (“fast as possible”) (Craik and Dutterer 1995; Finch 
et al. 2002). The time (s) taken (III) and the velocities (m/s) calculated (II, IV) were 
analyzed as the outcome. Two meters were allowed for acceleration and deceleration. 
The measure was done with PwMS wearing their shoes and using their usual ambu-
latory aid. Reliability has been assessed in many different studies for healthy adults 
and persons with neurologic disabilities (Wade et al. 1987; Liston and Brouwer 1996; 
Bohannon 1997; Rossier and Wade 2001; Finch et al. 2002; Horemans et al. 2004), and 
for PwMS (Schwid et al. 1999).
6-minute walk test (6MWT) distance. The 6MWT was conducted as described by 
Guyatt et al. (1984 and 1985) except that only one walk was performed. PwMS were 
instructed to walk from one end to the other of a 100 meter hallway at their own pace 
while attempting to cover as much distance as possible in the allotted 6 minutes. They 
were told that they may rest if they become too short of breath or tired to continue, 
but to resume walking when they are able to do so. While administering the test, the 
supervisor walked slightly behind and not beside the PwMS so to avoid influencing 
the subject’s self-selected walking pace. The PwMS were encouraged with a standard 
set of encouraging statements every one minute. The standard statements were (1) 
“You’re doing well” and (2) “Keep going on, only X minutes to go”. The measure was 
done with participants wearing their shoes and using their usual ambulatory aid. The 
distance walked during the 6MWT was recorded to the nearest 10 m covered (II–IV). 
Test-retest reliability has been assessed in many different studies for elderly (Harada et 
al. 1999; King et al. 2000) and for persons with different diseases (Finch et al. 2002).
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Clinical measures of the body functions
The domains measured were exercise tolerance functions (b455), gait pattern functions 
(b770), muscle power functions (b730), muscle endurance functions (b740), muscle tone 
functions (b735), and sensation of muscle stiffness (b780) (see Figure 4), using the fol-
lowing seven measures:
Exercise tolerance during the 6MWT. Three different exercise tolerance variables 
were measured during the 6MWT (II–IV). Rating of perceived exertion (the 15-grade 
RPE) (Borg 1970) during the last 10 seconds of the 6MWT was noted. Heart rate (HR) 
in beats per minute was recorded at rest and every 2 minutes during the 6MWT using 
the Polar Heart Rate Monitor. The resting rate was established during a 15-minute 
period while subject rested on a seat. Maximum heart rate (HRmax) at the end of 
the test and HR change (HR at 6 min – HR at rest) were recorded. The Physiological Cost 
Index (PCI, beats/m) (Nene 1993) was calculated by dividing the difference HR while 
walking – HR at rest (beats/min) by walking speed (m/min). The Heart Rate Monitors us-
ing chest electrodes (e.g., Polar) are considered to be reliable during physical stressful 
conditions (Achten and Jeukendrup 2003). Test-retest reliability of the PCI has been 
reported for healthy adults (Nene 1993; Bailey and Ratcliffe 1995; Graham et al. 2005), 
for children with cerebral palsy (Ijzerman and Nene 2002), and for persons with 
paraplegia (Ijzerman et al. 1999). In addition, inter-rater reliability has been studied 
in healthy adults (Graham et al. 2005).
Spatiotemporal parameters during the 10MWT. Gait pattern functions were meas-
ured at the participant’s normal speed 10MWT (II–IV). Actual step lengths were meas-
ured by the method described by Kokko et al. (1997). Each PwMS was asked to walk 
at his or her own speed on a plastic mat. Water-soluble markers were placed on both 
shoe heels. Each heel strike of the PwMS left a trace on the mat and thus step lengths 
could be measured. Mean stride lengths (cm) and cadence (steps/min) were calculated 
afterwards. In addition, the walk ratio (m/steps per min) (Sekiya and Nagasaki 1998) 
was calculated as a speed-independent index of gait pattern for describing temporal 
and spatial co-ordination. Test-retest reliability of the stride length and cadence us-
ing current method has not been reported, but it has been assessed in children and 
adults using a comparable footprint analysis method (Stolze et al. 1998) and in PwMS 
(Holden et al. 1984). Test-retest reliability of walk ratio has been reported for healthy 
adults (Sekiya and Nagasaki 1998).
Grip strength was measured using a Jamar dynamometer [Preston, Mississippi, U.S.A] 
following the instructions of the American Society of Hand Therapists (Mathiowetz 
et al. 1985a). Grip width was adjusted for each subject. The best result out of three 
trials using the right hand (III, IV) or both hands (II) was taken for the analysis. The 
reliability of isometric grip strength measure taken with the Jamar dynamometer has 
been well established in healthy individuals, but studies of different disease groups are 
rare. Test-retest reliability for patients with cervical radiculopathy has been reported 
(Peolsson et al. 2001)
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Maximal voluntary contraction (MVC) of the knee extensors. A custom-built dy-
namometer chair modified from a David 200 dynamometer (Häkkinen et al. 1995) 
was used to measure maximal isometric unilateral force in the test-retest reliability 
study (II) or bilateral force in the other studies (II–IV). The measure was conducted 
in the sitting position with the hips fixed on the dynamometer seat for a knee flexion 
angle of 100o. The PwMS were asked to exert maximal force as rapidly as possible and 
to maintain that force about 4–5 s. The ankle was attached to the support just above 
the malleoli. Three maximal isometric contractions with a 30-second rest period 
between each were performed. The best result out of three MVCs was taken for the 
analysis. The isometric forces were analysed using the Isopack program [Newtest 
Ltd, Oulu, Finland], and the maximum strength in kilograms was calculated. The 
reliability of isometric MVCs has been reported in healthy men (Viitasalo et al. 1980; 
Sipilä et al. 1991).
The repetitive endurance tests of the Invalid Foundation of Finland were used to 
assess muscle endurance of the upper and lower extremities (Alaranta et al. 1994). We 
used alternative dumbbell presses by standard weights (5 kilos for female participants 
and 10 kilos for male participants) to measure the endurance of the upper extremi-
ties. If necessary, the weights were adjusted for each participant, and that weight was 
used throughout the study. The participant stood feet 15 cm apart and elbows bent 
with a dumbbell in each hand, raised the right hand dumbbell upwards, and then 
returned it to the initial position. The same movement was done with the left hand 
and the alternate right and left movements were repeated as many times as possible 
at a constant rate (44 times per minute). In the results the number of repetitions was 
calculated (II) or the number of repetitions was multiplied by the weights (kg) lifted 
(III, IV). The muscle endurance of the lower extremities was assessed by the number 
of squats performed (II–IV). The participant stood feet 15 cm apart, performed a squat 
such that both thighs were horizontal, and then returned to a standing position. The 
movement was repeated as many times as possible at a constant rate (44 times per 
minute), and the number of repetitions was calculated. Test-retest reliability of repeti-
tive squatting has been reported for healthy adults (Alaranta et al. 1994).
The Modified Ashworth Scale (MAS). The muscle tone of 4 muscle groups on each 
side of the body (m.biceps and triceps brachii, m.flexors of the knee and m.quadriceps 
femoris) were tested by the 6-point MAS (Bohannon and Smith 1987). The PwMS were 
tested in the supine position except for the quadriceps femoris muscle for which the 
patient was prone position. To minimize changes in muscle tone as a consequence of 
movements, the number of stretches was limited to the minimum. In most cases, the 
raters were able to provide a score after two or three stretches of each muscle group. 
The combined upper- and lower-limb spasticity score (0–20) was the sum of the scores 
for the individual muscles (II–IV). Test-retest reliability has been studied in persons 
with stroke (Blackburn et al. 2002). Inter-rater reliability for PwMS (Nuyens et al. 
1994) and for other neurological deficits (Bohannon and Smith 1987; Blackburn et 
al. 2002) has been reported. 
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The passive straight leg raise (SLR) test (Gajdosik et al. 1993), assessing hamstring 
muscle flexibility was added to the outcome measures after the test-retest study. In 
the SLR the PwMS was positioned supine, the left thigh was stabilized flat against 
surface and the examiner’s left hand was placed over the distal anterior aspect of the 
right thigh to ensure that the knee remained at full extension. The examiner elevated 
the participant’s right leg with her right hand until firm resistance was felt and the 
subject confirmed that the full SLR had been reached. The same movement was done 
with the left leg. The ankles remained relaxed in plantarflexion during all tests. The 
angles (degrees) of the SLR in both legs were measured using a Dualer electronic 
inclinometer [JTECH, Midvale, UT, USA]. The result for both the right and left side 
(II-inter-rater reliability study) or only the right side were taken for the analysis (III, 
IV). Test-retest reliability for SLR has been studied in healthy adults (Harju et al. 1991; 
Hunt et al. 2001).
In addition, in the test-retest reliability study (II) the domain of involuntary movement 
reaction functions (b765) was measured by the shoulder tug test (Pastor et al. 1993). 
The PwMS stood with feet 10 cm apart, the examiner delivered a brief backwards tug 
to the shoulders, and graded the participant’s response to the external perturbation 
on a scale ranging from 1 to 5. The measure was excluded from the latter parts of the 
study owing to poor test-retest agreement found.
Health Condition
Disease severity, clinical course, and disease duration from symptom onset and 
from diagnosis were confirmed by a neurologist (TS) (II–IV). Disease severity 
was assessed using the EDSS scale (Kurtzke 1983), which is based on neurological 
examination of 7 functional systems (pyramidal, cerebellar, cerebral, sensory, 
brain stem, visual, and bowel and bladder) and walking ability. It grades disease 
severity due to MS on a continuum from 0 (normal neurological function) to 10 
(death due to MS) in 0.5-point increments. It addresses impairment (symptoms 
and signs) at the lower levels (0–3.5), mobility in the middle range (4.0–7.5), and 
upper limb (8.0–8.5) and bulbar function (9.0–9.5) at the higher levels (Hobart 
2003). In this study PwMS were categorized into three levels of disease severity: 
no disability (EDSS score 0–1.5), minimal disability (EDSS score 2.0–3.5), and 
moderate disability (EDSS score 4.0–6.5). The clinical course of the disease was 
defined as primary remitting (RRMS or SPMS) or primary progressive (PPMS). 
The interval from the previous relapse was recorded as reported by the PwMS 
(III, IV). 
Contextual Factors
Sociodemographic data obtained by the questionnaire and face-to-face interview 
were used as descriptive variables (II–IV) and independent variables (III) as neces-
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sary. These data included sex, age, body mass index (BMI) and other diseases from 
the personal factors, and medication, drugs and use of walking aids from the envi-
ronmental factors. 
Fatigue and depressive symptoms
The impact of MS-related fatigue during the past month (III, IV) was assessed by the 
Modified Fatigue Impact Scale (MFIS), which provides an assessment of the effects 
of fatigue in terms of physical, cognitive, and psychosocial functioning (Multiple 
Sclerosis Council for Clinical Practice Guidelines 1998). The MFIS consists of 21 
statements that describe the effects of fatigue. The respondents self-rated how often 
fatigue had affected them in the described way during the past four weeks. The total 
MFIS score ranges from 0 (no fatigue) to 84 (maximum fatigue), with cut-off values 
of 38 (Flachenecker et al. 2002). The forward-backward translation process was used 
to translate the Finnish version of the MFIS used in the present study. Two transla-
tors independently translated the MFIS into the target language and a reconciled 
translation was developed. A native English speaker who was fluent in Finnish then 
translated the reconciled form back into English, and the result was compared against 
the original English MFIS by the researcher. Good reproducibility for the MFIS has 
been demonstrated in PwMS, with no significant differences being noted between the 
Belgian, Italian, Slovenian or Spanish versions of the scale (Kos et al. 2005). 
Depressive symptoms during the past week was assessed by the Center of Epide-
miologic Studies Depression Scale (CES-D) (Radloff 1977). The CES-D is a 20-item 
self-report rating scale in which the respondents are asked to rate the frequency of 
20 symptoms over past week by choosing one of four response categories, ranging 
from 0 (rarely or none of the time) to 3 (most of all the time). The total score ranges 
from 0 to 60. A cut-off score of 16 has been recommended for indicating a clinically 
significant level of depressive symptoms and a score of 21 or higher has been found to 
indicate major depression. (Radloff 1977; Weissman et al. 1977). A Finnish version of 
the CES-D reported in the Nordic Research on Ageing study (Heikkinen et al. 1997) 
was used in the present study. The original CES-D has been shown to be reliable and 
valid among PwMS (Verdier-Taillefer et al. 2001), and it has previously been used in 
a MS study (Chwastiak et al. 2002).
In this study the items of the MFIS and CES-D were linked to the most precise ICF 
categories by two independent assessors (the same ones as for the FSQ), and were 
found to address several components and domains. Thus, as the focus in the present 
study was on physical functioning, fatigue and depressive symptoms were used as 
covariates in the cross-sectional study (III). In addition, the MFIS was used to assess 
the feasibility and safety of the set of measures (II). In the test-retest reliability study 
the instructions were modified so that the PwMS reported how often fatigue had af-
fected him/her in a particular way before the first measurement and during the week 
following each of the three measurement sessions. In the present study, the test-retest 
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reliability of the Finnish version of the MFIS was found to be high (ICC 0.91 with a 
SEM of 6.1 points) (II).
External criterion in the responsiveness study (IV)
To determine whether a participant’s score had changed (IV), two external criteria 
were applied: (1) the participant’s perception of change by a single item of the RAND 
36-Item Health Survey (Hays et al. 1993b) that indicates perceived change in health; 
and (2) the change in EDSS scores, representing the perspective of the clinician. The 
RAND-36 item used was: “Compared to one year ago, how would your rate your health 
in general now?” Participants rated their perceived change on a 5-point Likert-type 
scale: “much better now than one year ago”, “somewhat better now than one year 
ago”, “about the same”, “somewhat worse now than one year ago”, and “much worse 
now than one year ago”. 
4.3 Statistical analysis
Data were analysed using SPSS versions 11.0, 13.0 and 14.0 for Windows. Frequencies 
and descriptive statistics (means, standard deviations [SDs], 95% confidence intervals 
[CIs], ranges) were used to obtain the demographic data. Complete data were not ob-
tained for all the PwMS. Owing to occasional missing data, the sample size for each 
statistical procedure varies somewhat. The level of significance was set as 0.05. 
4.3.1 Population-based survey (I)
On the basis of the questionnaire a series of descriptive analyses were undertaken to 
explore functioning. One-way ANOVA was used to analyse differences between re-
spondents, nonrespondents and excluded PwMS, between the PwMS grouped accord-
ing to mobility level, and between disease duration groups. The differences between 
the symptoms / no symptoms groups were analysed using T-test. 
4.3.2 Reliability studies (II)
The intraclass correlation coefficient (ICC2,1) (Shrout and Fleiss 1979) and 95% confi-
dence interval (CI) was calculated using macros downloaded from the SPSS website. 
ICC values < 0.60 were interpreted as poor reliability and ICC ≥ 0.80 reflected high 
reliability (Richman et al. 1980). To estimate the amount of measurement variability 
within the individual score, the standard error of measurements (SEM) were cal-
culated (SEM = SD × √1-ICC) and expressed in the same metric unit as the measure 
(Baumgartner 1989). Coefficient of variation (CV) ([SD / mean] × 100) was used to 
interpret the consistency of measures across time. An extension of this in a sample 
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of individuals is to calculate the mean CV (Atkinson and Nevill 1998), which was 
used in this study. Limits of agreement according to Bland and Altman (1986) were 
generated to illustrate absolute reliability (mean difference ± 2 SD). Additionally, the 
percentage of agreement was calculated for the MAS and shoulder tug test and 80% 
agreement was chosen as the threshold value for satisfactory agreement. 
To provide an indicator of the feasibility and safety of the measures, the time needed 
to compete the whole set of measures and the time needed to complete each outcome 
measure, the perceived physical intensity of each outcome measure, the incidence of 
relapses, and feeling of tiredness and perceived fatigue were assessed during the test-
retest reliability study. The differences in tiredness and fatigue between the measure-
ment sessions were analysed using t-test and the Friedman test where appropriate.
4.3.3 Cross-sectional study (III)
For self-care, mobility and domestic life participants were classified into 3 groups: 
independent (FSQ score 100), independent with perceived difficulties (FSQ score 
66.6–99.9) and dependent (FSQ score 0–66.5). Because of the reclassification of the 
FSQ, the original warning zones (Jette et al. 1986) could not be used. In this study 
the cut-off scores were chosen to indicate important functional change. A FSQ score 
of 100 represents fully independent performance without any subjective difficulty in 
any FSQ item. A cut-off score of 66.5 was chosen to differentiate participants who 
perceived difficulties in one or more FSQ items but were independent from those 
who were dependent (i.e., needed assistance and/or assistive devices). The differences 
between these groups were analysed using the Kruskal-Wallis test.
Analyses included construction of side-by-side box plots to explore the distribution 
of the physical functioning variables in relation to the performance groups for self-
care, mobility and domestic life. Extreme values for a variable within a group were 
excluded from the analyses. Out of 23 variables, 8 had no extreme values, 12 had 1–4 
extreme values and 3 had more than 4 extreme values per analysis. These 3 variables 
and the number of excluded cases were: MAS lower limb scores (n = 9 for self-care), 
velocity moment with eyes open (n = 9 for self-care) and velocity moment with eyes 
closed (n = 9 for self-care and n = 9 for domestic life). 
Multinomial logistic regression was used for modelling. The variables associated with 
performance in self-care, mobility and domestic life were identified using odds ratios 
(OR) with a 95% CI for being fully independent versus independent with perceived dif-
ficulties, and for being dependent versus independent with perceived difficulties, adjusted 
for age and gender. The 9 variables in activities and 14 variables in body functions 
(Figure 4) were independent variables. All the calculations were conducted using 
primary sampling units except the PCI (beats/min × 100) and walk ratio (m/steps per 
min × 1000). In addition, a multinomial logistic regression was performed using the 
ICF Personal Factors (gender, age, BMI, other diseases than MS), ICF Health Condi-
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tion variables (disease severity measured by EDSS, disease duration since symptom 
onset, length of diagnosis, clinical course of the disease, time from previous relapse), 
the impact of MS-related fatigue (MFIS), and depressive symptoms (CES-D) as inde-
pendent background variables.
4.3.4 Responsiveness study (IV)
Data from the participants at baseline and 2 years later were analyzed. Group differ-
ences between participants and drop-outs and differences in baseline EDSS and in 
occurrence of relapses were compared using the Mann-Whitney U test or Kruskal-
Wallis test for continuous variables and the Pearson chi-square test for categorical 
variables. The percentage of raw agreement and the Cohen kappa were used to examine 
the agreement between the participants’ perceptions and the clinician’s ratings. 
Distribution-based methods
The minimal detectable change (MDC) was considered at the individual level and is 
presented in the units used. Responsiveness is captured as the MDC with a confidence 
level of 95%, as follows (Beaton et al. 2001; Haley and Fragala-Pinkham 2006): 
MDC = 1.96 × √2 x SEM, 
where SEM is the standard error of measurement [ SD × √1-ICC] representing the extent 
to which the measurement of a parameter can vary. The MDC was calculated using 
the average SEM values obtained from previous test-retest and inter-rater reliability 
studies (II). Changes smaller than MDC cannot (with a confidence level of 95%) be 
reliably interpreted as real changes in the score for an individual (Wyrwich et al. 
1999; Haley and Fragala-Pinkham 2006). MDCproportion was calculated to determine 
the proportion of the study group that achieved at least the minimal amount of reli-
able change (Haley and Fragala-Pinkham 2006).
Anchor-based methods
An interval of one year between the successive sets of ratings was used; these were after-
wards combined in the 2-year follow-up results separately for both external criteria. 
Trichotomous categorizations of the change scores were used. For the participants’ 
perception of change, participants were classified as follows: deteriorated (somewhat 
or much worse), stable (about the same), and improved (somewhat or much better) ac-
cording to the RAND-36 item. For the clinician’s ratings, a change in the participant’s 
EDSS score of 1.0 point was used as a cut-off point for deterioration or improvement 
as it has frequently been used in previous trials and has been considered as clinically 
meaningful for patients with a baseline EDSS score of < 6.0 (Noseworthy et al. 1990; 
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Pfennings et al. 1999). The participants were classified as follows: deteriorated (change 
in EDSS score of ≥ 1 point), stable (change in EDSS score between 0 and ± 0.5 point), 
and improved (change in EDSS score of ≥ −1 point). 
The area under the receiver operating characteristic (ROC) curve (AUC) with its 95% 
confidence interval (95% CI) were calculated for each physical functioning measure, 
using changes in scores at 2 years from baseline. Relative responsiveness was assessed 
separately for deterioration and improvement. For both external criteria the scores 
were dichotomized using the category stable (no change) as the reference category. 
To compute the AUC, we used a non-parametric method that does not make any 
distributional assumptions (Hanley and McNeil 1982). The AUC can take any value 
between 0 and 1 and is a combined measure of sensitivity and specificity and can be 
interpreted as the probability of correctly discriminating between participants who 
are deteriorated and those who are stable. The practical lower limit for the AUC is 0.5. 
The bigger the AUC is, the better the overall performance of the measure. 
The minimally important change score (MIC) was calculated as the mean change 
in participants who showed a minimally important change according to an external 
criterion (Crosby et al. 2003). The MIC was calculated separately for the participants’ 
perception and the clinician’s rating using linear regression analysis modified from 
de Groot et al. (2006): 
Y = α + β1 × Y(t0) + β2 × deteriorated + β3 × improved + ε.
Scores for the physical functioning measures at the last follow-up were used as the 
dependent variables (Y). Two dummy variables based on the external criteria (dete-
riorated, improved) and the scores for the physical functioning measure at baseline 
Y(t0) were used as independent variables. The stable group was used as the reference 
group. The regression model enabled us to estimate the MIC for deterioration and 
improvement in a single model. In the formula, β2 is interpreted as the mean change 
in the physical functioning score for participants who had deteriorated and provides 
an estimate of MICdeterioration. It indicates the smallest difference in the outcome variable 
that signifies an important rather than trivial difference in the participants’ perception 
or the clinician’s rating. Side-by-side box plots of the outcome variables were visually 
inspected, and extreme values were excluded from the analysis to ensure that they 
did not compromise the results. 
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5 RESULTS
5.1 The impact of MS on performance in self-care, mobility and domestic life domains in 
the population-based survey in Central Finland (I) 
Overall, 90% of the PWMS in the Central Finland region participated in this survey 
(n = 240, see table 4). Differences were found in the gender distribution between the 
respondents, nonrespondents and excluded PwMS (ANOVA, F = 6.202, p < 0.01), but 
not in age, clinical course of MS, or disease duration since symptom onset or diagnosis 
(ANOVA, not significant [NS] for all comparison). 
Over half of the PwMS (60.5%) were retired on either a full disability pension (n = 118), 
a part-time disability pension (n = 9) or an old age pension (n = 18). Mean duration 
from diagnosis to disability pension was 9.3 ± 7.5 years (range 0–31 years). Seventy-two 
PwMS (30.0%) were employed either full- or part-time or were students. In addition 
ten PwMS (4.2%) were unemployed, seven (2.9%) were a home mother/father and six 
(2.5%) were on sick leave. 
Eight PwMS out of 240 were in-patients in health centre wards and nine PwMS were 
living in sheltered accommodation. The remaining PwMS were living at home either 
alone (20%) or with family members (72%). Almost half of the PwMS (n = 111) received 
the Social Insurance Institution of Finland disease care allowance. The Social Insur-
ance Institution of Finland provided outpatient physiotherapy for 62 PwMS while a 
further 48 PwMS were receiving it in their local health care centres. The average of 
physiotherapy was 51 ± 30 times per year, ranging up to 120 times per year, with 87 
PwMS receiving it 30 or more times per year. 
The symptoms were listed in 13 impairments in body functions and in 3 activity limita-
tions according to the ICF components. The most frequent symptoms having an impact 
on daily life were fatigue (36%), balance problems (29%) and walking difficulties (28%). 
The frequency of symptoms along with the restrictions in daily living is presented in 
Figure 5. Of the PwMS, 38 reported that they had no symptoms or signs of MS at that 
moment. Their average age (38.8 ± 11.8 years) and disease duration (8.1 ± 6.4 years) were 
significantly lower (p < 0.001) than those who had symptoms of MS (correspondingly, 
49.8 ± 11.0 and 17.1 ± 10.8 years). Seven PwMS with disease duration ≥ 15 years had no 
symptoms of MS at that time. Of the PwMS, 48 (20%) were receiving disease modifying 
therapies and 75 (31%) used symptomatic medication for their MS symptoms. 
The mobility level of the PwMS and demographic variables are presented in Table 
5. In answer to an open-ended question, almost half of the PwMS (46%) reported 
permanent use of a walking aid outdoors and 33% indoors. The most typical walking 
aids used outdoors were a wheelchair (n = 38) and a bilateral support (n = 26). Nine 
PwMS had a power wheelchair. Average disease duration from symptom onset to the 
use of a permanent walking aid was 13.1 ± 8.3 years (range 1–34 years). Of the survey, 
25% were able to walk outdoors without any problem or a walking aid after disease 
duration from symptom onset of ≥ 15 years.
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Ambulation difficulties
Balance problems
Loss of dexterity
Spasticity
Muscle weakness
Sexual disturbances
Bladder of bowel symptoms
Swallowing problems
Fatigue
Difficulty in breathing
Speech symptoms
Pain
Sensory symptoms
Visual symptoms
Depression
Cognitive disturbance
No symptoms
Impairments in body functions
Activity limitations
10         20        30         40         5050        40         30         20         10            0
Restriction in domestic life (%)No restriction in domestic life (%)
Figure 5. Symptoms of MS (%) classified by perceived restriction in domestic life (no restriction n = 127, perceived restriction 
n = 111, missing data n = 2). Reproduced with the kind permission of the Foundation for Rehabilitation Medicine.
Table 5. Demographic variables classified by mobility level. Reproduced with the kind permission of the Foundation 
for Rehabilitation Medicine.
Description of mobility level N
(%)
Sex
% women
Age (years) # Years since 
onset #
Years since 
diagnosis # 
Were able to walk without 
any problems 
122
(50.8%)
78.7% 42.9 ± 11.7* 
(20–71)
11.1 ± 8.9* 
(0–34)
6.3 ± 6.4* 
(0–26)
Were able to walk unaided 
up to 500 m
27
(11.3%)
66.7% 47.6 ± 9.6*
(34–73)
14.5 ± 9.1* 
(1–34)
9.6 ± 7.7*
(0–30)
Required a walkin� aid to 
walk about 100 m
37
(15.4%)
70.3% 54.0 ± 7.1* 
(41–67)
20.0 ± 8.8* 
(5–42)
13.5 ± 8.5*
(3–42)
Used wheelchair regularly 38
(15.8%)
73.7% 55.9 ± 9.6*
(36–76)
23.2 ± 11.8*
(4–56)
16.5 ± 8.9*
(1–39)
Were confined to bed 16
(6.7%)
68.8% 58.4 ± 9.0* 
(39–74)
26.1 ± 7.1* 
(6–38)
20.9 ± 6.5*
(5–35)
# Mean ± SD (ran�e).
* P < 0.001 for comparison between �roups (�NOV�).
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The mean WIQ walking distance score was 50.3 ± 43.6. Of the PwMS, 31.8% reported 
that they could walk distances over one kilometre without any difficulty, 25.1% had 
slight difficulties walking without walking aids, 20.5% had considerable difficulties 
walking without a walking aid and 22.6% of the PwMS were unable to walk even 
5 metres indoors without a walking aid. Of the PwMS, who reported being able to 
walk without any problems according to the mobility level scale (n = 122, see Table 5), 
38% reported slight or considerable difficulties in walking without a walking aid over 
the different WIQ distances. 
The mean FSQ scores were 80.2 ± 33.2 and 55.6 ± 38.6 for self-care and domestic life, 
respectively. The majority of the PwMS (82%) classified themselves as independent 
with no or some difficulties regarding self-care activities (Figure 6). In domestic life, 
25% of the PwMS were fully independent without any subjective difficulties in all 
three FSQ items, 28% were independent but perceived subjective difficulties in one 
or more of the items, and 47% reported restriction in domestic life, i.e. needed some 
aid or assistance or could not perform the items at all because of MS. The FSQ items 
are illustrated graphically in Figure 6. 
The mean scores of the WIQ and FSQ for self-care and domestic life decreased 
gradually with disease duration from symptom onset (p < 0.001 for all comparisons) 
(Figure 7). Half of the PwMS with ≥ 20 years of disease duration from symptom onset 
were fully independent in self-care, whereas the impact of MS was clearly seen in 
walking capacity without assistance and performance in domestic life (Table 6). 
0% 20% 40% 60% 80% 100%
Self-care
Eating,dressing, bathing
Domestic life
Household tasks
Errands
Gardening
No difficulty Subjective difficulties Some aid or assistance Not do because of MS
Figure 6. Performance in self-care and domestic life items according to the FSQ items. Reproduced with the kind 
permission of the Foundation for Rehabilitation Medicine.
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39.4
64.6
45.0
49.3
82.9
51.2
56.6
87.1
68.1
66.4
86.8
81.8
79.8
96.7
Self-care (FSQ)
Domestic life 
(FSQ)
Walking capacity 
(WIQ)
Figure 7. Performance in self-care (FSQ) and in domestic life (FSQ) and walking capacity (WIQ) according to  
disease duration (years) from symptom onset (mean).
Table 6. Proportion of fully independent and fully dependent PwMS in walking capacity, self-care and domestic life 
according to disease duration (years) from symptom onset (n = 238, missing n = 2).
Disease duration from symptom onset (years)
0–4 y 
(n = 41)
5–9 y 
(n = 44)
10–14 y 
(n = 31)
15–19 y 
(n = 39)
≥ 20 y
(n = 83)
Walkin� capacity of PwMS 
− No difficulties # (%)
− Not able to walk 
58.5%
2.4%
48.8%
9.3%
32.3%
16.1%
 
23.1%
17.9%
 
13.3%
44.6%
Self-care (FSQ)
− Fully independent # PwMS (%)
− Fully dependent § PwMS (%)
92.7%
0%
72.7%
2.3%
67.7%
0%
69.2%
5.1%
54.3%
24.7%
Domestic life (FSQ)
− Fully independent # PwMS (%)
− Fully dependent § PwMS (%)
51.2%
7.3%
31.8%
11.4%
22.6%
19.4.%
12. 9%
10.3 %
16.0%
35.8%
# Fully independent, without assistance or sub�ective difficulties (WIQ = 100; FSQ = 100).
 Were not able to walk at all without walkin� aid (WIQ = 0).
§ Fully dependent in self-care and domestic life (FSQ = 0).
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5.2 Reliability and feasibility of the physical functioning measures
5.2.1 Reliability (II)
The ICC values were greater than 0.80 in 17 of 23 parameters for test-retest reliability 
and correspondingly in 20 out of 26 parameters for inter-rater reliability (II). The 
weakest test-retest reliability was obtained for the PCI of the 6MWT (ICC 0.59, with 
SEM 0.13 beats/meter). The other ICC values of the test-retest reliability study and all 
of the ICC values of the inter-rater reliability study were greater than 0.60, indicating 
acceptable reliability. The CV of the measures over the one-week intervals ranged 
from 1.1% to 36.6% in the test-retest reliability study and from 1.3% to 48.5% in the 
inter-rater reliability study. A moderate amount of variability was discovered for the 
Kela Coordination Test, velocity moments and muscle endurance tests. The reliability 
values (ICC, SEM and CV) and Bland-Altman plots for each of the outcome measures 
are presented in Appendix 3. 
The MAS scores ranged from 0–4 and thus were not distributed across the entire 
scale. Normal muscle tone (grade 0) was obtained in 93% and 81% of cases in the 
test-retest reliability study and 81% and 76% of cases in the inter-rater reliability study 
for upper limbs and lower limbs, respectively. Percentage of agreement was 93.4% 
for the combined upper limb spasticity score and 71.1% for the combined lower limb 
spasticity score in the test-retest reliability study and 80.6% for the combined upper 
limb spasticity score and 63.9% for the combined lower limb spasticity score in the 
inter-rater reliability study. 
The data obtained from the shoulder tug test were highly skewed because of the high 
frequency of the score 1 (normal response) and the scores were not distributed across 
the entire scale. Twelve out of 19 PwMS showed a normal response while only 1 PwMS 
showed an abnormal response to the shoulder tug test in all the test-retest measure-
ments. The overall percentage of agreement was 68.4% between the measurements. 
Most of the agreement was found for those who had a score of 1.
5.2.2 Feasibility
The feasibility and safety of the set of outcome measures were examined during the 
test-retest reliability study. The average time taken to perform the whole set of outcome 
measures, including rest periods, was 73.8 ± 3.5 minutes (range 64–91 min). Individual 
variation in the duration of the measurement session over the three occasions was 10 
minutes on average (range 1–20 min). The largest variation was in the group who re-
quired assistance to walk about 100 metres (EDSS score 4.0–6.0). Each test took from 
four to ten minutes. There was considerable variation in perceived exertion (RPE, scale 
6–20) (Borg 1970), which was elicited immediately after performance of each measure. 
Overall, the highest RPE values were reported after the repetitive endurance tests (mean 
RPE 15, range 10–20), whereas the other tests were felt to be quite easy (Figure 8).
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No relapses or other major acute complications occurred during the test-retest reli-
ability study. The set of measures was well tolerated, as indicated by the willingness 
of the PwMS to return for their second and third testing sessions. A visual analogue 
scale (VAS, score 0–100 mm) was used to assess the feeling of tiredness instantly 
after the measurement (Figure 9a), later the same evening (Figure 9b), and the next 
day (Figure 9c). Mean VAS was 42 ± 21 mm instantly after the measurement, 37 ± 27 
mm later the same evening and 31 ± 26 mm the next day, showing a slight but not 
significant decrease (Friedman test, p = 0.121). 
Figure 8. Mean perceived exertion (RPE, scale 6–20) in three test-retest measurement sessions elicited immediately 
after performance of each outcome measure. 
Figure 9. Feeling of tiredness during the three measurements in test-retest reliability study (n = 19) assessed by visual 
analogue scale (VAS, 0–100 mm): (A) after each test-retest measurement session, (B) later the same evening, and (C) 
the next day. 
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Perceived fatigue was measured by the MFIS before the 1st measurement and one 
week after the 1st, 2nd and 3rd measurements (Figure 10). There were no statistically 
significant changes in fatigue during the test-retest reliability study. Mean MFIS was 
40.6 ± 20.9 before the 1st measurement and 36.3 ± 19.8 one week after the 3rd meas-
urement (t-test, t = 1.626, p = 0.122). The largest variation in fatigue was in the group 
without disability (EDSS score 0.0–1.5). When controlling for effects of the baseline 
fatigue, no correlation was found between the perceived exertions of the measures 
(RPE) and feeling of tiredness (VAS).
Figure 10. MS-related fatigue (MFIS, range 0–84) before the 1st and one week after the 1st, 2nd and 3rd 
measurements (mean and 95% CI) assessed during the test-retest reliability study (n = 19). 
5.3 Predictors of self-reported performance in self-care, mobility and domestic life 
in ambulatory PwMS: a cross-sectional study (III)
Cross-sectional data on 120 ambulatory PwMS with a mean age of 45 years and mean 
disease duration since onset of 12 years (see Table 4) were analyzed. Average (SD) 
FSQ scores for self-care, mobility, and domestic life were 93.8 ± 11.9 (range, 50–100), 
81.8 ± 26.4 (range, 7–100), and 76.9 ± 28.3 (range, 0–100), respectively. Restrictions 
in self-reported performance were substantially more prevalent in the mobility and 
domestic life domains than in the self-care domain (Figure 11). All scales showed 
statistically significant differences between the fully independent, independent with 
perceived difficulties, and dependent groups (Kruskal-Wallis test, p < 0.001). 
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Figure 11. Self-reported performance obtained from the FSQ: (A) self-care, (B) mobility, and (C) domestic life. Boxes 
show 25%–75% quartiles; whiskers 10%–90% percentiles; solid lines median values. Reproduced with the kind 
permission of Elsevier.
Associations between personal factors and self-reported performance 
A multinomial logistic regression was used to analyze the relationships between self-
reported performance in self-care, mobility and domestic life and personal factors 
(age, sex, BMI, other diseases). Significant associations were found only between age 
and mobility (OR = 1.06; 95% CI, 1.00–1.18 for dependent vs. perceived difficulties) 
and between age and domestic life (OR = 0.95; 95% CI, 0.91–0.99 for independent vs. 
perceived difficulties). 
Associations between health condition and self-reported performance
Among the health condition variables, mild disease severity (EDSS < 4.0) was sig-
nificantly associated with independent performance in self-care (OR = 11.39; 95% CI, 
4.21–30.76 for independent vs. perceived difficulties) and with dependency in mobil-
ity and in domestic life (OR = 0.03; 95% CI, 0.01–0.14; OR = 0.16; 95% CI, 0.00–0.07, 
respectively, for dependent vs. perceived difficulties). In addition, RRMS was associ-
ated with dependency in mobility (OR = 6.42; 95% CI, 1.25–32.86 for dependent vs. 
perceived difficulties). Disease duration from symptom onset, disease duration from 
diagnosis, and relapse during the preceding 6 months were not significantly related 
to self-reported performance.
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Associations between outcomes of physical functioning measures and self-reported performance
Self-care. The associations between the dependent PwMS and independent PwMS with 
perceived difficulties in self-care performance were excluded from results because of 
the small number of PwMS in the dependent group (n = 6). The Kela Coordination 
Test was the only outcome measure of activities which did not influence independ-
ence in self-care (Table 7). The measure most strongly associated with independence 
in self-care was 10MWT time at maximal speed. As the calculations were made using 
primary sampling units, these effects are quite large. 
In body functions, when comparing the independent PwMS with those who perceived 
difficulties in self-care, significant predictors were HR change and RPE during the 
6MWT, 10MWT stride length and cadence, MVC of the knee extensors, repetitive 
squatting and right hand dumbbell presses, and MAS score for both upper and lower 
limbs (Table 8). 
Mobility. All the measures of activities were significantly associated with performance 
in mobility when the independent PwMS were compared with those who perceived 
difficulties (Table 9). The Kela Coordination Test was the only outcome measure of 
activities which had no influence on the dependency in mobility. The effects in par-
ticularly of the BBS and 10MWT are large, i.e., the likelihood of being independent 
rather than perceiving difficulties in mobility increased over 2-fold (OR = 2.15) if 
the PwMS had a 1-point better score in the BBS, a 1-point lower BBS increased the 
likelihood of being dependent in mobility by approximately one third (OR = 0.67), 
and a 1-second faster walking time at normal speed increased by 50% the likelihood 
of being fully independent rather perceiving difficulties in mobility.
Table 10 presents age- and sex-adjusted ORs and their CIs for the association between 
the clinical outcome measures of the ICF body functions and self-reported performance 
in mobility. Of the measures, 10MWT stride length and cadence, and MAS score for 
the lower limbs predicted performance in mobility when both the independent and 
dependent PwMS groups were compared to the group with perceived difficulties. 
Domestic life. Table 11 presents age- and sex-adjusted ORs and their CIs for the 
association between the clinical outcome measures of the ICF activities and self- 
reported performance in domestic life. Self-reported performance in domestic life was 
predicted by the BBT for the dominant hand, BBS, velocity moment with eyes open, 
10MWT time at normal speed, and 6MWT distance in the ICF activities. The ICF 
body functions variables which most strongly predicted self-reported performance 
in domestic life were the 6MWT RPE, 10MWT stride length and repetitive squatting 
when both the independent and dependent PwMS groups were compared to the group 
with perceived difficulties (Table 12).
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Effect of depressive symptoms and fatigue on self-rated performance in self-care, mobility  
and domestic life
Overall 40% (n = 49) of the PwMS experienced depressive symptoms when a CES-D 
cut-off score of 16 was used. The average CES-D score was 14.9 ± 11.6 (range, 0–47). 
When assessed as a continuous measure, the only significant association between 
CES-D and ADL performance was in domestic life when the independent PwMS were 
compared with those who perceived difficulties (OR = 2.69; 95% CI, 1.09–6.77).
The average level of MS-related fatigue measured by the MFIS was 35.0 ± 16.5 (range, 
0–84) and almost 50% of the PwMS (n = 57) scored above the cut-off value of 38. In 
domestic life, those who were independent had significantly less fatigue compared 
to the PwMS who perceived difficulties or were dependent (MFIS, 20.9 ± 12.0, 39 ± 
14.3, and 45.7 ± 12.8, respectively, p < 0.001). Fatigue was an independent predictor in 
self-reported performance in self-care (OR = 0.94; 95% CI, 0.91–0.97), mobility (OR = 
0.95; 95% CI, 0.93–0.98), and domestic life (OR = 0.90; 95% CI, 0.87–0.94) when the 
independent PwMS were compared with those who perceived difficulties. Instead, it 
was an independent predictor only in domestic life (OR = 1.04; 95% CI, 1.00–1.08) 
when the dependent PwMS were compared with those who perceived difficulties.
Because of the substantial level of fatigue, additional multinomial logistic regression 
analyses adjusted for age, sex, and fatigue (MFIS) were conducted between physical 
functioning and self-reported performance in self-care, mobility and domestic life. 
Only minor changes in the significant associations were found. In activities, the BBT 
for the dominant hand (see Table 9) no longer showed a significant association with 
mobility (OR = 1.04; 95% CI, 1.00–1.09 for the independent PwMS vs. those who 
perceived difficulties; p = 0.064). In body functions, when comparing the indepen-
dent PwMS with those who perceived difficulties, the ORs between the 6MWT RPE 
(see Table 8) and performance in self-care (OR = 0.85; 95% CI, 0.66–1.10; p = 0.208) 
and between the 6MWT RPE (see Table 12) and performance in domestic life (OR 
= 0.69; 95% CI, 0.47–1.02; p = 0.062) became nonsignificant, while the ORs between 
the walk ratio of the10MWT (see Table 8) and performance in self-care became sig-
nificant (OR=0.65; 95% CI, 0.43–0.98; p = 0.038). When the dependent PwMS were 
compared with those who perceived difficulties, the OR between the change in heart 
rate during the 6MWT (see Table 10) and performance in mobility became nonsig-
nificant (OR = 0.96; 95% CI, 0.93–1.00; p = 0.056), while the OR between the 6MWT 
PCI (see Table 12) and performance in domestic life became significant (OR = 1.03; 
95% CI, 1.00–1.05; p = 0.021).
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Table 7. Associations between self-reported performance in self-care (FSQ) and clinical outcome measures of activities 
(capacity) (ORs and 95% CIs from multinomial logistic regression analyses). Reproduced with the kind permission of 
Elsevier.
Self-care
Activities (capacity) Independent (n = 83) vs.
perceived difficulties (n = 31)
Dependent (n = 6) vs.
perceived difficulties (n = 31)
OR (95% CI) OR (95% CI)
BBT of dominant hand (number/min) 1.07 (1.03–1.12) N�
BBS score (0–56) 1.24 (1.11–1.38) N�
�ela Coordination Test: time (s) 0.99 (0.97–1.01) N�
�ela Coordination Test: faults (number) 0.99 (0.91–1.07) N�
Velocity moment eyes open (mm2/s) 0.95 (0.91–0.99) N�
Velocity moment eyes closed (mm2/s) 0.97 (0.95–0.99) N�
10MWT time at normal speed (s) 0.72 (0.60–0.87) N�
10MWT time at maximal speed (s) 0.52 (0.37–0.73) N�
6MWT distance (m) 1.01 (1.00–1.01) N�
NOTE: Values in bold are statistically si�nificant (p < 0.05). Values are ad�usted for a�e and sex.
N�, not applicable (omitted because of the small number of the participants in the ‘dependent’ �roup).
Table 8. Associations between self-reported performance in self-care (FSQ) and clinical outcome measures of body functions 
(ORs and 95% CIs from multinomial logistic regression analyses). Reproduced with the kind permission of Elsevier.
Self-care
Body functions Independent (n = 83) vs.
perceived difficulties (n = 31)
Dependent (n = 6) vs.
perceived difficulties (n = 31)
OR (95% CI) OR (95% CI)
6MWT HRmax at end (beats/min) 1.02 (1.00–1.05) N�
6MWT HR chan�e (beats/min) 1.05 (1.02–1.08) N�
6MWT PCI (beats/m × 100) 1.01 (0.98–1.03) N�
6MWT RPE (6–20) 0.78 (0.62–0.98) N�
10MWT stride len�th (cm) 1.04 (1.02–1.06) N�
10MWT cadence (steps/min) 1.06 (1.03–1.09) N�
10MWT walk ratio (m/steps per min × 1000) 0.86 (0.60–1.23) N�
Ri�ht hand �rip stren�th (k�) 1.02 (0.96–1.09) N�
MVC of the knee extensors (k�) 1.03 (1.01–1.05) N�
Repetitive squattin� (times) 1.12 (1.05–1.20) N�
Ri�ht hand repetitive dumbbell presses (k� × times) 1.03 (1.01–1.04) N�
M�S score for upper limbs (0–20) 0.38 (0.21–0.69) N�
M�S score for lower limbs (0–20) 0.44 (0.29–0.67) N�
SLR for ri�ht hamstrin� muscle flexibility (de�ree) 1.02 (0.99–1.05) N�
NOTE: Values in bold are statistically si�nificant (p < 0.05). Values are ad�usted for a�e and sex.
N�, not applicable (omitted because of the small number of the participants in the ‘dependent’ �roup).
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Table 9. Associations between self-reported performance in mobility (FSQ) and clinical outcome measures of activities 
(capacity) (ORs and 95% CIs from multinomial logistic regression analyses). Reproduced with the kind permission of 
Elsevier.
Mobility
Activities (capacity) Independent (n = 57) vs.
perceived difficulties (n = 37)
Dependent (n = 26) vs.
perceived difficulties (n = 37)
OR (95% CI) OR (95% CI)
BBT of dominant hand (number/min) 1.05 (1.01–1.10) 0.93 (0.89–0.98)
BBS score (0–56) 2.15 (1.45–3.14) 0.67 (0.54–0.83)
�ela Coordination Test: time (s) 0.98 (0.96–0.99) 0.97 (0.92–1.02)
�ela Coordination Test: faults (number) 0.90 (0.83–0.98) 0.90 (0.74–1.09)
Velocity moment eyes open (mm2/s) 0.86 (0.80–0.93) 1.04 (1.01–1.07)
Velocity moment eyes closed (mm2/s) 0.97 (0.95–0.99) 1.01 (1.00–1.02)
10MWT time at normal speed (s) 0.50 (0.34–0.74) 1.87 (1.29–2.69)
10MWT time at maximal speed (s) 0.38 (0.21–0.67) 2.43 (1.41–4.21)
6MWT distance (m) 1.01 (1.00–1.01) 0.99 (0.98–0.99)
NOTE: Values in bold are statistically si�nificant (p < 0.05). Values are ad�usted for a�e and sex.
Table 10. Associations between self-reported performance in mobility (FSQ) and clinical outcome measures of body functions 
(ORs and 95% CIs from multinomial logistic regression analyses). Reproduced with the kind permission of Elsevier.
Mobility
Body functions Independent (n = 57) vs.
perceived difficulties (n = 37)
Dependent (n = 26) vs.
perceived difficulties (n = 37)
OR (95% CI) OR (95% CI)
6MWT HRmax at end (beats/min) 1.01 (0.99–1.04) 0.97 (0.94–1.00)
6MWT HR chan�e (beats/min) 1.02 (0.99–1.05) 0.96 (0.92–1.00)
6MWT PCI (beats/m × 100) 1.00 (0.98–1.02) 1.04 (1.01–1.07)
6MWT RPE (6–20) 0.78 (0.60–1.02) 1.33 (0.99–1.78)
10MWT stride len�th (cm) 1.05 (1.02–1.08) 0.94 (0.91–0.97)
10MWT cadence (steps/min) 1.05 (1.01–1.09) 0.93 (0.89–0.96)
10MWT walk ratio (m/steps per min × 1000) 1.36 (0.87–2.12) 1.52 (0.94–2.46)
Ri�ht hand �rip stren�th (k�) 1.02 (0.95–1.09) 1.00 (0.92–1.08)
MVC of the knee extensors (k�) 1.01 (0.99–1.04) 0.94 (0.91–0.97)
Repetitive squattin� (times) 1.10 (1.04–1.17) 0.93 (0.84–1.03)
Ri�ht hand repetitive dumbbell presses (k� × times) 1.00 (1.00–1.01) 0.93 (0.90–0.97)
M�S score for upper limbs (0–20) 0.18 (0.05–0.67) 1.51 (0.98–2.31)
M�S score for lower limbs (0–20) 0.17 (0.05–0.52) 1.47 (1.13–1.91)
SLR for ri�ht hamstrin� muscle flexibility (de�ree) 1.02 (0.99–1.05) 0.99 (0.96–1.02)
NOTE: Values in bold are statistically si�nificant (p < 0.05). Values are ad�usted for a�e and sex.
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Table 11. Associations between self-reported performance in domestic life (FSQ) and clinical outcome measures of 
activities (capacity) (ORs and 95% CIs from multinomial logistic regression analyses). Reproduced with the kind 
permission of Elsevier.
Domestic life
Activities (capacity) Independent (n = 38) vs.
perceived difficulties (n = 51)
Dependent (n = 31) vs.
perceived difficulties (n = 51)
OR (95% CI) OR (95% CI)
BBT of dominant hand (number/min) 1.07 (1.02–1.12) 0.93 (0.89–0.98)
BBS score (0–56) 1.68 (1.13–2.49) 0.66 (0.55–0.80)
�ela Coordination Test: time (s) 0.98 (0.96–1.01) 1.02 (1.00–1.05)
�ela Coordination Test: faults (number) 0.95 (0.87–1.03) 1.03 (0.92–1.16)
Velocity moment eyes open (mm2/s) 0.85 (0.76–0.94) 1.09 (1.03–1.14)
Velocity moment eyes closed (mm2/s) 0.98 (0.95–1.01) 1.03 (1.01–1.05)
10MWT time at normal speed (s) 0.53 (0.34–0.81) 1.52 (1.22–1.89)
10MWT time at maximal speed (s) 0.63 (0.39–1.02) 1.79 (1.31–2.45)
6MWT distance (m) 1.01 (1.00–1.01) 0.99 (0.99–0.99)
NOTE: Values in bold are statistically si�nificant (p < 0.05). Values are ad�usted for a�e and sex.
Table 12. Associations between self-reported performance in domestic life (FSQ) and clinical outcome measures of body 
functions (ORs and 95% CIs from multinomial logistic regression analyses). Reproduced with the kind permission of 
Elsevier.
Domestic life
Body functions Independent (n = 38) vs.
perceived difficulties (n = 51)
Dependent (n = 31) vs.
perceived difficulties (n = 51)
OR (95% CI) OR (95% CI)
6MWT HRmax at end (beats/min) 1.02 (0.99–1.05) 0.98 (0.95–1.01)
6MWT HR chan�e (beats/min) 1.02 (0.99–1.04) 0.95 (0.91–0.98)
6MWT PCI (beats/m × 100) 1.00 (0.98–1.03) 1.02 (1.00–1.04)
6MWT RPE (6–20) 0.64 (0.46–0.88) 1.32 (1.03–1.70)
10MWT stride len�th (cm) 1.04 (1.01–1.08) 0.94 (0.91–0.97)
10MWT cadence (steps/min) 1.02 (0.98–1.06) 0.88 (0.83–0.94)
10MWT walk ratio (m/steps per min × 1000) 1.27 (0.83–1.94) 1.19 (0.80–1.76)
Ri�ht hand �rip stren�th (k�) 0.99 (0.93–1.06) 0.96 (0.89–1.02)
MVC of the knee extensors (k�) 1.00 (0.98–1.02) 0.94 (0.91–0.97)
Repetitive squattin� (times) 1.07 (1.03–1.12) 0.90 (0.83–0.99)
Ri�ht hand repetitive dumbbell presses (k� × times) 1.00 (1.00–1.01) 0.94 (0.91–0.97)
M�S score for upper limbs (0–20) 0.41 (0.11–1.55) 2.82 (1.51–5.28)
M�S score for lower limbs (0–20) 0.35 (0.12–1.00) 2.32 (1.54–3.50)
SLR for ri�ht hamstrin� muscle flexibility (de�ree) 1.02 (0.99–1.04) 0.98 (0.95–1.01)
NOTE: Values in bold are statistically si�nificant (p < 0.05). Values are ad�usted for a�e and sex.
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5.4 Responsiveness in the 2-year prospective longitudinal study of ambulatory PwMS (IV)
5.4.1 Distribution-based responsiveness of the clinical measures of physical functioning
The minimal detectable change (MDC) provides an estimate of the magnitude of the 
change found in the clinical epidemiological data for the ambulatory PwMS (IV) dur-
ing the 2-year follow-up period. The MDC was considered at the individual level and 
is presented in the units of the respective measures. The MDCs for each of the physical 
functioning measures are presented in Appendix 3. For example, the responsiveness 
findings with regard to the BBS showed a MDC of 2.3 points, indicating that changes 
in the BBS need to be at least 3 points before a real change rather than a chance fluc-
tuation can be reliably concluded. In addition, the MDC for the MFIS was examined 
and found to be 16.9 points. 
The MDCproportion indicates a stable situation in 61% of outcomes, as in those measures 
less than 10% of the participants’ scores exceeded the MDC. During the 2-year fol-
low-up the largest fluctuations (MDCproportion over 20%) were seen for muscle power 
functions (21.3% for grip strength and 44.1% for MVC of the knee extensors), upper 
extremity muscle endurance function (27.7% for right hand repetitive dumbbell 
presses), fine hand use (30.3% for BBT) and the Berg Balance Scale (25.7%) for chang-
ing and maintaining body position.
5.4.2 Deterioration in physical functioning; anchor-based responsiveness
Data from the PwMS at baseline and 2 years later were analyzed. The average age and 
disease duration from symptom onset and from diagnosis of those PwMS who dropped 
out (n = 11) were similar to the average age and disease durations of those PwMS who 
completed the study (n = 109) (Mann-Whitney U test, NS for all comparisons). The 
participants and drop-outs were also similar in sex distribution, baseline disease 
severity as assessed by the EDSS, and clinical course of the disease (chi-square test, 
NS for all comparisons). The results for the physical functioning measures at baseline 
and at the 2-year follow-up (n = 109) are presented in Table 13.
Overall, 51.4% of the PwMS did not report any relapse during the 2-year follow-up, 
28.0% had 1 relapse and 20.6% had 2 or more relapses. The association between oc-
currence of relapses and deterioration according to the EDSS rating was statistically 
significant (Pearson χ2(4) = 15.76, p < 0.01); however, this was not the case when the 
occurrence of relapses were compared to the participants’ own perception of change 
assessed by the RAND-36 item (Pearson χ2(4) = 4.70, p = 0.320). With the Kruskal-
Wallis test, the changes in the parameters significantly related to the occurrence of 
relapses were Kela Coordination Test time, velocity moment with eyes open and eyes 
closed, 6MWT distance, change in HR during the 6MWT, and self-reported perform-
ance (FSQ) in self-care and in domestic life. 
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The percentage of the PwMS showing deterioration according to their own per-
ception and to the clinician’s rating over the 2-year follow-up period were 51.4% 
(n = 56) and 25.7% (n = 28), respectively. A small percentage of PwMS improved 
(17.4% according to the participants’ perception and 7.3% according to the clini-
cian’s rating). Thus, the results for improvement were less clear, and the data are not 
shown. According to the participants’ perceptions, 31.2% (n = 34) remained stable 
compared with the 67.0% (n = 73) rated as stable by the clinician. The agreement 
between the participants’ perceptions and the clinician’s ratings in classifying the 
PwMS as deteriorated, stable or improved was 46% (қ = 0.16). Pearson chi-square 
showed no significant association between baseline EDSS scores and deterioration 
according to either the participants’ perceptions or the clinician’s rating. 
Irrespective of the external criterion applied, the measures most responsive to 
deterioration were: self-reported performance in self-care, mobility and domestic 
life measured by the FSQ; distance and change in heart rate during the 6MWT; 
10MWT velocities, stride length and cadence; repetitive squatting; and BBT. The 
AUC values ranged from 0.43 to 0.76 and had wide CIs. For 14 out of 26 param-
eters (clinician’s rating) and 11 out of 26 parameters (participants’ perceptions), the 
AUC significantly differed from 0.50. For MICdeterioration, 15 out of 26 parameters 
(clinician’s rating) and 10 out of 26 parameters (participants’ perceptions), the MIC 
significantly differed from zero. 
The results for deterioration drawn from AUC and MICdeterioration according to the cli-
nician’s rating can be found in Table 14 and according to the participants’ perceptions 
in Table 15. All the self-reported performance measures (i.e., FSQ scores for self-care, 
mobility, and domestic life) had significant AUC values and MICdeterioration values. Of 
the clinician’s ratings there were 6 significant AUC values out of 9 and 6 MICdeterioration 
values out of 9 for the ICF activities component, whereas for the ICF body functions 
component, the proportion of significant values was smaller (5 out of 14 AUC values 
and 6 out of 14 MICdeterioration values). Of the participant’s perceptions, there were 5 out 
of 9 significant AUC values and 4 out of 9 MICdeterioration values for the ICF activities, 
whereas there were only 3 out of 14 significant AUC values and 3 out of 14 MICdeterioration 
values for the ICF body functions.
In addition to the physical functioning measures, AUC and MICdeterioration values were 
calculated for the MFIS and CES-D. The MFIS showed significant AUC and MIC-
deterioration values both for the participants’ perceptions (0.69; 95% CI 0.59−0.79 and 
11.0; 95% CI 5.9–16.2, respectively) and clinician’s ratings (0.67, 95% CI 0.56–0.78 
and 6.7; 96% CI 1.3–12.2, respectively). For CES-D there were no significant AUC or 
MICdeterioration values. 
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Table 13. Data from the outcome measures of the PwMS who participated in the 2-year follow-up study (IV) at baseline 
and 2 years later (n = 109). Reproduced with the kind permission of the American Physical Therapy Association.
Physical functioning measure
Score
Baseline 2-year
Mean (SD) N Mean (SD) N
Activities and Participation (performance)
FSQ Self-care 0–100 93.5 (12.2) 109 90.5 (15.7) 109
FSQ Mobility 0–100 80.8 (26.2) 109 76.5 (28.6) 109
FSQ Domestic life 0–100 75.5 (28.7) 109 72.4 (28.8) 109
Activities (capacity)
BBT of dominant hand no. of blocks/min 62.1 (12.9) 109 64.3 (13.8) 109
BBS score 0–56 50.9 (8.0) 109 50.4 (8.8) 109
�ela Coordination Test time s 75.5 (31.4) 80 75.6 (30.5) 80
�ela Coordination Test faults number 8.4 (7.5) 80 8.5 (7.0) 80
Velocity moment eyes open mm2/s 21.9 (33.9) 106 23.9 (53.1) 104
Velocity moment eyes closed mm2/s 57.5 (94.3) 100 46.3 (65.7) 99
10MWT velocity at normal speed m/s 1.2 (0.5) 109 1.2 (0.5) 109
10MWT velocity at maximal speed m/s 1.6 (0.6) 109 1.6 (0.6) 109
6MWT distance meter 474.0 (184.8) 108 474.4 (186.6) 104
Body Functions
6MWT HRmax at end beats/min 112.2 (19.0) 104 112.8 (17.6) 103
6MWT HR chan�e (beats/min) beats/min 44.9 (18.1) 104 44.8 (17.5) 103
6MWT PCI beats/m 0.6 (0.5) 103 0.7 (0.5) 105
6MWT RPE 6–20 13.3 (2.0) 107 13.5 (2.2) 106
10MWT stride len�th cm 133.3 (33.1) 109 130.5 (33.0) 109
10MWT cadence steps/min 106.9 (22.2) 109 106.3 (23.1) 109
10MWT walk ratio m/steps/min 0.006 (0.001) 109 0.006 (0.001) 109
Ri�ht hand �rip stren�th k� 33.4 (10.9) 108 32.5 (12.1) 109
MVC of the knee extensors k� 76.0 (27.5) 106 76.5 (28.2) 102
Repetitive squattin� no. of repetitions 26.0 (21.4) 95 28.1 (24.7) 90
Ri�ht hand repetitive dumbbell presses k� × no. of 
repetitions
97.1 (67.8) 102 107.0 (71.5) 94
M�S score for upper limbs 0–20 0.6 (1.1) 109 0.9 (1.9) 109
M�S score for lower limbs 0–20 1.6 (3.0) 109 1.8 (3.5) 108
SLR for ri�ht hamstrin� muscle flexibility de�ree 86.3 (18.0) 109 85.3 (17.8) 109
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Table 14. Results of anchor-based methods for deterioration using the clinician’s rating (EDSS) as external criterion. 
Reproduced with the kind permission of the American Physical Therapy Association.
Physical functioning measure AUC MIC deterioration
AUC 95% CI p B 95% CI p
Activities and participation (performance)
FSQ Self-care 0.73 0.61–0.85 < 0.001 –9.54 –13.66– –5.43 < 0.001
FSQ Mobility 0.71 0.61–0.82  0.001 –10.87 –17.02– –4.71  0.001
FSQ Domestic life 0.66 0.54–0.79  0.009 –11.33 –18.62– –4.05  0.003
Activities (capacity)
BBT of dominant hand 0.71 0.59–0.83  0.001 –5.23 –8.58– –2.07  0.002
BBS score 0.57 0.44–0.69 0.306 –0.60 –2.24–1.05 0.473
�ela Coordination Test time 0.54 0.38–0.69 0.624 –0.25 –11.28–10.79 0.965
�ela Coordination Test faults 0.59 0.42–0.75 0.253 1.40 –0.23–3.03 0.090
Velocity moment eyes open 0.63 0.49–0.77 0.043 4.95 0.71–9.19 0.023
Velocity moment eyes closed 0.70 0.57–0.83 0.003 16.33 7.13–25.54 0.001
10MWT velocity at normal speed 0.64 0.52–0.75 0.033 –0.08 –0.15– –0.01 0.025
10MWT velocity at max.speed 0.76 0.66–0.86 < 0.001 –0.19 –0.28– –0.11 < 0.001
6MWT distance 0.76 0.65–0.86 < 0.001 –55.06 –79.51– –30.62 < 0.001
Body Functions
6MWT HRmax at end 0.61 0.48–0.73 0.106 –5.13 –10.46–0.20 0.059
    6MWT HR chan�e (beats/min) 0.65 0.52–0.78 0.023 –6.77 –11.90– –1.64 0.010
6MWT PCI 0.43 0.30–0.56 0.280 –0.01 –0.07–0.05 0.855
6MWT RPE 0.54 0.41–0.66 0.564 0.33 –0.40–1.05 0.374
10MWT stride len�th 0.63 0.51– –0.74 0.049 –3.96 –9.18–1.26 0.135
10MWT cadence 0.57 0.45–0.69 0.281 –3.90 –7.44– –0.37 0.031
10MWT walk ratio 0.55 0.44–0.67 0.417 –0.0001 –0.00–0.00 0.414
Ri�ht hand �rip stren�th 0.67 0.54–0.79 0.009 –2.35 –3.99– –0.71 0.006
MVC of the knee extensors 0.58 0.45–0.71 0.226 –4.18 –9.83–1.48 0.146
Repetitive squattin� 0.68 0.55–0.81 0.012 –4.47 –7.72– –1.23 0.008
Ri�ht hand repetitive dumbbell 
presses 0.52 0.37–0.67 0.671 –1.77 –20.12–16.59 0.849
M�S score for upper limbs 0.59 0.46– 0.72 0.159 0.85 0.19–1.52 0.012
M�S score for lower limbs 0.54 0.40–0.67 0.573 0.27 –0.64–1.18 0.555
SLR for ri�ht hamstrin� muscle 0.63 0.51–0.75 0.041 –6.32 –11.31– –1.34 0.013
NOTE: Values in bold are statistically si�nificant (p < 0.05).
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Table 15. Results of anchor-based methods for deterioration using participants’ perceptions as external criterion. 
Reproduced with the kind permission of the American Physical Therapy Association.
Physical functioning measure AUC MIC deterioration
AUC 95% CI p B 95% CI P
Activities and participation (performance)
FSQ Self-care 0.76 0.67–0.85 < 0.001 –8.01 –11.95– –4.06 < 0.001
FSQ Mobility 0.64 0.53–0.74 0.015 –7.17 –13.58– –0.76 0.029
FSQ Domestic life 0.62 0.51–0.72 0.038 –10.51 –17.80– –3.23 0.005
Activities (capacity)
BBT of dominant hand 0.62 0.51–0.72 0.037 –3.48 –6.83– –0.13 0.042
BBS score 0.62 0.51–0.72 0.037 –1.41 –3.00–0.18 0.082
�ela Coordination Test time 0.50 0.37–0.63 0.964 5.00 –5.60–15.60 0.350
�ela Coordination Test faults 0.50 0.36–0.64 0.996 0.73 –0.85–2.31 0.360
Postural stability eyes open 0.47 0.35–0.58 0.558 0.62 –3.52–4.75 0.767
Postural stability eyes closed 0.53 0.42–0.65 0.574 4.83 –4.25–13.91 0.293
10MWT velocity at normal speed 0.69 0.59–0.79 0.001 –0.14 –0.21– –0.07 < 0.001
10MWT velocity at max.speed 0.62 0.52–0.73 0.028 –0.11 –0.20– –0.01 0.026
6MWT distance 0.76 0.67–0.85 < 0.001 –53.35 –77.97– –28.72 < 0.001
Body Functions
6MWT HRmax at end 0.58 0.47–0.70 0.158 –4.45 –9.66–0.77 0.094
    6MWT HR chan�e (beats/min) 0.60 0.49–0.72 0.072 –5.21 –10.23– –0.20 0.042
6MWT PCI 0.52 0.41–0.64 0.690 0.004 –0.06–0.06 0.896
6MWT RPE 0.51 0.40–0.62 0.845 0.50 –0.22–1.23 0.172
10MWT stride len�th 0.66 0.56–0.76 0.005 –6.49 –11.68– –1.30 0.015
10MWT cadence 0.69 0.60–0.79 0.001 –6.94 –10.12– –3.77 < 0.001
10MWT walk ratio 0.46 0.35–0.57 0.460 0.00 –0.00–0.00 0.916
Ri�ht hand �rip stren�th 0.56 0.45–0.67 0.322 –0.43 –2.08–1.21 0.603
MVC of the knee extensors 0.58 0.47–0.69 0.173 –3.70 –9.28–1.88 0.191
Repetitive squattin� 0.62 0.51–0.74 0.046 –0.64 –4.16–2.89 0.719
Ri�ht hand repetitive dumbbell 
presses 0.55 0.44–0.67 0.370 –15.35 –33.09–2.38 0.089
M�S score for upper limbs 0.53 0.42–0.64 0.649 0.21 –0.47–0.89 0.540
M�S score for lower limbs 0.53 0.42–0.64 0.625 0.47 –0.43–1.38 0.301
SLR for ri�ht hamstrin� muscle 
flexibility 0.57 0.46–0.68 0.205 –4.44 –9.43–0.55 0.080
NOTE: Values in bold are statistically si�nificant (p < 0.05).
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6 DISCUSSION
6.1 Performance in self-care, mobility and domestic life of PwMS in the Central Finland 
region (I)
Although the epidemiology of MS is well known, relatively little information exists on 
the extent and nature of functional limitations in this population, despite its obvious 
importance for health and social service planning (McDonnell and Hawkins 2001), 
and for counselling newly diagnosed PwMS and interpreting clinical trials (Myhr et 
al. 2001). The degree of functional limitation caused by MS have been estimated in 
some population-based studies (Rodriguez et al. 1994; Midgard et al. 1996; Pina et 
al. 1998; McDonnell and Hawkins 2001; Modrego et al. 2001). So far no such studies 
have been performed in Finland.
In this population-based survey, a postal questionnaire focusing on the ICF domains 
of self-care, mobility and domestic life were used to identify the level of physical func-
tioning of PwMS in the Central Finland region. The aim was to describe what PwMS 
do in their current environment, i.e., to describe their performance. The number of 
PwMS (n = 240) in this study indicated it one of the largest population-based assess-
ments of MS-related physical functioning in the literature. The rationale for studying a 
population-based sample was to gain as representative a picture as possible, free from 
the biases inherent in clinical or hospital-based studies. Given that the study covered 
87% of the prevalent population in Central Finland region, this has been achieved. 
Differences between the respondents, nonrespondents and excluded PwMS were found 
only in sex distribution, and thus the present study showed good internal validity. 
This study is limited by its cross-sectional design. Many of the questions raised by the 
study relate to temporality, and a cross-sectional design cannot address this issue.
Self-report measures are comfortable because they are relatively inexpensive to obtain, 
data collection is rapid, and they take into account the influence of both environmental 
and personal factors (Finch et al. 2002). It has to be remembered that the perception of 
difficulty is a personal experience influenced by each individual’s frame of reference. 
The need of some PwMS for help in filling out the questionnaire may have influenced 
the answers in the present study. There is always a risk that questions in surveys are 
misunderstood or interpreted differently by different persons. Cognitive impairments 
(Lynch et al. 2005) and depression (Smith and Young 2000) can also adversely affect 
PwMS’ perception of their disability. However, cognitive impairment in MS has not 
been found to affect the reliability of self-report health measures (Gold et al. 2003). 
The reliability of the version of the questionnaire used in this study is not known, 
and may therefore constitute a possible cause of bias. However, the FSQ scale has 
been found to be internally consistent and valid for PwMS (Murphy et al. 1998) and 
the WIQ has been used in population based surveys to measure community-walk-
ing ability (Regensteiner et al. 1990; McDermott et al. 1998; Chong et al. 2002). The 
findings in the present study show that both the FSQ and WIQ seemed to be suitable 
for use among PwMS.
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The sex ratios, age, disease duration and clinical presentation resemble those of previ-
ous larger population-based studies in Northern Ireland (n = 248) (McDonnell and 
Hawkins 2001) and in the USA (n = 162) (Rodriguez et al. 1994). In the present study 
the proportion of independent PwMS in self-care without any perceived difficulties 
(69%) compares with the results obtained in the USA. In contrast, in Northern Ireland 
only 29% were independent in self-care. The impact of the disease was more apparent 
after 10 years of disease duration from symptom onset in walking capacity without a 
walking aid and performance in domestic life, and after 20 years in self-care. In ac-
cordance with previous studies (Benedikz et al. 2002; Sundstrom et al. 2004; Tremlett 
et al. 2006), the results showed that MS may be a rather more benign disease than has 
previously been recognized. 
The most common symptoms of MS such as visual abnormalities, weakness, spasticity 
and sensory symptoms (Poser et al. 1979; Kraft et al. 1986) appeared in the present 
study. However, fatigue was the most frequent complaint, its impact on the daily 
functioning of PwMS resembling the findings of the earlier studies (Goldman et al. 
2006). In previous studies fatigue has been found to be related to working ability 
(Midgard et al. 1996) and might separately increase the limitations on functioning of 
PwMS (Bergamaschi et al. 1995).
Of the PwMS, 43% of those of working-age were engaged in working life after average 
disease duration of 15.8 years from symptom onset. Nonetheless, the proportion of 
working PwMS is relatively small considering the high level of self-reported activity 
and participation. For example, 82% reported independence in self-care, 53% the 
ability to carry out domestic life independently, and 50% the ability to walk without 
any problems. One fourth of the PwMS were in full- or part-time employment, as 
similarly reported in Northern Ireland (McDonnell and Hawkins 2001); however the 
proportion was low compared to the 53% in a sample studied in the USA (Rodriguez 
et al. 1994). Premature retirement cannot be explained solely by the impact of MS or 
of physical disability factors. There is known to be an interaction between physical/
psychosocial disability and social program factors that contributes to employment 
status (Johnson et al. 2004). 
In line with the previous population-based studies (Rodriguez et al. 1994; Midgard 
et al. 1996; Pina et al. 1998; McDonnell and Hawkins 2001; Modrego et al. 2001) only 
a minority of PwMS in the present study (6%) were institutionalized or in sheltered 
accommodation. However one-third of the PwMS were dependent in self-care and 
domestic life, indicating that they might need some kind of special services provided 
by local authorities for people with disabilities, such as a personal assistant, caregiver’s 
allowance, transportation or home conversion. 
Even in the initial stage of MS, when neurological deficits are relatively minor, PwMS 
were experiencing limitations in physical functioning (de Groot et al. 2005; Martin et 
al. 2006).  This was confirmed by our study. In the present study the majority of PwMS 
classified themselves as independent in self-care and domestic life, but a considerable 
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number of them reported difficulties in various domestic life items (35–62%). The 
corresponding proportion for self-care among the independent PwMS was found to 
be lower (16%). Of those who reported being able to walk without any problems in 
answer to the question on their mobility level, 38% reported slight or considerable 
difficulties in walking without a walking aid over the different WIQ distances. Thus, 
PwMS could manage independently, but they might have to put additional effort into 
managing their physical disability by selection, optimization, or compensation (Baltes 
and Baltes 1990). This group of PwMS might be at high risk for further deteriora-
tion and thus should be a target of preventive health care and rehabilitation services 
aimed at maintaining their independence in self-care, mobility and domestic life for 
as long as possible.
The representativeness of the study sample is also good. It formed 4% of the estimated 
Finnish MS population, and thus can be deemed adequate for the purpose of estimat-
ing national needs for rehabilitation and social services. Overall, 48% of this cohort 
received physiotherapy compared to the 23% in the study by Freeman and Thompson 
(Freeman and Thompson 2000). The present population-based survey showed that 
MS remains a disabling disease with a large proportion of PwMS receiving disability 
pensions, medication and physiotherapy. Our results for 240 PwMS provide informa-
tion that can be used by local and national authorities in planning and co-ordinating 
rehabilitation interventions and social services. Because legislation varies from country 
to country, the results of this study should be viewed accordingly. 
6.2 Methods used in the physical functioning studies (II–IV)
6.2.1 Self-report measures (II–IV)
In the same way that patients’ self reports of symptoms are essential in diagnosing 
chronic diseases, self-report of the symptomatic effects of disability aids our under-
standing of disability, in both the clinical and research purposes (Leveille et al. 2004). 
The self-report measures used in the present study were the FSQ for performance in 
self-care, mobility and domestic life (III, IV), the MFIS for fatigue (II–IV), and the 
CES-D for depressive symptoms (III, IV). The aim of these measures was to describe 
what PwMS do in their current environment, i.e., to describe their performance. 
Consensus between two health professionals was used to decide which ICF category 
should be linked to each item/concept in these questionnaires. 
The importance in rehabilitation of individually identifying restrictions individually 
in different domains has been highlighted in previous studies, showing that PwMS 
can be independent in self-care, while still being limited in instrumental ADL 
(Finlayson et al. 1998; Mansson and Lexell 2004). In the present study, only the 
physical function items of the FSQ were included, and these were reclassified 
to link the results to the ICF categories. Thus, we were able to assess mobility 
performance separately from the self-care and domestic life items; whereas the 
previous P-ADL and I-ADL both included mobility items (Coster et al. 2004). The 
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reclassification of the FSQ items questions according to the ICF needs further 
study. In the present study, the FSQ scores of “usually did with no difficulty” and 
“usually did with some difficulty” assessed performance without assistive devices 
or personal assistance. In clinical practice, the same scores might also be used to 
assess performance with assistive devices, for example “usually did with much 
difficulty, requiring aids”. In this way it is possible to assess whether the use of 
the aids removes the limitations on functioning in specific domains. 
The original language of these questionnaires was English. The back-translation 
method was used in the present study with the FSQ and MFIS. The Finnish CES-D 
has previously been translated and evaluated with adults aged 65+ (Heikkinen et al. 
1997; Lampinen et al. 2000; Heikkinen and Kauppinen 2004; Tiikkainen and Heik-
kinen 2005). The FSQ scale has been found to be internally consistent and valid for 
MS as a quality of life measure (Murphy et al. 1998). The MFIS and CES-D have been 
shown to be reliable and valid among PwMS (Verdier-Taillefer et al. 2001; Kos et al. 
2005), and both have been previously used in several studies among PwMS. The use 
of the total scores of the MFIS and CES-D was found to be limited, because it was 
not possible to link the items of the MFIS and CES-D to single component of the ICF. 
Reliability studies are lacking in the case of the Finnish version of the FSQ and CES-
D for PwMS. Thus, estimates of the SEM are missing and consequently their MDC 
values could not to be calculated. This issue needs to be investigated further. 
The disadvantages of using self-report questionnaires, which include larger amounts 
of missing data, language or reading deficits and the effects of depressive or 
cognitive symptoms (Smith and Young 2000; Lynch et al. 2005) were minimized 
by having the interviewer check the form and clarify any questions. In addition, 
Gold et al. (Gold et al. 2003) did not find cognitive impairment in MS to affect the 
reliability of self-report health measures. 
6.2.2 Clinical measures of physical functioning (II–IV)
In the present study, the PwMS were assessed on several outcome measures in order 
to measure different aspects of physical functioning in body functions and activi-
ties, using the ICF classification as a framework. Instead of developing new outcome 
measures, existing potential, clinically relevant measures were used in the present 
studies (II–IV). In this study, the concept of functioning refers to the ICF limitations 
and restrictions related to a health problem. The relevant ICF domains for ambulatory 
PwMS were identified, clinical physical functioning measures were selected to each 
domain on the basis of a review of the literature, and the outcomes were linked to the 
most precise ICF category. If a measure encompassed different parts, the information 
in each part was linked to the ICF. For example, 6MWT distance was linked to activi-
ties and change in heart rate during the 6MWT to body functions (see Figure 4). 
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On the basis of the literature search conducted, a rather limited documentation on 
the reproducibility of the outcome measures used in RCT studies of PwMS was found. 
The present reliability studies (II) provided estimates of reliability for these selected 
clinical outcome measures for ambulatory PwMS. Because the measures used to 
detect important effects related to physical therapy interventions must be valid (i.e., 
measure what is intended), responsive (i.e., able to detect an important change), and 
interpretable (i.e., the intended audience must understand the magnitude of the effect) 
(McHorney 1999; Guyatt et al. 2002), a 2-year-long prospective longitudinal study 
was conducted in ambulatory PwMS in order to assess the associations between the 
physical functioning factors in the ICF components and self-reported performance in 
mobility, self-care and domestic life (III), and to provide estimates of responsiveness 
for these physical functioning measures (IV). 
Subjects, study design and results of the reliability studies (II)
One focus of the present studies (II) was to assess relative and absolute test-retest reli-
ability and inter-rater reliability (see Appendix 3). Overall the results showed good 
reliability, despite some variation in rater scores in the MAS. Poor relative reliability 
defined as ICC < 0.60 was obtained only for the PCI of the 6MWT in the test-retest 
reliability study. Relatively low ICC values were found only for velocity moments, the 
SLR and the 6MWT in the present study. In general, the absolute reliability values were 
good. A moderate amount of variability was discovered for the Kela Coordination Test, 
velocity moments and muscle endurance tests. The reliability of each outcome meas-
ured was similar to that found in earlier studies with healthy adults or other disease 
groups (see paper II). The reliabilities found among the measures of activities and body 
functions in the ICF seem to be on a similar level. The acceptable test-retest reliability 
and inter-rater reliabilities of these measures found in the present study indicate that 
they are suitable for both research and clinical practice in ambulatory PwMS. 
Theoretically, in addition to the variability attributable to the measure and to the 
subject (found in the test-retest study), rater differences are expected to influence the 
results. Thus, both test-retest reliability and inter-rater reliability are clinically im-
portant, and both of them were studied (II). The results of the present study indicate 
that written standardized instructions and a brief training period were sufficient for 
an inexperienced examiner to reach a level of reliability comparable to that of an 
experienced examiner. In the present study, the PwMS were assumed to be clinically 
stable. Thus much of the variability (CV) found in this study can be attributed to vari-
ation in the performance of PwMS, thus reflecting some of the practical difficulties 
involved in assessing movement disorders in MS.
The sex distribution in the test-retest reliability study does not represent the distribu-
tion of PwMS cohorts in general. Otherwise the participants of the reliability studies 
represent typical PwMS with a wide spectrum both of disease duration (1–24 years) 
and age (24–58 years). In addition, the sample of PwMS was selected so as to include 
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the entire range of EDSS from 0 to 6.5. Thus the samples of reliability studies were 
representative enough to generalize the results of present studies to similar ambula-
tory PwMS populations.
The motivation among the PwMS was high, which might have influenced the results. 
They occasionally gave subjective feedback, such as feeling they would not do well 
that day due to a poor night’s sleep, or because the previous day had been a tiring one. 
These potential errors were uncorrected since they are likely to be present whenever 
the clinical measurement of subjects is attempted. 
The design of the reliability studies were structured to minimize most sources of meas-
urement error arising from the environment (distractions, equipment, positioning of 
subject) or examiner (instructions, visual observation), perhaps even more stringently 
than would be the case in normal clinical practice. In an attempt to control known 
risk of error, standardized instructions were used. According to some authors, time 
of day may influence the values measured, such as hand grip strength (Hamilton et 
al. 1992). This was taken into account in the study. Conducting the measures at the 
same time of the day minimized errors due to intra-subject variability. The choice 
of a 1-week interval between measurements was based on the need to avoid changes 
in the condition of PwMS while allowing a reasonable period of recovery between 
sessions. 
After the test-retest reliability study the assessment model was re-analyzed. Minor 
modifications were made to the measure of MVC of the knee extensors (i.e., meas-
ured bilaterally), the shoulder tug test was excluded from the study for reasons of 
poor agreement, and it was concluded that information about the tightness of the 
hamstring muscles should be gathered when assessing ambulatory PwMS. Thus the 
passive straight leg raise test (SLR) was added to the study. The standardization of the 
protocol and instructions of all the measures were re-evaluated after the test-retest 
reliability study. This may have influenced to the slightly higher ICC values obtained 
for some variables in the inter-rater reliability study.
Feasibility of a set of measures
A clinically useful instrument should be easy for both PwMS and professional to 
understand and should be easy to administer (Thompson 1998; Freeman 1999; Ham-
mond 2000; Finch et al. 2002). The present set of outcome measures, as examined 
during the test-retest reliability study (II), seems to fulfil these requirements. Each 
of the measures used in the study was reasonably short and simple. The whole set 
of measures was relatively long, but it was found to be safe. The measures were well 
tolerated by the PwMS without increased fatigue. Thus, these outcome measures are 
not only reliable, but they are also highly practicable in the clinical setting with am-
bulatory PwMS. In clinical assessments, thorough standardization of the procedure 
to be used is of the utmost importance. 
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6.3 The cross-sectional study in ambulatory PwMS (III)
6.3.1 Study design and subjects
The present study was an exploratory analysis conducted to obtain further insight 
into the discrepancy between performance in self-care, mobility, and domestic life 
and to identify the factors underlying performance. Odds ratios (ORs) were used to 
determine the strength of the independent associations found between the clinically 
measured physical functioning variables and self-reported performance in mobility, 
self-care, and domestic life. Only the results of the univariate model were reported, as 
there was considerable multicolinearity between the factors. The ORs were presented 
using primary sampling units, thus allowing clinically meaningful implications. 
A population-based sample of 120 ambulatory PwMS was studied in this cross-sec-
tional study (III). The disease severity in our sample varied from EDSS sore 0 to score 
6.5, but overall it focused on ambulatory PwMS and thus the participants were only 
mildly disabled. Of the PwMS, 69%, 48% and 32% were fully independent reporting 
no difficulties in self care, in mobility, and in domestic life, respectively. The propor-
tion of dependent participants (5% in self-care, 22% in mobility, and 26% in domestic 
life) is relatively small considering that approximately half of the PwMS had had MS 
symptoms for over 10 years and that the average disease duration from symptom 
onset was 12 years. Thus the proportion of dependent participants could be expected 
to be small compared with the general MS population. In addition, because of the 
small number of dependent participants in self-care we were not able to analyze the 
associations between dependent and independent with perceived difficulties in self-care 
performance. 
6.3.2 Associations between clinical measures of physical functioning and performance in 
self-care, mobility and domestic life
The clinical presentation of MS is highly variable and is characterized by various physi-
cal, emotional, and cognitive changes (LaBan et al. 1998). Previous studies indicate 
that MS causes a range of symptoms, including, but not limited to, muscle weakness, 
autonomic dysfunction, abnormal gait mechanism, and poor balance (LaBan et al. 
1998; Kesselring and Beer 2005). Performance in daily functioning in PwMS has been 
found to be reduced (Gulick 1998; Freeman 2001; Goverover et al. 2005; Einarsson et 
al. 2006) and to have a considerable impact on the social roles of PwMS and on the 
well-being of their families (Hakim et al. 2000). Nevertheless, it has remained unclear 
how the documented symptoms relate to performance in daily functioning, because 
symptoms and performance have often been examined separately. Some MS studies 
have focused on the relation between measures of functional ability and measures of 
global cognitive status (Rao et al. 1991; Kessler et al. 1992; Beatty et al. 1995). However, 
to our knowledge, the specific associations between physical functioning and perform-
ance in self-care, mobility and domestic life studied here has not been reported earlier 
in PwMS. Therefore, greater knowledge of the factors that reliably predict perform-
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ance in PwMS could improve physiotherapy strategies, thereby enhancing the daily 
functioning of PwMS and helping them to maintain their ability to live independently 
in society. The simultaneous assessment of several physical functioning measures 
and self-reported questionnaires enables direct comparison of the associations and 
facilitates interpretation of the results. 
The results of the present study (III) demonstrate some clear associations, which per-
sist after controlling for the effect of age and sex. The Berg Balance Scale (BBS), Box 
and Block Test (BBT) of dominant hand, velocity moment with EO, 10MWT time at 
normal speed, 6MWT distance, and repetitive squatting were the strongest predictors 
of perceived difficulties in self-care, mobility, and domestic life. When the depend-
ent PwMS were compared with those who perceived difficulties, the most significant 
predictors of mobility and domestic life were change in HR during the 6MWT, stride 
length and cadence of the 10MWT, MVC of knee extensors, right hand repetitive 
dumbbell presses, and MAS score for the lower limbs. Further study on the associa-
tions between the components of activities and body functions is needed.
The underlying factors in independent and dependent ambulatory PwMS were inves-
tigated separately from those PwMS who reported being independent with perceived 
difficulties. There was an advantage in using the group with perceived difficulties as the 
comparison group in this study, as minor differences in physical functioning between 
the groups were more readily found. The results showed that the influence of underlying 
factors, that is, the results of the physical functioning measures of activities and body 
functions, was dissimilar in these 3 groups of participants. Significant associations 
with ADL performance were found even when the independent participants were 
compared with those who were independent but reported having perceived difficul-
ties. Thus, the results show the value of the use of physical functioning measures in 
detecting these minor decrements in physical functioning which precede and often 
predict the onset of clinically detectable dependence in performance.
Mobility limitations are thought to be the main factor contributing to physical dis-
ability (Chan and Heck 2000). Declines in functional mobility are associated with loss 
of social connections, reduced participation, and altered abilities to perform self-care, 
productivity, and leisure activities (Finlayson et al. 1998; Hakim et al. 2000; Einars-
son et al. 2006). Thus, it is important to know that the clinical outcome measures of 
changing and maintaining body position (a410–a429) and walking (a450) can predict 
perceived limitations in mobility. As the calculations were made using primary sam-
pling units, the effects of the associations are quite large. For example, 10MWT time 
at normal speed was inversely associated with independence in mobility (OR = 0.50), 
which means that a 1-second faster walking time at normal speed represents a 50% 
likelihood of being fully independent rather than perceiving difficulties in mobility. 
The likelihood of being independent rather than perceiving difficulties in mobility 
increased over 2-fold if the PwMS had a 1-point better score in the BBS (OR = 2.15), 
and a 1-point lower BBS increased the likelihood of being dependent in mobility by 
approximately one third (OR = 0.67). 
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In a previous study by Provinciali et al. (Provinciali et al. 1999), age and disability 
in MS were not related, while other studies (Confavreux et al. 2003; DiLorenzo et al. 
2004) have found a higher prevalence of physical limitations among older than younger 
PwMS. In our study, older age was associated with dependence in mobility (OR = 1.06) 
and, inversely, with independence in domestic life (OR = 0.95), compared to those with 
perceived difficulties. That means that a change in age of a year corresponds to a 5% 
to 6% probability of being dependent in mobility or perceiving difficulties in domestic 
life. Age was the only personal ICF factor which predicted ADL performance in the 
present study. Despite the fact that there were no significant associations between the 
sex of PwMS and ADL performance, we conducted analyses adjusted by sex and age 
because of the considerable sex bias in the study group and because a significant age 
by sex interaction effect has previously been found for ADL (Duran and Fisher 1996; 
Provinciali et al. 1999; Iezzoni 2004). 
As the disease progresses the ability to perform daily functioning is reduced, thus 
leading to dependence (Finlayson et al. 1998; Mansson and Lexell 2004). Earlier studies 
have indicated that MS tends to progress over time, but that the course of the disease 
is unpredictable and individual (Provinciali et al. 1999). This was confirmed by the 
present study; thus whether dependence or perceived difficulties in ADL perform-
ance was not associated with either disease duration since symptom onset or time 
since diagnosis.
The findings of the present study contribute to the importance of targeting in inter-
ventions for fatigue. Half of the PwMS reported significant fatigue; this corresponds 
to the numbers found in previous studies of fatigue prevalence (Kraft et al. 1986), 
although in some studies up to 90% of PwMS have been reported as perceiving fatigue 
(Goldman et al. 2006). One reason for these disparities might be the fact that a clear 
definition of fatigue is lacking as is a generally approved fatigue measurement scale 
(Multiple Sclerosis Council for Clinical Practice Guidelines 1998; Flachenecker et al. 
2002). On the other hand, fatigue showed only minor significant associations with 
physical functioning, these mainly appearing in exercise tolerance functions (heart 
rate, PCI, RPE). Thus, physical functioning measures and the MFIS seem to assess 
different aspects of functioning. The FSQ score “usually did with some subjective 
difficulty” can be viewed as containing an element of fatigue. Although it was not 
possible to link the MFIS to the ICF, in the clinical setting it might be sufficient to 
assess perceived difficulties in ADL performance by the FSQ to identify PwMS who 
perceive fatigue as limiting their functioning.
Overall, 40% of PwMS in the present study had depressive symptoms; this corre-
sponds to the estimates of 275 to 50% found in previous prevalence studies in which 
depression has been estimated in PwMS (Goldman et al. 2006). Mental health is a 
potentially important risk factor for rehabilitation outcome and an independent as-
sociation between depressive symptoms and limitations in activities in PwMS has been 
reported (Gottberg et al. 2007). This association, however, was not clearly found in the 
present study. Depressive symptoms were a determinant of performance in domestic 
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life in independent participants with perceived difficulties. It might be that the ef-
fort required to participate in domestic life has to be increased and that this causes 
depressive symptoms. Depression can also hinder a person’s ability to develop coping 
strategies. Surprisingly, we observed no effect of depressive symptoms on domestic 
life in dependent participants compared with those who were independent with per-
ceived difficulties. In addition, our study did not confirm that good mental health is 
of importance in self-care or mobility in subjects reporting perceived difficulties or 
dependence. The effect of the associations between fatigue and depressive symptoms 
on ADL performance needs further investigation. 
6.4 The 2-year prospective longitudinal study of ambulatory PwMS (IV)
6.4.1 Study design and subjects 
Responsiveness has been defined an instrument’s ability to detect change over time (de 
Groot et al. 2006), but no consensus in the literature exists on the exact definition of 
responsiveness. An integrated system for defining clinically meaningful change that 
combines anchor-based and distribution-based methods, as previously recommended 
(Crosby et al. 2003; Haley and Fragala-Pinkham 2006), was adopted in the present 
study. Anchor-based methods focus on the correspondence between change in the 
outcome measure of interest and change in an external criterion (Haley and Fragala-
Pinkham 2006) whereas distribution-based methods include those based on statistical 
significance, sample variability, and measurement precision (Crosby et al. 2003).
In previous studies with MS, the responsiveness of self-reported questionnaires 
(Hobart et al. 2005; de Groot et al. 2006), measures of health-related quality of life 
(Pfennings et al. 1999), Multiple Sclerosis Functional Composite (MSFC) (Vaney et al. 
2004; de Groot et al. 2006), and five other clinical rating scales used in MS research 
(Sharrack et al. 1999) have been reported. As far as we know, no other findings have 
been published with regard to the responsiveness of the clinical measures of physical 
functioning used in PwMS. This dearth of published data raises question about the 
use of these measures for monitoring clinical recovery of MS or responses to interven-
tions, despite the fact that a large number of different outcome measures have been 
widely used for these purposes. 
One of the main criteria for responsiveness (Lohr 2002) is the evidence of changes in 
the scores of the measure. An important strength of this study is the simultaneous 
assessment of several physical functioning measures. Head-to-head comparisons of 
the responsiveness of the measures used in MS will help to determine their relative 
advantages, thereby enabling an evidence-based choice of measures for research and 
for clinical practice. By using separate measures for different ICF domains, it is pos-
sible to find simple outcomes that have the advantage of being meaningful both for 
the PwMS and the clinician. 
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At baseline, the study comprised 120 PwMS from the population-based database. 
Eleven PwMS (9%) were subsequently lost to follow-up. Participants and drop-outs 
were similar in sex, age, disease duration from symptom onset, baseline disease sever-
ity as assessed by the EDSS, and clinical course of the disease, thus showing the study 
to have good internal validity. 
Longitudinal methods are preferable to cross-sectional methods as the former are 
more directly linked to change (Lohr 2002; Crosby et al. 2003). Thus, three repeated 
measures were conducted. Data using changes in scores at 2 years from baseline 
were analyzed. In future, the use of longitudinal data-analysis techniques might be 
appropriate. Overall, half of the participant did not report any relapse during the 2-
year follow up. About half of the PwMS deteriorated, 31% remained stable and 17% 
improved according to their own perception, as against to clinician’s ratings of 26%, 
67% and 7%. At the time of the measures, the PwMS were without ongoing relapses. 
Further work is needed to determine whether responsiveness is dependent on the 
primary level of disability. In addition, future responsiveness studies should focus on 
more severely disabled (EDSS ≥ 7.0) populations.
6.4.2 Meaningful change in the outcome measures
Among several distribution-based methods, the minimal detectable change (MDC) 
that relies on variation in the SEM (Haley and Fragala-Pinkham 2006) was analyzed. 
Other distribution-based methods evaluate change in relation to sample variation, 
such as baseline variation in sample (effect size) and variation in change scores (stand-
ardized response mean) (Crosby et al. 2003; Haley and Fragala-Pinkham 2006), and 
thus are limited indicators of responsiveness, at least to clinical epidemiological data 
of this kind (Guyatt et al. 2002). 
The MDC values found have facilitated the interpretation of score changes in future 
studies and in clinical practice in ambulatory PwMS. The MDC values can be used by 
clinicians to assist in determining whether a PwMS has experienced a real change. It is 
assumed that a real change takes place when the difference in the scores of an individual 
at two separate points exceeds the MDC. For example, the MDC of 92 meter for the 
6MWT distance means that a change of less than 92 meter cannot (with a confidence 
level of 95%) reliably be interpreted as real change for the individual compared with 
chance fluctuations. However, if the individual’s 6MWT distance changes over ± 92 
meter (i.e., the change noted is likely not due to measurement error), the question 
follows whether the change is clinically meaningful. Anchor-based methods had to 
be used in order the address this issue. 
Reporting the proportion of participants achieving a degree of change that is beyond 
measurement error (MDCproportion) is a more informative method for describing natural 
changes or the effects of interventions than overall mean change. The results showed 
that, in 61% of the parameters, less than 10% of the participants’ scores exceeded the 
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MDC, indicating a stable situation in those activities or body functions. However, ac-
cording to the external criteria, only 31% of the participants remained stable according 
to the participants’ own perceptions compared with the 67% rated as stable by the 
clinician. The MDC seems to be more conservative in detecting change than anchor-
based methods. In the present study, a 95% confidence level was used to calculate 
the MDC and the multiplier of √2 was used to control for the additional uncertainty 
introduced by using different scores from measurements at 2 points in time (Beaton 
et al. 2001; Haley and Fragala-Pinkham 2006). Thus, the precision of the MDC was 
notably high, indicating that only definite changes in scores were registered. If the 
MDC is computed using a 90% confidence level, the resulting MDC values will be 
lower and, therefore, less change will be required for real change.
6.4.3 Relative responsiveness of the physical functioning measures in the sub-sample who 
deteriorated
In the present study both deterioration and improvement were studied, as the course 
of the disease is both unpredictable and individual (Confavreux et al. 2003), and 
previous studies have shown that the responsiveness scores for deterioration and im-
provement are not necessarily equal (Cella et al. 2002; de Groot et al. 2006). Overall, 
51% showed deterioration according to the participant’s own perception (RAND-36 
item) compared to the 26% rated as deteriorated by the clinician (EDSS). Only 19 and 
8 PwMS, according to their own perception and according to the clinician’s rating, 
respectively, showed improvement. The data of those who improved need further 
analysis and thus are not presented here. The separation of those who deteriorated 
and improved would increase the homogeneity of the present data and, compared to 
other traditional methods such as minimally clinically important change (MCID), 
could raise the responsiveness.
The agreement between the participant’s perceptions and the clinician’s ratings in 
classifying the participants as deteriorated, stable or improved was poor. As Crosby 
et al. (2003) have stated, in defining clinically meaningful change, these perspectives 
may not always be in agreement. One reason for the mismatch might be that the 
EDSS mainly explores impairments in the physiological functions of body systems 
(i.e., body functions according to the ICF), whereas the RAND-36 item measures 
participants’ perceptions of changes in their overall health. This was demonstrated 
in the present study, where twice as many significant parameters for deterioration 
were found in body functions according to the EDSS criterion than according to the 
participants’ perceptions. A meaningful change for the clinician may be linked to a 
change in disease prognosis. In the ICF terms (WHO 2001), the RAND-36 item we 
used assesses change in general well-being, including physical, mental, and social 
aspects. In future studies, it might be much more appropriate to ask specifically about 
changes in physical functioning. 
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The present study clearly showed the relative responsiveness of different measures in 
the sub-sample who deteriorated. We used two anchor-based methods, the ROC curve 
and the MIC, to analyze the relative responsiveness of the measures. The minimal 
clinically important difference quantifies the minimal difference that a PwMS or 
clinician considers clinically important and thus indicates a relevant change in the 
functioning of the PwMS. Since there appears to be a lack of consensus on how to 
quantify responsiveness, strict comparison with the literature is difficult. However, the 
results from the present study can be applied as indicators of approximate thresholds 
in the utility of physical functioning measures as outcome measures.
Anchor-based approaches require an external, independent standard or anchor against 
which clinical importance can be assessed. One of the central problems with most 
measures used in physiotherapy practice is the lack of a clear external criterion to help 
with the interpretation of the scores (Haley and Fragala-Pinkham 2006). For instance, 
what does it mean to the PwMS if he or she is able to lift an additional 5 kg in knee 
extension? Since a single gold standard for change is lacking (Crosby et al. 2003), not 
one but two external criteria, self-ratings and a clinician’s rating, each with its own 
advantages and limitations were used.
One of the limitations of an anchor-based method that relies on self-ratings is their 
susceptibility to recall bias (Haley and Fragala-Pinkham 2006). Such a method re-
quires that participants are mentally able to subtract a previous situation from the 
present situation (Stratford et al. 1996). A question drawn from the RAND-36, which 
is widely accepted in MS studies, was used. Although cognitive dysfunction is among 
the main symptoms of MS, the report by Gold et al. (Gold et al. 2003) provides evi-
dence that cognitive impairment in MS does not affect the reliability and validity of 
self-report health measures. An interval of one year between the successive sets of 
testing was used in order to minimize this bias and the ratings were combined in the 
2-year follow-up. 
The EDSS (Kurtzke 1983) is the most frequently used scale for rating disability in MS. 
Several limitations of the EDSS have been reported, including low reproducibility in 
the lower ranges of the scale, absence of both high cortical function and arm function 
measurements, and poor sensitivity (Sharrack et al. 1999; Hobart et al. 2000; Winger-
chuk and Weinshenker 2000; Hobart 2003). These might make it relatively unsuitable 
as an external criterion for change. However, despite this criticism, it is a scale that is 
very well known among clinicians, and was used in 14 out of 17 physiotherapy RCTs 
reviewed in the literature search (see Appendix 2). Therefore, we used the EDSS to 
determine important change from a clinician’s point of view. In our study, the same 
neurologist assessed the EDSS scores on every measurement session in order to ensure 
the scale’s reliability. 
In the present study, the emphasis was on finding measures that would enable com-
parison between the deteriorated and stable groups. Finding such measures would 
increase our confidence in the measure, as it would imply that the results obtained 
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would have the same meaning for both the PwMS and the clinician. The selection of 
the most responsive measure was mainly based on relative responsiveness (highest 
AUC values) and whether self-ratings and clinician’s rating were comparable. Because 
of the skewness of the data, the MIC scores for the FSQ, the BBS and the MAS should 
be interpreted with caution. However, the significance of the MICdeterioration  values were 
consistent with the AUC values computed by using a non-parametric method.
We found several measures that had significant AUC and MIC values for deterioration 
from both the participants’ and from clinician’s perspectives. These were self-reported 
performance in ICF activities and participation (FSQ self-care, mobility and domestic 
life scores); in ICF activities such as fine hand use (BBT of the dominant hand) and 
walking (10MWT velocities at normal and maximal speeds and 6MWT distance); 
and in ICF body functions such as exercise tolerance functions (6MWT HR change), 
gait pattern functions (10MWT stride length and cadence), and muscle endurance 
functions of the lower extremities (repetitive squatting). 
Given that mobility is the paramount aim of physiotherapy, it is important to know 
whether the measures of walking are among the most responsive. One possible rea-
son might be that the EDSS heavily emphasizes mobility. However, the participants’ 
perceptions showed a similar level of responsiveness. In addition, there is evidence 
that gait and balance may begin to deteriorate in the early stages of MS, even when 
the neurological signs are mild (Martin et al. 2006). The present study group consisted 
of PwMS with mild disability secondary to MS; nevertheless 27% of the PwMS who 
completed the follow-up study (IV) were not able to manage the Kela Coordination 
Test. Even it was not shown to be responsive to deterioration, it seemed to be the most 
demanding measure and thus further studies are needed to examine its suitability for 
use in determining the early signs of balance problems.
Previous studies of the responsiveness of outcome measures are rare. The responsive-
ness of the 10MWT was examined in the study by de Groot et al. (2006). The compari-
son of their results with the present study is difficult, because they did not mention 
whether the 10MWT was conducted at normal speed or at maximum speed. Depending 
on the external criterion they used, they found in their sample that to exceed meas-
urement error a change of 2.6–3.0 s for the 10MWT was required. Their AUC values 
for the clinician’s and participants’ perspectives [0.69 (95% CI 0.59–0.78); 0.65 (95% 
CI 0.56–0.74), respectively] were comparable to the present results for the 10MWT. 
Contrary to the present study, de Groot et al. found that the MIC for the 10MWT 
did not significantly differ from zero. Both study samples were mildly disabled, but 
the disease duration was much longer in the present study than that of de Groot et al. 
(average time since symptoms = 12.3 years and 2.15 years, respectively). Most of the 
other measures in their study were questionnaires or semistructured interviews, thus 
not allowing comparison with the present study. (de Groot et al. 2006.)
To the best of our knowledge, no other responsiveness values for PwMS have been 
reported for the physical functioning measures used in the present study. However, 
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some studies of other neurological diseases have been presented. In a study of am-
bulatory patients with Parkinson’s disease (Lim et al. 2005), MDC values of 0.19 m/s 
for a comfortable walking speed in the 10MWT, of 13 steps/min for cadence, and of 
2.84 points for the BBS were reported. The MDC values of 0.16 m/s for a comfortable 
walking speed and of 0.18 m/s for maximal walking speed in the 10MWT were found 
in a study of stroke patients (Kwakkel et al. 2002). These responsiveness values were 
in accordance with those found the present study. However, the responsiveness of the 
BBS has been found to be greater when assessed for stroke patients (Stevenson 2001). 
Stevenson found differences in the MDC values depending on the balance ability of 
the subjects: the MDC (with 95% confidence level) was 8.1 points for stroke patients 
who required physical assistance while walking, and 6.1 points for patients who were 
independently ambulant. The effect of disability on the level of responsiveness in 
PwMS needs further research. 
6.5 Physical functioning in regards to the ICF model
6.5.1 Recommendations for assessing ambulatory PwMS
In neurological rehabilitation, there is a need for suitable clinical measures that are 
based on the biopsychosocial model and a life-long approach (Freeman et al. 1996). 
In accordance with the earlier studies (Thompson and Hobart 1998; National Col-
laborating Centre for Chronic Conditions 2004), the literature search found very 
few studies that have evaluated the reproducibility of outcome measures in the as-
sessment of PwMS. The results of the present thesis produced recommendations for 
the assessment of ambulatory PwMS which take account of the reliability, feasibility 
and responsiveness of the measures used and are based on outcomes that genuinely 
represent the phenomena of interest.
Preventive rehabilitation services and early interventions 
Traditionally, physiotherapy interventions have targeted PwMS with definite and more 
severe limitations in physical functioning. The results (I, III) showed that even in the 
early stage of MS, when neurologic deficits were relatively minor and PwMS were 
ambulatory, a major proportion of PwMS were experiencing limitations in physical 
functioning. This indicates that accurate assessment of physical functioning for setting 
realistic rehabilitation goals and for reducing or postponing disability should targeted 
at PwMS who are not yet disabled but are at high risk. Because MS is a progressive 
condition, PwMS need follow-up assessment at regular intervals (Thompson 2001).
On the basis of the results of the present population-based survey (I), assessments 
need to be extended to those whose are independent but perceive difficulties in ADL 
performance. Self-reported difficulties indicates a need for interventions to prevent 
overload, increased dependence and participation restrictions, thereby enabling PwMS 
to enhance their ADL performance and independent living in society. 
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The timing and mode of rehabilitation in PwMS should be set individually, with 
account taken of the degree or extent of disability, and personal and environmental 
factors (Kesselring and Beer 2005). Fatigue and balance problems were found to be 
the most prevalent complaints in independent PwMS (I) and thus interventions in 
the domains should be carried out from the onset of the disease. In turn, those who 
reported restrictions in domestic life had greater variation in symptoms; thus effective 
physiotherapy must address, on the individual level, the full range of impairments in 
body functions, activity limitations and participation restriction. 
Determinants of self-reported performance
In the present research, the ICF was used as a theoretical framework and was found 
to help in the selection of the most appropriate domains to be assessed. Outcomes 
were described both by health-care professionals and patient-oriented, as both per-
spectives offer different yet complementary information. The clinical presentation of 
MS is highly variable and thus, instead of using only a single composite score, several 
different physical functioning measures were used. This constitutes an important 
value of the present thesis. 
Self-reports on self-care, mobility, and domestic life separately were found to be im-
portant in evaluating performance in everyday life (III). From a clinical perspective, 
using the self-report FSQ may facilitate the detection of impaired functioning that 
would otherwise go unrecognized and may help physiotherapists to value patients’ 
priorities, particularly in terms of rehabilitation goals. 
The results of the cross-sectional study (III) revealed the value of the clinical outcome 
measures in detecting minor decrements in physical functioning that precede and 
often predict the onset of clinically detectable dependence in performance. The finding 
that in particular clinical measures in the ICF activities component predicted poor 
outcomes in ADL performance is important for health-care professionals. The present 
recommendations focus on the predictors of perceived difficulties in self-care, mobility 
and domestic life in ambulatory PwMS, as the proportion of dependent participants 
in the present study was small compared with the general MS population. The most 
significant predictors are presented in Figure 12. The selection was based on signifi-
cant ORs adjusted for age and sex; or adjusted for age, sex and fatigue, if significant 
associations were found to change after controlling for the effect of fatigue. The MAS 
scores were excluded as they did not reach an acceptable level of reliability.
All the outcome measures in the present thesis were classified according to the ICF 
level of assessment they include. The ICF seemed to be a useful tool to examine and 
compare the contents of the physical functioning measures used in this study. The 
categories of activities and body functions used in the present study correspond to the 
ICF domains that were aimed by physiotherapy in a neurological community health 
care situation (Finger et al. 2006), with the exception that there is an obvious need to 
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assess respiratory functions in more severely disabled PwMS. These results support 
the view that body functions and activities and their inter-relationship are the main 
areas of competence among physiotherapists (Soukup and Vollestad 2001; Gustavsen 
and Mengshoel 2003; Finger et al. 2006). Future studies are needed to examine the 
associations between the activity and body function domains in order to determine, 
for example, the predictors of walking ability. 
Spasticity is a phenomenon which affects the independent functioning of PwMS 
during the course of their disease. The measure used in the present study, the MAS, 
was known to be subjective and have questionable reliability (Bohannon and Smith 
1987; Nuyens et al. 1994; Blackburn et al. 2002). However, it was chosen because it 
was the most commonly used clinical scale for the measurement of spasticity. The 
present study (II) was unable not adequately to test the reliability of the MAS due to 
the infrequency of the occurrence of grades 3 and 4 (i.e., severe spasticity). Its use 
was found to be limited in the case of high-functioning ambulatory PwMS, and thus 
the MAS was not considered when the predictive measures were chosen. During the 
last few years, many clinical and laboratory-based methods have been developed and 
studied to measure spasticity. e.g., the Anglo-Dutch spasticity measurement tool, the 
Tardieu scale, and the Resistance to Passive movement (Haugh et al. 2006; Platz et 
al. 2007; Voerman et al. 2007). However, further research is needed to find a reliable 
and valid measure to quantify spasticity in PwMS.
The findings of the present studies (I, III) contribute to the importance of targeting 
in interventions for fatigue. The MFIS were found to be a reliable (II) and responsive 
measure of deterioration from the PwMS perspective (IV), but the linking of MFIS 
items to the ICF needs further studies and limits the use of the MFIS. As a clear defini-
tion of fatigue is lacking, as is a generally approved fatigue measurement scale (Multiple 
Sclerosis Council for Clinical Practice Guidelines 1998; Flachenecker et al. 2002), the 
FSQ score “usually did with some subjective difficulty” can be viewed to contain an 
aspect of fatigue and might be sufficient to identify PwMS who have fatigue. 
Restrictions in performance are not necessarily a consequence of activity limitations 
or impairments in body functions only, but may also be an effect of properties of 
the physical environment (WHO 2001; Schneidert et al. 2003; Iezzoni 2004). How-
ever, in the present study, the impact of the environmental factors included in the 
ICF was not evaluated in performance. In clinical practice, it is important to ensure 
that rehabilitation efforts include measures to improve the physical environment of 
PwMS as well as to address personal factors or resources that are important in the 
rehabilitation process. Several self-reported measures of environmental factors have 
been developed, for example the Facilitators And Barriers Survey of environmental 
influences on participation by Gray et al. (2007), which could be a potentially useful 
measure in PwMS.  
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The most responsive physical functioning measures
The results of this thesis include that a minimum set of reliable, responsiveness and 
clinical usefulness outcome measures in ambulatory PwMS should include both 
self-reported performance scales in self-care, mobility and domestic life, and clinical 
outcomes measures. The selection of the most responsive measure was based on rela-
tive responsiveness (AUC and MICdeterioration) from the PwMS perspective. A summary 
of the results obtained for the proposed measures is presented in Figure 13.
It is important to identify early decline, using responsive measures, in order to plan 
delay in progression. Since there appears to be a lack of consensus on how to quantify 
responsiveness, strict comparison with the literature is difficult. The responsiveness of 
clinical measures of physical functioning in ambulatory PwMS has not been reported 
adequately in the literature. Thus, the results of the present study can be applied as 
Figure 13. Summary of the results in the ICF framework concerning the most responsive outcome measures from the 
PwMS perspective; the intra class correlation (ICC) and standard error of measurement (SEM) values for test-retest 
reliability, the minimal detectable change (MDC), and the relative responsiveness (the minimally important change 
[MIC]) in the sub-sample who deteriorated compared to the stable group (MIC
deterioration
 ).
Test-retest ICC = 0.80 (95% CI, 0.62–0.91),
MDC = 21 beats/min
MIC = –5.2 beats/min (95% CI, –10.2–
Test-retest ICC = 0.91 (95% CI, 0.83–0.96),
MDC = 23 cm
MIC = –6.5 cm (95% CI, –11.7–
Test-retest ICC = 0.79 (95% CI, 0.61–0.90), with SEM 5.7 
steps/min
MDC = 16 steps/min 
MIC = –6.9 steps/min (95% CI, –10.1–
Test-retest ICC = 0.91 (95%
MDC = 0.26 m/s
MIC = –0.14 m/s (95% CI, –0.21–
Test-retest ICC = 0.95 (95%
MDC = 0.26 m/s
MIC = –0.11 m/s (95% CI, –0.20–
Test-retest ICC = 0.96 (95% CI, 0.91–0.98), with SEM 30.7 m
MDC = 92 m
MIC = –53.4 m (95% CI, –78.0–
Test-retest ICC = 0.87 (95% CI, 0.72–0.95), with SEM 3.5 n/min 
MDC = 8 number/min 
MIC = –3.5 number/min (95% CI, –6.8–
Test-retest ICC = 0.85 (95% C
MDC = 2 points
MIC = –1.4 points (95% CI, –3.0–0.2) for deterioration
MIC = –10.5 (95% CI, –17.8–
MIC = –7.2 (95% CI, –13.6–
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− –0.1) for deterioration 
BBS score (0– 56 points) (a410–a429)
− I, 0.72–0.94), with SEM 0.8 points 
−
−
10MWT velocity (m/s) at normal speed (a450)
− CI, 0.81–0.96), with SEM 0.1 m/s 
−
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10MWT velocity (m/s) at maximal speed (a450) 
− CI, 0.90–0.98), with SEM 0.1 m/s 
−
− –0.01) for deterioration 
6MWT distance (m) (a450) 
−
−
− –28.7) for deterioration 
6MWT HR change (beats/min) (b455) 
−
 with SEM 9.0 beats/min
−
− –0.2)
Stride length (cm) at normal speed 10MWT (b770)
−
−
− –1.3) for deterioration
Cadence (steps/min) at normal speed 10MWT (b770) 
−
−
− –3.8)
Ambulatory persons with Multiple Sclerosis
FSQ Self-care (0–100) (d510–d560)
MIC = –8.0 (95% CI, –12.0–−   –4.1) for deterioration 
FSQ Mobility (0–100) (d450–d475) 
−  –0.8) for deterioration 
FSQ Domestic life (0–100) (d610–d640)
−  –3.2) for deterioration 
Environmental Factors     Personal Factors 
for deterioration 
for deterioration
with SEM 6.1 cm 
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indicators of the utility of physical functioning measures as outcome measures. Further 
work is needed to determine whether responsiveness is dependent on the primary 
level of disability. 
In addition to the outcome measures presented in Figure 13, the MSFC could be used 
as a measure of disease severity (Kaufman et al. 2000; Vaney et al. 2004; de Groot et 
al. 2006) and health-related quality of life (Pfennings et al. 1999) as a measure of the 
overall effectiveness of rehabilitation from the PwMS perspective. 
Clinical implications 
Outcome measures should have clinical usefulness and relevance, a low responder 
burden and be easy to understand, concise and time-efficient (Thompson 1998; Free-
man 1999; Hammond 2000; Finch et al. 2002; Auger et al. 2006). In the present study 
(II–IV), the measures used were well tolerated by the PwMS and were found to be 
practicable in the clinical setting with ambulatory PwMS. The measures can be used 
in the same measurement session or a physiotherapist can choose the domains and 
outcome measures according to what is considered important for individual PwMS 
or the objectives of physiotherapy. Physiotherapists should understand the rationale 
for each measure and be able to interpret of the results according the ICF concept. 
The ICF-based sheet based might be a useful tool for identifying and documenting 
PwMS complaints and clinical findings (see figure 13, adapted from Cieza and Stucki 
2004). 
The test-retest reliability of the outcome measures used is important, because re-
peated measurement situations are susceptible to several sources of error, including 
the PwMS, tester, and equipment errors (Freeman 1999; Finch et al. 2002). As seen in 
Figure 13, most of the selected outcome measures had high relative reliability (ICC ≥ 
0.80) (II). In the individual assessments, the SEM values (II) expressed in the actual 
units of the measure, represent the absolute reliability, i.e., the SEM values could be 
used to ascertain whether the difference in measurements is real or due to measure-
ment error. In clinical practice, the physiotherapist should be aware of the potential 
errors inherent in their clinical measurements and thorough standardization of the 
procedure is of the utmost important. In order to draw valid conclusions from self-
report questionnaires, the physiotherapist must ensure that the PwMS understand 
the instructions and questions and responded as intended.
It is necessary to understand the clinical importance of the results for responsiveness. 
Changes smaller than the MDC cannot be reliably interpreted as real changes in an 
individual’s score (IV). However, it should be remembered that the precision of the 
MDC used in the present study was very high because of the acceptable 95% confi-
dence level and the multiplier of √2, indicating that only definite changes in scores 
were noted. Thus, the MDC seems to be more strictly in detecting change compared 
to the MICdeterioration. The latter quantifies the minimal difference that PwMS consider 
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clinically important and indicates a relevant change in functioning in the subsample 
that deteriorated. 
The difficulty of using any one scale to cover the range from extremely severe limita-
tions to only minor limitations and a high level of functioning is well known (Schapiro 
2002). The focus of the present study was on ambulatory PwMS. Thus, the outcome 
measures are recommended for use in ambulatory PwMS in the context of the assess-
ment of physical functioning. Further work is needed to determine whether reliability 
and responsiveness is dependent on the primary level of disability. Future prospec-
tive studies with representative population samples are also needed to establish the 
reliability, responsiveness and clinical usefulness of the outcome measures in more 
severely disabled (EDSS ≥ 7.0) PwMS. In the future, by using standardized outcome 
measures the effectiveness of interventions could be studied in more detail. 
6.5.2 Usefulness of the ICF
One of the objectives of the ICF is to provide a scientific basis for understanding and 
studying health and health-related states, outcomes, and determinants. For the ICF 
to be truly useful as a framework for research, it is critical that the classification con-
tains distinct and measurable domains (Jette 2006). Thus, in the present thesis the 
constructs of clinical physical functioning measures and the self-report questionnaires 
were linked to the most precise ICF domain and category. The linking process furthers 
understanding of the relationship between outcome measures and the ICF. The ICF 
can be very helpful in clarifying the information contained in existing measures, 
and objectively describing impairments, limitations in activities and restrictions in 
participation. 
The process of developing systematic approaches to establishing linkages between 
existing measures and the ICF is an important one in the ongoing attempt to create 
an international language and measurement standard. Recently, several rehabilita-
tion outcome studies for this purpose have been published, for example, for stroke 
rehabilitation (Salter et al. 2005a, b and c), for rheumatology and musculoskeletal 
rehabilitation (Stamm et al. 2004), for mental disorders (Brockow et al. 2004), and for 
osteoarthritis, osteoporosis and stroke (Weigl et al. 2003; Borchers et al. 2005; Geyh 
et al. 2007). In the present study, the linking of clinical measures was relatively easy 
to conduct, whereas linking of the existing questionnaires of fatigue (the MFIS) and 
depressive symptoms (the CES-D) to the ICF were not straightforward, as has been 
found in earlier studies (Cieza et al. 2002; Stucki et al. 2003; Jette et al. 2007). The 
item-to-item mapping recommendations published by Cieza et al. (2002 and 2005) 
after the present study was conducted is warmly recommended for use in future 
linking process.
In contrast, it was not possible to link the self-reported performance categories of the 
FSQ clearly either to the activities or the participation component of the ICF. These 
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finding is in line with the latest analyses of Jette et al. concerning patients with post 
acute care (Jette et al. 2007). The WHO has also acknowledged the problem, and four 
alternative options are allowed in the ICF manual (WHO 2001). Thus, in the present 
study the analysis was conducted for both activities and participation by allowing 
total overlap of domains using performance qualifiers (option 4). The categories used 
in the present study to measure self-reported ADL performance resemble those by 
Jette et al. (2003). The aim of the FSQ was to describe what PwMS do in their current 
environment, i.e., to describe their performance (WHO 2001). This is distinct from 
capacity, which indicates the highest probable level of functioning that a person may 
reach in a standardized environment (WHO 2001). This distinction might be one 
reason for the poor associations between self-report questionnaires and ADL measures 
conducted by health-care professionals (Goverover et al. 2005), rather than merely 
inaccurate measurement. 
Some recent studies have attempted to develop new ICF-based measures, such as a 
measure for the impact of the MS (the Multiple Sclerosis Impact Profile [MSIP]) (Wy-
nia et al. 2007), a questionnaire for the assessment of mobility, self-care and domestic 
life (the MOSES questionnaire) (Farin et al. 2007), and a measure for surveying daily 
activities (Activity Measure for post-acute care) (Haley et al. 2004b). The challenge in 
the development of measures is to examine the applicability of the ICF, and work on 
evaluation needs to be done to demonstrate that they actually live up to their potential 
within the rehabilitation environment. 
The use of a core set of standardized outcome measures which cross all domains of the 
ICF could facilitate the comparison of results from different studies and meta-analyses. 
Since functioning is an important outcome for PwMS, an effort to develop the ICF 
core sets for MS was launched in 2007 (Coenen et al. 2007). Some preliminary find-
ings have recently been published (Khan and Pallant 2007a and b). A total of 170 ICF 
categories were identified in the cross-sectional survey of 101 PwMS and the average 
number of perceived problems reported was 18 (Khan and Pallant 2007a). To identify 
the preliminary comprehensive and brief core sets for MS, a Delphi process using the 
ICF was conducted by Khan and Pallant (2007b). Their comprehensive MS ICF core 
set includes 34 (24%) categories from the component body function, 68 (47%) from 
activities and participation and 36 (25%) from the component environmental factors. 
Even the brief set comprises 21% categories (n = 30) of the comprehensive core set. 
As seen from the above, several categories are found, mainly because of the highly 
variable manifestations of MS. Thus, further research is needed.
Because the ICF now contains the neutral terms body functions and structures and 
activities and participation as compared with the prior negative terms impairment, 
disability, and handicap, it very much conforms to the positive view and the resource-
oriented perspective of physical therapists. The use of the ICF framework helps health-
care professionals understand a PwMS individual functioning and disability. The 
ICF is also a language that can be understood by patients. Therefore, the documenta-
tion of intervention categories based on the ICF may enable a focus on the needs of 
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PwMS and improve communication with them. The ICF model is being increasingly 
utilized in clinical practice to structure patient problems and describe rehabilitation 
intervention (Steiner et al. 2002; Cieza and Stucki 2004; Wade 2005; Rimmer 2006). 
The simultaneous application of the ICF and physical functioning measures demon-
strates the usefulness of the ICF in creating a common language for clinical practice, 
teaching, and research, and thus improves the comparability of clinical trials. The 
challenges that surround the measurement of ICF concepts need to be resolved, and 
consequently much more research is needed in this area.
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7 CONCLUSIONS
The main goal of this thesis was to examine the psychometric properties of selected 
physical functioning measures in ambulatory persons with MS (PwMS) and, more 
globally, to illustrate the impact on the interpretation of the results. In this study, we 
were able to examine a representative, population-based sample of ambulatory PwMS 
(EDSS ≤ 6.5). The design of the present study matches the usual care of PwMS, which 
increases the validity of the results. 
The main findings and conclusions of the thesis can be summarized as follows: 
1 The results of the population-based survey revealed that the disability progno-
sis for PwMS may be rather more benign than has previously been recognized. 
However, even in the early stage of MS, when neurologic deficits were relatively 
minor and PwMS were ambulatory, a major proportion of PwMS were experi-
encing limitations in physical functioning. Thus, although PwMS were coping 
independently, for many it was necessary to put additional effort into managing 
in daily life. The proportion of working PwMS was relatively small considering 
their high level in activities and participation.
2 On the basis of the results of the reliability study, the present outcome measures 
can be used with confidence in research and clinical setting, providing there is 
a thorough standardization of the procedure. The measures can be safely used 
in the same measurement session or a physiotherapist can choose from among 
the domains and outcome measures according to what is considered important 
for the individual PwMS or the objectives of physiotherapy. The ICF was found 
to be helpful in clarifying the information contained in the existing measures, 
and in objectively describing the physical functioning of ambulatory PwMS.
3 In the present cross-sectional study the most relevant factors underlying self-re-
ported performance in self-care, mobility and domestic life with respect to activity 
limitations and impairments in body functions in PwMS were identified, and the 
complexity of the interactions between the different ICF categories revealed. The 
individual course of the disease confirmed as dependence or perceived difficul-
ties in ADL performance, was not associated with disease duration. The most 
significant predictors of perceived difficulties or dependence in performance 
included: (1) lower scores in the Box and Block Test; (2) lower Berg Balance Scale 
scores; (3) greater velocity moment when standing with eyes open; (4) slower 10-
meter walk test times and shorter stride length at normal speed; and (5) shorter 
distance in the six-minute walk test.
4 A combination of anchor- and distribution-based approaches we used to deter-
mine the responsiveness of various physical functioning measures in ambulatory 
PwMS during a 2-year follow-up. The measures most responsive to deterioration 
were the FSQ self-care, mobility and domestic life items; distance and change 
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in heart rate during the 6-minute walk test; the 10-meter walk test velocities, 
stride length and cadence, repetitive squatting; and the Box and Block Test of the 
dominant hand. In addition, the minimal detectable changes (MDCs) provide 
an estimate of the magnitude of the change found in clinical epidemiological 
data, thereby helping to interpret the results. 
The ICF was found to be helpful in supplementing the information provided by the 
measures and in describing the physical functioning of ambulatory PwMS. The 
results of the present study have some implications for the future prevention of dis-
ability. The course of the disease was found to be unpredictable and individual since 
dependence or perceived difficulties in performance was not associated with either 
disease duration since symptom onset or time since diagnosis. Instead of continuing 
disability prevention as secondary or tertiary treatment with already disabled PwMS, 
prevention should focus on the early stages of disability. The monitoring of physical 
functioning should be extended to those independent PwMS who report difficulties 
in performance, thereby enabling them to enhance their functioning, performance, 
working ability and independent living in society. By using responsive measures it 
is possible to identify early decline of physical functioning in order to plan delay in 
progression. The study provides recommendations for the use of a core set of outcome 
measures and determines the minimal clinically relevant difference required to detect 
a treatment effect for future trials and for use in clinical settings. 
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8 YHTEENVETO
Tausta ja tavoitteet
Multippeliskleroosi eli keskushermoston pesäkekovettumatauti (MS-tauti) on 
merkittävä toimintarajoitteiden aiheuttaja erityisesti nuorilla ja keski-ikäisillä. Se 
ilmenee tavallisimmin 20–40 vuoden iässä ja on naisilla yli kaksinkertainen mie-
hiin verrattuna. Sairauden esiintyvyyserot maan eri osien välillä ovat hyvin suuret. 
Etelä-Pohjanmaalla tautia esiintyy noin 200:lla 100 000:ta asukasta kohden, kun taas 
Keski-Suomessa 105:llä 100 000:ta asukasta kohden. Kaikkiaan Suomessa arvioitiin 
olevan noin 6 000 MS-tautia sairastavaa henkilöä vuonna 2000.
MS-tauti on pitkäaikaissairaus, jolla on laajoja vaikutuksia yksilön toimintakykyyn, 
hyvinvointiin, koettuun terveyteen ja osallistumiseen eri elämänalueilla. MS-taudin 
kulku on hyvin vaihteleva ja vaikeasti ennakoitavissa. On arvioitu, että noin kol-
masosalla MS-tauti aiheuttaa vaikea-asteisia toiminnan rajoituksia, kun taas noin 
neljäsosalle sairastuneista ei vuosikymmenienkään aikana kehity mitään merkittäviä 
toimintakyvyn rajoitteita. Kelan tilastojen mukaan vuonna 2000 eläkkeellä oli 2 919 
MS-tautia sairastavaa (1,1 % kaikista eläkkeensaajista), Kelan vammais- tai hoito-
tukea sai 2 062, kuntoutuspalveluita 1 769 ja korvauksia lääkekustannuksista 3 006 
MS-tautia sairastavaa. 
Pätevä tieto eri sairausryhmien vaikutuksista toimintakykyyn ja sen muutoksiin 
ovat terveyspolitiikan tärkeä lähtökohta ja arviointiväline (Sosiaali- ja terveysminis-
teriö 2006). Tätä tietoa tarvitaan myös kuntoutuksessa ja muussa kliinisessä työssä 
sekä toiminnanvajavuuksiin liittyviä etuuksia koskevia päätöksiä tehtäessä. Koko-
naisvaltaista kartoitusta MS-tautia sairastavien fyysisestä toimintakyvystä ja siinä 
tapahtuvista muutoksista sekä toimintarajoitteisiin liittyvistä tekijöistä ei Suomessa 
ole aiemmin tehty. 
Fyysistä toimintakykyä voidaan arvioida monenlaisilla menetelmillä, jotka voivat 
perustua henkilön itsearviointiin tai terveydenhuoltoalan ammattilaisen tekemään 
mittaukseen. Mittarin tulee olla validi ja reliaabeli, sopia sille ryhmälle, jota on tarkoi-
tus arvioida, ja lisäksi sen tulee kyetä erittelemään tutkittavaa ilmiötä ja mittaamaan 
muutosta. MS-taudin fysioterapiasta tehdyn kirjallisuuskatsauksen perusteella sekä 
tuki- ja liikuntaelimistöön ja liikkeisiin liittyviin toimintoihin että liikkumiseen 
kohdistuvissa satunnaistetuissa tutkimuksissa (RCT) käytettiin mittareita, joissa vain 
harvoissa reliabiliteetti oli raportoitu MS-tautia sairastavilla. 
Tämän väitöskirjan tavoitteena oli kuvailla MS-tautia sairastavien toimintakykyä ja 
selvittää käytössä olevien fyysistä toimintakykyä arvioivien mittareiden psykomet-
risia ominaisuuksia ja kliinistä käyttökelpoisuutta kävelevillä MS-tautia sairastavilla 
henkilöillä. Toimintakykyä tarkasteltiin kansainvälisen Toimintakyvyn, toiminta-
rajoitteiden ja terveyden kansainvälisen luokituksen (ICF) viitekehyksessä. Väitöskirja 
koostui neljästä osatyöstä, joiden tarkoitus oli 
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−	 kuvata Keski-Suomen alueella asuvien MS-tautia sairastavien toimintakykyä ja 
erityisesti koettua suoritustasoa itsestä huolehtimisessa, liikkumisessa ja koti-
elämässä 
−	 arvioida fyysisen toimintakyvyn mittareiden käyttökelpoisuutta ja reliabiliteettia 
kävelevillä MS-tautia sairastavilla henkilöillä
−	 selvittää koettua suoristustasoa ennustavia tekijöitä kävelevillä MS-tautia sairas-
tavilla henkilöillä tutkimalla kliinisten fyysisten toimintakykymittareiden ja itse 
arvioidun suorituskyvyn välisiä yhteyksiä
−	 analysoida fyysisten toimintakykymittareiden herkkyyttä osoittaa kliinisesti 
merkitsevää muutosta.
Aineisto ja menetelmät
Tämän väestötutkimuksen perusjoukon muodostivat Keski-Suomen alueella vuonna       
2000 asuneet Poserin kriteerein varmaa MS-tautia sairastavat (n = 277). Toiminta-
kyvyn tasoa kartoittava kysely lähetettiin 266 MS-tautia sairastavalle (11 suljettiin 
pois eettisin perustein), joista siihen vastasi 240 (90 %). Heistä naisia oli 75 % (n = 179) 
ja miehiä 25 % (n = 61). Heidän keski-ikänsä oli 48 vuotta (vaihteluväli 20–76 vuotta) 
ja sairauden kesto ensioireesta keskimäärin 16 vuotta (vaihteluväli 0–56 vuotta). Kyse-
lyyn vastanneet, vastaamatta jättäneet ja tutkimuksesta pois suljetut henkilöt eivät 
eronneet toisistaan iältään, sairautensa kululta eivätkä sairautensa kestolta. 
Mittareiden psykometrisia ominaisuuksia ja kliinistä käyttökelpoisuutta käsittele-
vien tutkimusten aineisto koostui itsenäisesti tai apuvälinein kävelevistä MS-tautia 
sairastavista henkilöistä. Valintakriteerinä oli, että neurologin tekemässä sairauden 
vaikeusasteen arvioinnissa EDSS-luokka (Expanded Disability Status Scale) tuli olla 
enintään 6,5. 
Reliabiliteettitutkimukseen osallistuneet valittiin mittauksia edeltäneen kolmen 
kuukauden aikana neurologin vastaanotolla käyneistä kävelevistä MS-tautia sairasta-
vista. Tutkimuksessa mittareiden reliabiliteettia tarkasteltiin mittauksen pysyvyyden 
kannalta sekä eri mittauskertojen välillä (n = 19) että eri testaajien välillä (n = 9). Li-
säksi mittareiden soveltuvuutta MS-tautia sairastaville arvioitiin eri mittauskertojen 
välisen tutkimuksen yhteydessä. Tutkimuksessa käytetyt fyysisen toimintakyvyn 
osa-alueita arvioivat mittarit valittiin jo olemassa olevista menetelmistä niin, että 
kuusi kohdistui ICF-luokituksen suoritukset-osa-alueelle ja seitsemän ruumiin/kehon 
toiminnot -osa-alueelle. Näistä laskettiin useita erilaisia muuttujia, jotka luokiteltiin 
ICF-luokituksen kuvauskohteisiin.
Kahden vuoden seurantatutkimukseen kutsuttiin kyselytutkimuksen perusteella 
kaikki kävelevät MS-tautia sairastavat, joiden diagnoosi oli varmistettu ennen 1.8.2000 
(n = 153). Heistä 10 suljettiin pois muun sairauden takia ja 23 ei halunnut osallistua. 
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Seurantatutkimuksessa käytettiin reliabiliteettitutkimuksessa hyviksi havaittuja fyy-
sisen toimintakyvyn mittareita yhdessä kyselylomakkeiden kanssa, jossa tutkittava 
arvioi mielialaa (CES-D) ja MS-fatiikkia (MFIS) sekä omaa suoritustasoaan itsestä 
huolehtimisessa, liikkumisessa ja kotielämässä (FSQ-kysely). 
Seurantatutkimuksen tutkimusjoukosta (n = 120) 90 oli naisia ja 30 miehiä ja (keski- 
ikä 45 vuotta; vaihteluväli 20–71 vuotta). Sairauden kesto oireiden alusta oli keski-
määrin 12 vuotta (vaihteluväli 1–39 vuotta) ja EDSS-luokka vaihteli nollan ja 6,5:n 
välillä (mediaani 2,0). Ensimmäisen mittauskerran poikkileikkausaineistosta ana-
lysoitiin koettua suoristustasoa ennustavia tekijöitä multinomiaalisen logistisen 
regressionanalyysin avulla laskemalla ikä- ja sukupuolivakioidut ristitulosuhteet 
(odds ratio, OR). 
Kahden vuoden seurantatuloksista analysoitiin fyysisessä toimintakyvyssä tapahtu-
neita muutoksia. Seurantaan osallistuneiden (n = 109) ja tutkimuksen keskeyttäneiden 
(n = 11; 10 keskeytti ja 1 kuoli) välillä ei ollut tilastollisesti merkitseviä eroja suku-
puolessa, iässä, sairauden kestossa, sairauden kulussa eikä alkutilanteen sairauden 
vaikeusasteessa EDSS-luokituksella arvioituna. Kliinisesti merkitsevää muutosta ana-
lysoitiin ROC-käyrän ja pienimmän merkitsevän muutoksen (minimally important 
change, MIC) avulla. Ulkoisina kriteereinä käytettiin sekä tutkittavan omaa arviota 
terveydentilan muutoksesta perustuen RAND-36-elämänlaatukyselyn kysymykseen 
että neurologin tekemää EDSS-luokitusta. Lisäksi tutkimuksessa laskettiin kullekin 
muuttujalle minimimuutos (minimal detectable change, MDC).
Tulokset
Toimintakykyä kartoittavaan kyselytutkimukseen osallistuneista 240:stä MS-tautia 
sairastavasta 16 %:lla ei ollut mitään MS-oireita tutkimushetkellä. Eniten arkielämän 
toiminnanrajoitteisiin liittyivät fatiikki (36 %), tasapainon epävarmuus (29 %) ja kävely-
vaikeudet (28 %). MS-tautia sairastavista 61 % oli koko- tai osa-aikaeläkkeellä ja lähes 
puolet sai Kelan hoito- tai vammaisetuuksia. Fysioterapiaa Kelan kustantamana sai 
62 henkilöä ja terveyskeskuksen toteuttamana 48 henkilöä. Keskimääräinen fysio-
terapiakertojen määrä oli 51 kertaa vuodessa ja enimmillään 120 kertaa vuodessa. 
MS-tautia sairastavista 195 (82 %) koki olevansa itsenäisiä itsestä huolehtimisessa ja 
127 (53 %) kotielämään liittyvissä askareissa sekä 122 (51 %) ilmoitti kykenevänsä 
kävelemään ilman vaikeuksia. Itsenäisestä selviytymisestä huolimatta kuitenkin 
varsin iso osa koki jonkinasteista hankaluutta etenkin raskaimmissa kotipuuhissa. 
Kotielämän askareissa itsenäisesti selviytyvistä noin puolet koki, että selviytymiseen 
liittyi väsymystä tai muuta vaikeutta. Vastanneista 10 % ei kyennyt lainkaan huoleh-
timaan pukeutumisesta, peseytymisestä tai vastaavista toimista ilman apua eikä 20 % 
kotielämään liittyvissä askareista. 38 % käytti säännöllisesti liikkumisen apuvälinettä. 
Keskimääräinen sairauden kesto oireiden alusta pysyvään apuvälineen käyttämiseen 
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oli 13 vuotta (vaihteluväli 1–34 vuotta). MS-taudin vaikutukset olivat yksilölliset ja 
näkyivät selvemmin 20 vuoden jälkeen itsensä hoidossa (pesut, pukeutuminen ym.) 
ja 10 vuoden jälkeen kävelykyvyssä ja kotielämän askareiden hoidossa.
Fyysistä toimintakykyä arvioivien mittareiden reliabiliteetti osoittautui riittäväksi 
usealla eri menetelmällä tarkasteltuna (ICC, SEM, CV, Bland-Altman). Ainoastaan 
spastisuutta ja asentoheijasteita arvioivat mittarit eivät täyttäneet reliabiliteettivaa-
timuksia. Käytetyt mittarit osoittautuivat hyvin soveltuviksi kävelevillä MS-tautia 
sairastavilla. Keskimääräinen aika kaikkien testien tekemiseen, sisältäen myös 
tarvittavat lepotauot, oli 74 minuuttia (vaihteluväli 64–91 minuuttia). MS-taudin 
pahenemisvaiheita ei ilmaantunut eikä kolme mittauskertaa viikon välein lisännyt 
tutkittavien kokemaa MS-fatiikkia. 
Poikkileikkausaineiston kävelevät MS-tautia sairastavat kokivat vaikeutta tai avuntar-
vetta eniten kotielämästä suoriutumisessa ja liikkumisessa. Fyysisen toimintakyvyn 
mittareilla voitiin havaita niitä vähäisiä muutoksia, jotka usein edeltävät ja ennustavat 
koettuun suoritustasoon ilmaantuvia rajoituksia. Erityisesti ICF-luokituksen suori-
tukset-osa-alueen mittarit ennustivat huonoa suoritustasoa. Selkeimmin yhteydessä 
kävelevien MS-tautia sairastavien itsensä hoidossa, liikkumisessa ja kotielämässä 
kokemiin rajoituksiin olivat 1) alhaisemmat pisteet käden toimintoja arvioivassa Box 
and Block -testissä, 2) pienempi pistemäärä Bergin tasapainotestissä, 3) suurempi huo-
junnan nopeus voimalevyanturilla silmät auki seistessä, 4) hitaampi aika 10 metrin 
kävelytestissä sekä omalla että maksiminopeudella tehtynä ja lyhyempi askelparin 
pituus oman nopeuden testissä ja 5) lyhyempi matka 6 minuutin kävelytestissä. 
Kahden vuoden seurannassa 51 % kävelevistä MS-tautia sairastaneista koki terveyden-
tilansa huonontuneen oman arvioinnin perusteella (RAND-36; kysymys 2) verrattuna 
niihin 26 %:iin, joiden sairauden vaikeusaste heikkeni neurologin tekemän arvioinnin 
mukaan (EDSS-luokan muutos ≥ 1). Fyysisen toimintakyvyn heikentymistä herkim-
min arvioivat mittarit olivat 1) omaa koettua selviytymistä itsensä hoidossa, liikku-
misessa ja kotielämässä arvioiva FSQ-kysely, 2) matka ja sykkeen muutos 6 minuutin 
kävelytestissä, 3) 10 metrin kävelytestin nopeus omalla ja maksimivauhdilla sekä 
askelparin pituus ja askeltiheys 4) Invalidisäätiön toistokyykistystesti ja 5) Box and 
Block -testi. Minimimuutos, joka vaaditaan, jotta muutos on suurempi kuin mittarin 
mittavirhe, ilmoitetaan jokaiselle muuttujalle erikseen.
Päätelmät
Tutkimusaineisto on väestöpohjainen kohortti, ja se käsittää 277 MS-tautia sairastavaa 
henkilöä, joista 240 osallistui toimintakykyä kartoittavaan kyselytutkimukseen ja 
heistä 120 kävelevälle MS-tautia sairastavalle on tehty kahden vuoden prospektiivinen 
seuranta. Näin ollen pystyttiin tutkimaan edustava joukko MS-tautia sairastavia, ja 
tämä mahdollisti tulosten yleistettävyyden. 
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Kaikkinensa Keski-Suomen alueella vuonna 2000 asuneiden MS-tautia sairastanei-
den kokema selviytyminen arkielämän toiminnoissa antoi varsin suotuisan kuvan 
toimintakyvystä vastaten uusimpien kansainvälisten tutkimusten tuloksia. Kuitenkin 
sairauden aiheuttamat toiminnanrajoitukset ja vaikutukset osallistumiseen näkyivät 
selkeästi mm. siinä, että varsin iso osa tutkittavista MS-tautia sairastavista oli pois 
työelämästä sekä tarvitsi fysioterapiaa ja erilaisia sosiaali- ja vammaisetuuksia. 
Tässä tutkimuksessa tarkasteltiin jo olemassa olevia fyysisen toimintakyvyn mittareita 
ja todettiin ne käyttökelpoiseksi. Tutkimuksessa käytetty laaja fyysistä toimintakykyä 
arvioiva testipatteristo ei aiheuttanut haittaa MS-tautia sairastaville. Näin ollen niitä 
voidaan turvallisesti käyttää kliinisessä työssä. Arviointitilanne on standardoitava ja 
ohjeita tulee noudattaa, jotta jokainen arviointikerta olisi mahdollisimman saman-
lainen ja tulokset luotettavia. 
Tulosten perusteella voidaan todeta, että MS-taudin kulku on yksilöllinen ja vaihteleva 
eivätkä avuntarve tai koetut vaikeudet arkielämän suoritustasossa olleet yhteydessä 
sairauden kestoon. Koetut vaikeudet, kuten esimerkiksi kotielämään liittyvissä as-
kareissa haittaava väsymys, ovat ennakoiva merkki toimintakyvyn heikkenemisestä 
ja edellyttävät kuntoutusinterventioita lisääntyvien toiminnanrajoitusten vähentä-
miseksi tai lykkäämiseksi. Seurannan ja arvioinnin tulee ulottua myös niihin MS-
tautia sairastaviin, jotka suoriutuvat itsenäisesti mutta kokevat siinä vaikeuksia, eikä 
pelkästään säännöllistä apua tarvitseviin henkilöihin. Tällä tavoin voidaan vaikuttaa 
MS-tautia sairastavien osallistumiseen niin arkielämään kuin työhönkin.
Tutkimuksessa esitetään suositukset reliaabeleista, muutokselle herkistä ja kliinisesti 
käyttökelpoisista mittareista fyysisen toimintakyvyn arviointiin kävelevillä MS-tautia 
sairastavilla ICF-luokituksen viitekehyksessä. Tutkimuksessa käytettyjä mittareita 
voidaan käyttää fysioterapian tavoitteita asetettaessa ja vaikuttavuutta arvioitaessa yhtä 
lailla kuin esimerkiksi lääkehoidon vaikuttavuutta arvioitaessa. Tulokset helpottavat 
käytännön työssä tehtävää arviointia, ts. millaisen muutoksen perusteella voidaan 
tehdä johtopäätös siitä, että muutos on kliinisesti merkitsevä. Herkkiä mittareita 
käyttämällä on mahdollista tunnistaa fyysisen toimintakyvyn heikentyminen jo 
varhaisvaiheessa ja suunnitella kuntoutusta toimintakyvyn ylläpitämiseksi.
ICF-luokituksen mukaan ihmisen toimintakyky koostuu fyysisestä, psyykkisestä 
ja sosiaalisesta ulottuvuudesta, joihin ympäristö- ja yksilötekijät vaikuttavat monin 
tavoin. Tässä tutkimuksessa keskityttiin fyysisen toimintakyvyn ulottuvuuteen. 
ICF-luokitus todettiin hyödylliseksi täydentämään mittareiden antamaa tietoa ja 
kuvaamaan MS-tautia sairastavien fyysistä toimintakykyä. 
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APPENDIX 1
The concepts
The definitions and explanations presented below are taken primarily from official 
publications or scientific papers. Other explanations are proposed in cases where no 
published definitions have been found.
�ctivities and 
Participation (ICF)
� component which covers the complete ran�e of domains denotin� aspects of 
functionin� from both the individual and a societal perspective (WHO 2001).
�ctivities of daily 
livin�
Personal activities and Instrumental activities (those activities that are required 
for community livin�) of daily livin�.
�ctivity (ICF) The execution of a task or action by an individual (WHO 2001). 
�DL performance � person’s involvement in life situations, includin� self-care, mobility and 
domestic life accordin� to the ICF.
�ssessment � process of makin� a rehabilitation dia�nosis throu�h identifyin� and 
sometimes quantifyin� the presence of various abnormalities.
Body Functions (ICF) The physiolo�ical functions of the body system (includin� psycholo�ical 
functions) (WHO 2001).
Body Structures (ICF) �natomical parts of the body such as or�ans and limbs (WHO 2001).
Capacity (ICF) �n individual’s ability to execute a task or an action (i.e., the hi�hest probable 
level of functionin� that a person may reach in a �iven moment in the �ctivities 
and Participation domain). It reflects the environmentally ad�usted ability of the 
individual. (WHO 2001.)
Cate�ories (ICF) Classes and subclasses within a domain of a component, i.e. units of 
classification (WHO 2001).
Clinical measure � clinical quantitative measure that follows a standardized procedure which is 
less open to sub�ective interpretation by potentially biased observers and study 
participants; observations made by, and implications drawn by, professionals. 
In this context, as opposite to self-report measure.
Clinical relevance Usefulness in terms of intervention plannin�, priority settin� and identification 
of client difficulties.
Clinical usefulness � term used when a measure is appraised in a specific clinical context, for a 
specific purpose.
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Components (ICF) The main subdivisions of the parts of the ICF (WHO 2001).
Deterioration Implies �enerally the impairment of value or usefulness. The process or 
condition of becomin� worse. 
Disability (ICF) �ny alteration in functionin� in terms of performance or capacity – impairments, 
activity limitations, and participation restrictions (WHO 2001).
Domain (ICF) � practical, meanin�ful set of related physiolo�ical functions, anatomical 
structures, actions, tasks, or areas of life. They make up the different chapters 
and blocks within each ICF component. (WHO 2001.)
Domestic life (ICF) Carryin� out domestic and everyday actions and tasks (WHO 2001).
Effectiveness The extent to which a specific intervention, procedure, re�imen, or service, 
when deployed in the field, does what it is intended to do for a defined 
population (Finch et al. 2002).
Environmental 
Factors (ICF)
Describes the physical, social, and attitudinal contexts in which people live and 
conduct their lives. These factors are external to individuals and can have a 
positive or ne�ative influence on the individual’s performance. (WHO 2001.)
Feasibility The quality of bein� feasible; practicability; capable of used or dealt with 
successfully; suitable.
Functionin� (ICF) �n umbrella term of the ICF for Body functions, body structures, activities and 
participation. It denotes the positive aspects of interaction between an 
individual (with a health condition) and that individual’s contextual factors 
(environment and personal factors). (WHO 2001.)
International 
Classification 
of Functionin�, 
Disability and Health 
(ICF)
� multipurpose classification of health and health-related states developed by 
the World Health Or�anization and desi�ned to provide a unified and standard 
lan�ua�e and framework (WHO 2001).
Interpretation The processes whereby one determines the clinical meanin� or si�nificance of 
data after the relevant statistical analyses have been performed. 
These processes often involve developin� an explanation of the data that are 
bein� evaluated.
Inter-rater reliability The extent to which multiple raters provide a consistent ratin� of a measure.
Len�th of dia�nosis Disease duration since dia�nosis (years).
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Measurement � way of quantifyin� somethin�; 1) the act or process of measurin�, 2) a fi�ure, 
extent, or amount obtained by measurin�.
Mobility (ICF) Includes movin� by chan�in� body position or location or by transferrin� from 
one place to another, by carryin�, movin� or manipulatin� ob�ects, by walkin�, 
runnin� or climbin�, and by usin� various forms of transportation (WHO 2001).
Multiple sclerosis The disease process involves episodes where white matter within the brain or 
spinal cord becomes inflamed and then dama�ed by the person’s own im-
mune system. These inflamed areas become scarred, �ivin� the disease its 
name: multiple areas of hardenin� (sclerosis) within the brain and spinal cord. 
(National Collaboratin� Centre for Chronic Conditions 2004.)
Outcome � characteristic or construct that is expected to chan�e as a result of the 
provision of a strate�y, intervention, or pro�ram. � successful outcome includes 
improved or maintained physical function when possible, slows functional 
decline where the status quo cannot be maintained, and/or is considered 
meanin�ful to the client. (Finch et al. 2002.)
Outcome measure � measurement tool (instrument, questionnaire, ratin� form, etc.) used to 
document chan�e in one or more constructs over time (Finch et al. 2002).
Participation (ICF) Involvement in a life situation (WHO 2001).
Performance (ICF) What individuals do in their current environment, and so brin�s in the aspect 
of a person’s involvement in life situations. Because the current environment 
includes a societal context, performance can also be understood as “involve-
ment in life situation” or “the lived experience” of people in the actual context 
in which they live. (WHO 2001.)
Personal Factors (ICF) The particular back�round of an individual’s live and livin�, and comprise 
features of the individual that are not part of a health condition or health state 
such as a�e, �ender and social back�round (WHO 2001).
Psychometric  
properties
The reliability and validity, includin� responsiveness and sensitivity to chan�e, 
of a measurement tool (Finch et al. 2002).
Relapse The return of symptoms and si�ns of a disease after a period of improvement. 
Reliability Reliability refers to a method of measurement that consistently �ives the same 
results (free from random error).
Reproducibility The ability of a measure to �ive the same results when administered on 
separate occasions.
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Responsiveness The ability of a measure to assess clinically important chan�e over time. 
This term is often used interchan�eably with sensitivity to chan�e. 
(Finch et al. 2002.)
Self-care (ICF) Carin� for oneself, washin� and dryin� oneself, carin� for one’s body and body 
parts, dressin�, eatin�, and lookin� after one’s health (WHO 2001).
Self-report measure Questionnaires or interviews completed by the client or someone actin� on 
behalf of the client (care�iver) (Finch et al. 2002). In this context, as opposite to 
clinical measure. 
Si�ns Observable abnormalities (absence or chan�e), often elicited explicitly; and 
deficits assumed from observations (ob�ective/external).
Standardized  
measure
� published measurement tool, desi�ned for a specified purpose in a �iven 
population, with detailed instructions provided on administration and scorin� 
and the results of reliability and validity testin� published in a peer-reviewed 
�ournal (Finch et al. 2002).
Symptoms Somatic sensation, experienced moods, thou�hts. experienced by the person 
(sub�ective/internal).
Symptom onset The time of the first appearance of neurolo�ical si�ns and symptoms 
attributable to MS.
Test-retest reliability The extent to which a measure, procedure or instrument yields the same result 
in repeated trials. 
Validity The extent to which a measure assesses what it is intended to measure 
(Finch et al. 2002).
Well-bein� (ICF) � concept combinin� an individual’s health, their quality of life, and their 
satisfaction. There is no universally a�reed definition that is useful in the 
context of health care. (WHO 2001.)
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APPENDIX 3
Reliability (II) and distribution-based responsiveness (IV) of physical functioning measures.
One focus of the present reliability studies (II) was to assess relative reliability by 
means of the ICCs. The SEM and CV were used to describe absolute reliability, i.e., 
the degree to which repeated measurements vary for individuals. In addition, the 
data were presented graphically by plotted limits of agreement. Test-retest reliability, 
inter-rater reliability, and distribution-based responsiveness (MDC) for each of the 
outcome measure are presented in Tables (reproduced with the kind permissions of 
John Wiley & Sons Limited and the American Physical Therapy Association). Test-
retest (A) and inter-rater (B) reliability plots using the Bland-Altman plot, that is, 
the differences between scores are plotted against the averaged scores for outcome 
measures, are shown in Figures. Reference lines of the mean difference (solid line) and 
± 2 standard deviations of the mean difference (dashed lines) for each Bland-Altman 
plot are given. 
Measures of Activity (capacity) in ambulatory PwMS (II, IV)
Fine hand use (a440)
Test-retest reliability (II) 
(n = 19)
Inter-rater reliability (II) 
(n = 9)
Responsiveness 
(IV) 
ICC 
(95% CI)
SEM CV ICC 
(95% CI)
SEM CV MDC
(n)
BBT of dominant
hand (number/min)
0.87 
(0.72–0.95)
3.54 4.4 0.93 
(0.73–0.98)
2.43 4.4 8.11
(n = 109)
BBT, Box and Block Test; ICC, intraclass correlation coefficient; SEM, standard error of measurement; CV, coefficient of 
variation; MDC, minimal detectable chan�e.
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Changing and maintaining body position (a410–a429)
Test-retest reliability (II) 
(n = 19)
Inter-rater reliability (II) 
(n = 9)
Responsiveness 
(IV) 
ICC 
(95% CI)
SEM CV ICC 
(95% CI)
SEM CV MDC
(n)
BBS score (0–56) 0.85
(0.72–0.94)
0.83 1.1 0.99
(0.97–1.00)
0.85 1.3 2.33
(n = 109)
�ela Coordination 
Test time (s)
0.74 
(0.53–0.89)
15.69 11.8 0.83 
(0.33–0.97)
14.37 14.3 41.66
(n = 78)
�ela Coordination 
Test faults (number)
0.81 
(0.63–0.92)
3.35 37.1 0.98 
(0.88–0.99)
1.55 20.7 6.79
(n = 78)
Velocity moment 
(mm2/s) eyes open
0.63 
(0.38–0.82)
13.75 36.6 0.77
(0.19–0.95)
12.95 39.2 37.07
(n = 104)
Velocity moment 
(mm2/s) eyes closed
0.68 
(0.45–0.85)
50.46 41.2 0.86 
(0.49–0.97)
47.69 31.7 136.03
(n = 98)
BBS, Ber� Balance Scale, ICC, intraclass correlation coefficient; SEM, standard error of measurement; CV, coefficient of variation; 
MDC, minimal detectable chan�e.
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Walking (a450)
Test-retest reliability (II) 
(n = 19)
Inter-rater reliability (II) 
(n = 9)
Responsiveness 
(IV) 
ICC  
(95% CI)
SEM CV ICC  
(95% CI)
SEM CV MDC 
(n)
10MWT velocity at 
normal speed (m/s)
0.91 
(0.81–0.96)
0.09 5.5 0.93 
(0.72–0.98)
0.10 8.6 0.26
(n = 109)
10MWT velocity at 
max. speed (m/s)
0.95 
(0.90–0.98)
0.11 5.1 0.96 
(0.84–0.99)
0.08 4.4 0.26
(n = 109)
6MWT distance (m) 0.96 
(0.91–0.98)
30.65 3.9 0.93 
(0.74–0.98)
35.85 6.8 92.16
(n = 104)
10MWT, 10-meter walk test; 6MWT, 6-minute walk test; ICC, intraclass correlation coefficient; SEM, standard error of measure-
ment; CV, coefficient of variation; MDC, minimal detectable chan�e.
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Measures of Body Function in ambulatory PwMS (II, IV)
Exercise tolerance functions (b455)
Test-retest reliability (II) 
(n = 19)
Inter-rater reliability (II) 
(n = 9)
Responsiveness 
(IV) 
ICC  
(95% CI)
SEM CV ICC  
(95% CI)
SEM CV MDC 
(n)
6MWT HRmax at 
end (beats/min)
0.82 
(0.66–0.92)
8.82 6.5 0.91 
(0.66–0.98)
6.91 5.2 21.80
(n = 100)
6MWT HR chan�e 
(beats/min)
0.80 
(0.62–0.91)
8.97 17.9 0.90 
(0.61–0.98)
6.29 19.9 21.15
(n = 100)
6MWT PCI (beats/m) 0.59 
(0.33–0.80)
0.13 17.5 0.77 
(0.28–0.94)
0.17 23.6 0.42
(n = 102)
6MWT RPE (6–20) 0.74 
(0.53–0.88)
1.15 4.4 0.73 
(0.14–0.93)
0.68 3.0 2.54
(n = 106)
6MWT, 6-minute walk test; HR, heart rate; PCI, Physiolo�ical Cost Index; RPE, Ratin� of perceived exertion; ICC, intraclass  
correlation coefficient; SEM, standard error of measurement; CV, coefficient of variation; MDC, minimal detectable chan�e.
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Gait pattern functions (b770)
Test-retest reliability (II) 
(n = 19)
Inter-rater reliability (II) 
(n = 9)
Responsiveness 
(IV) 
ICC  
(95% CI)
SEM CV ICC  
(95% CI)
SEM CV MDC 
(n)
10MWT stride len�th
(cm)
0.91 
(0.83–0.96)
6.14 3.7 0.88 
(0.55–0.97)
10.14 7.0 22.56 
(n = 109)
10MWT cadence 
(steps/min)
0.79 
(0.61–0.90)
5.74 3.2 0.89 
(0.60–0.98)
6.00 4.3 16.27
(n = 109)
10MWT walk ratio 
(m/steps per min)
0.92 
(0.84–0.97)
0.001 3.0 0.87 
(0.51–0.97)
0.0005 7.5 0.002
(n = 109)
10MWT, 10-meter walk test; ICC, intraclass correlation coefficient; SEM, standard error of measurement; CV, coefficient of 
variation; MDC, minimal detectable chan�e.
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Muscle power functions (b730)
Test-retest reliability (II) 
(n = 19)
Inter-rater reliability (II) 
(n = 9)
Responsiveness 
(IV) 
ICC  
(95% CI)
SEM CV ICC  
(95% CI)
SEM CV MDC 
(n)
Ri�ht hand �rip 
stren�th (k�)
0.98  
(0.96–0.99)
1.81 4.6 0.98 
(0.90–0.99)
1.42 3.2 4.48
(n = 108)
MVC of the knee 
extensors (k�) a)
0.95 
(0.90–0.98)
3.39 7.8 0.98 
(0.92–1.00)
3.14 5.8 8.70
(n = 102)
MVC, maximal voluntary contraction; ICC, intraclass correlation coefficient; SEM, standard error of measurement;  
CV, coefficient of variation; MDC, minimal detectable chan�e.
a) For ri�ht le� in the test-retest reliability study, and for both le�s for inter-rater reliability and responsiveness studies.
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Muscle endurance functions (b740)
Test-retest reliability (II)  
(n = 19)
Inter-rater reliability (II)  
(n = 9)
Responsiveness 
(IV) 
ICC  
(95% CI)
SEM CV ICC  
(95% CI)
SEM CV MDC 
(n)
Repetitive squattin�  
(times)
0.85 
(0.72–0.93)
10.00 18.3 0.92 
(0.71–0.98)
8.83 20.3 26.10 
(n = 89)
Ri�ht hand repetitive 
dumbbell presses  
(k� x times)
0.95 
(0.89–0.98)
15.48 18.6 0.93 
(0.71–0.98)
10.81 15.1 36.44 
(n = 94)
ICC, intraclass correlation coefficient; SEM, standard error of measurement; CV, coefficient of variation; 
MDC, minimal detectable chan�e. 
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Muscle tone functions (b735)
Test-retest reliability (II) 
(n = 19)
Inter-rater reliability (II) 
(n = 9)
Responsiveness 
(IV) 
ICC  
(95% CI)
SEM CV ICC  
(95% CI)
SEM CV MDC 
(n)
M�S score for upper 
limbs (0–20)
0.85 
(0.72–0.94)
0.49 N� 0.58 
(–0.08–0.89)
0.64 N� 1.57
(n = 109)
M�S score for lower
limbs (0–20)
0.62 
(0.37–0.82)
1.66 N� 0.66 
(0.05–0.91)
1.25 N� 4.03
(n = 108)
M�S, modified �shworth scale; ICC, intraclass correlation coefficient; SEM, standard error of measurement; CV, coefficient 
of variation; MDC, minimal detectable chan�e.
N�, not applicable.
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Sensation of muscle stiffness (b780)
Test-retest reliability (II) 
(n = 19)
Inter-rater reliability (II) 
(n = 9)
Responsiveness 
(IV) 
ICC  
(95% CI)
SEM CV ICC  
(95% CI)
SEM CV MDC 
(n)
Hamstrin� flexibility:
SLR ri�ht (de�ree)
N� N� N� 0.60 
(0.02–0.89)
10.27 11.8 24.72
(n = 109)
SLR, strai�ht le� raise test; ICC, intraclass correlation coefficient; SEM, standard error of measurement; CV, coefficient of 
variation; MDC, minimal detectable chan�e. 
N�, not applicable (not measured in the test-retest reliability study).
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Multiple sclerosis (MS) is an inflammatory autoimmune disorder
of the central nervous system and potentially the most common
cause of neurological disability in young adults. It is important to
identify early decline in physical functioning in persons with MS.
The data obtained from a population-based cohort of persons
with MS (n=277) living in Central Finland in 2000 give a clear
indication of favourable functioning in mobility, self-care and
domestic life. The results revealed the value of clinical outcome
measures in detecting minor decrements in physical functioning
that precede and often predict the onset of detectable dependence
in performance.
This thesis provides recommendations for reliable, responsive
and clinically useful physical functioning measures suitable for
assessing ambulatory persons with MS. By using responsive
measures it is possible to identify early decline and plan interventions
to maintain functioning. The ICF was found to be helpful in
supplementing the information provided by the measures and in
describing the physical functioning.
